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2 
Abstract 
 
New general methodology for the stereoselective synthesis of unnatural  -amino 
acids has been developed.  Early work focussed on investigating methods for the 
generation of chiral allylic alcohols using cross-metathesis of a simple enone with 
various terminal alkenes, followed by an asymmetric ketone reduction. 
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The allylic alcohols were then converted to protected allylic amines  via Overman 
rearrangement  chemistry.    Oxidative  alkene  cleavage  and  hydrolysis  of  these 
intermediates  generated  a  range  of  -amino  acid  targets.    Attempts  were  also 
made  to  apply  the  developed  methodology  to  the  synthesis  of  a  simple  -
disubstituted -amino acid target. 
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The  Overman  rearrangement  was  also  applied  to  the  generation  of  a  late-stage 
intermediate  which  could  be  used  in  the  synthesis  of  (2S,3S)-capreomycidine,  a 
component of a number of peptides which exhibit antibacterial activity. 
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1.0 Introduction 

1.1 -Amino acids 

1.1.1 Properties of -amino acids 
-Amino acids are very important natural products, which constitute the subunits of 
proteins.  Their prevalence in nature means that they have a vast range of potential 
applications across many fields including biology, medicine, and chemistry.
1 
 
-Amino acids exist in either the D or L form, as shown in Figure 1 and all of the 
natural proteinogenic examples are of the L form with the exception of glycine (R = 
H), which does not bear a stereogenic centre. 
 
NH2
HO2C R
H
L-amino acid
NH2
HO2C H
R
D-amino acid 
Figure 1. -Amino acid structures 

,-Disubstituted  -amino  acids  bear an  additional group  on  the  -carbon  atom 
relative to their natural counterparts (Figure 2), and this gives these compounds a 
number of interesting properties.   
 
NH2
HO2C
R2
R1  
Figure 2.  ,-Disubstituted -amino acids 
 
The incorporation of these units into peptides gives rise to a number of unusual 
secondary structures as a result of the additional steric bulk.
2,3  ,-Disubstituted 
-amino  acids  can  therefore  be  used  to  design  and  synthesise  peptides  with 
relatively rigid, well-defined secondary structures which may give rise to improved 
substrate specificity and biological activity.  The lack of an -hydrogen atom also  
 
11 
means that these structures have the potential to act as enzyme inhibitors which 
have the ability to bind to an active site, but not to undergo a number of standard 
enzymatic  reactions.    The  ,-disubstituted  -amino  acid  motif  is  found  in  a 
number of pharmaceutical compounds, such as methyldopa 1 (Figure 3), a known 
anti-hypertensive drug.
4 
 
HO
HO
OH
O
NH2
1  
Figure 3.  Methyldopa 
 
While many methods for the synthesis of -amino acids have been published in the 
literature, with the addition in recent years of methodology for generating  ,-
disubstituted examples, there remains the need for fast and efficient syntheses of 
both classes of compounds which are flexible for the generation of a wide range of 
these  targets  with  varying  side  chains.    In  particular,  routes  which  lead  to  the 
formation of these compounds in a highly enantioselective manner are desirable. 
 
 
1.1.2 Previous syntheses of -amino acids 
The development of methods for the enantioselective synthesis of -amino acids is 
commonplace  in  the  literature  and  often  makes  use  of  the  chiral  pool,  or 
approaches using chiral auxiliaries
5 or chiral catalysis.
6,7  While a detailed review of 
these methods is outwith the scope of this thesis, selected examples of approaches 
to their synthesis are summarised below: 
 
  Asymmetric addition of cyanide to aldehydes (Strecker synthesis) 
In 1850, Strecker first published a method for the synthesis of -amino acids which 
involves the condensation of an aldehyde 2 with ammonia to give a Schiff base, to 
which  cyanide  can  be  added,  yielding  an  -amino  nitrile  intermediate  3.  
Subsequent  hydrolysis  then  yields  the  racemic  -amino  acid  product  4,  as 
summarised in Scheme 1.1.
8  
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R H
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2 3 4  
Scheme 1.1.  Strecker synthesis of -amino acids 
 
More recently, asymmetric variants of the Strecker synthesis have been reported in 
the literature, which make use of both organocatalysts and metal catalysts,
9 and 
the first of these was reported in 1996 by Lipton and co-workers.
10  This method 
makes use of a diketopiperazine organocatalyst 7 in the generation of the -amino 
nitrile  intermediates  6  from  pre-formed  imines  5,  as  shown  in  Scheme  1.2.  
Formation of the  -amino nitriles proved successful in high yield, and with high 
enantiomeric excess values observed in the products with a range of substituted 
aryl groups.  For example, when R = Ph, a 97% product yield with >99% e.e. was 
reported.    This  approach  was  not  applicable,  however,  to  examples  with 
heteroaromatic or aliphatic R groups, where e.e. values were as low as <10%. 
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Scheme 1.2.  Diketopiperazine-catalysed Strecker synthesis 
 
  Catalytic asymmetric hydrogenation of dehydroamino acids 
A particularly efficient method for the stereoselective synthesis of -amino acids is 
the  asymmetric  hydrogenation  of  dehydroamino  acids  using  metal  catalysts, 
typically rhodium(I) or ruthenium(II), complexed with a chiral ligand which can be 
capable of achieving addition of hydrogen across a carbon-carbon double bond in a  
 
13 
highly  enantioselective  manner.  An  early,  well-known  example  of  a  chiral 
phosphane  ligand  used  for  this  reaction  is  DiPAMP  11,  a  dimeric  form  of 
methylphenyl-o-anisylphosphane (PAMP) which was developed by Knowles and co-
workers.
11  The utility of this ligand, complexed to rhodium, is highlighted in its 
application to a key step in an industrial synthesis of L-3,4-dihydroxyphenylalanine 
(L-DOPA)  10,  a  drug  used  in  the  treatment  of  Parkinson’s  disease.  The 
dehydroamino acid intermediate 8 can be hydrogenated enantioselectively in the 
presence  of  [Rh(DiPAMP)(COD)]BF4,  giving  the  protected  L-DOPA  derivative  9  in 
quantitative yield, and with an enantiomeric excess value of 95%.  Completion of 
the  L-DOPA target was then achieved by removal of the protecting groups under 
acidic conditions, as shown in Scheme 1.3.
12 
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Scheme 1.3.  Synthesis of L-DOPA via asymmetric hydrogenation 
 
  Asymmetric carbon-nitrogen bond formation 
It  is  possible  to  incorporate  the  -amino  group  of  -amino  acids  using  either 
nucleophilic  or  electrophilic  nitrogen  sources.    One  such  use  of  an  electrophilic 
reagent was discussed in 2002 by Jørgensen and co-workers, who reported the -
amination of aldehydes 12 with azodicarboxylates 13, allowing eventual access to a 
range of -amino acid products.
13  The presence of L-proline as an organocatalyst 
allowed  these  amination  reactions  to  be  carried  out  with  moderate  levels  of 
enantioselectivity by forming an enamine intermediate with the aldehyde substrate  
 
14 
and  then  directing  the  incoming  nitrogen  atom  of  the  azodicarboxylate  13 
selectively to one face.  The approach is summarised in Scheme 1.4.  
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Scheme 1.4.  L-Proline-catalysed electrophilic amination of aldehydes 
 
Conversion of the -aminated products 14 to protected -amino acids was possible 
using a series of relatively straightforward transformations.  One particular example 
15  discussed  in  the  paper  is  shown  below  in  Scheme  1.5,  and  involved  the 
conversion  of  the  aldehyde  to  the  corresponding  methyl  ester  by  permanganate 
oxidation followed by treatment with (trimethylsilyl)diazomethane.  Trifluoroacetic 
acid was then employed to remove the Boc groups, and reduction and finally Boc 
reprotection gave protected -amino acid 16 with no loss of enantiomeric excess 
established in the amination step (>90% e.e.). 
 
H
O
iPr
N
HN
O
O
tBu
O tBu
O
MeO
O
iPr
H
N O tBu
O
(i) KMnO4
(ii) TMSCHN2
(iii) TFA
(iv) Raney nickel
(v) Boc2O/DMAP 15 16  
Scheme 1.5.  Completion of protected -amino acid 16 
 
  Asymmetric alkylation of glycine derivatives 
In  1981,  Schöllkopf  and  co-workers  published  details  of  a  method  for  the 
enantioselective synthesis of (R)-amino acids using L-valine 17 as a chiral auxiliary.  
L-Valine  was attached to the ethyl  ester of glycine,  and  this  was followed by  a 
cyclisation to generate diketopiperazine 20, and finally O-methylation to give bis-
lactim ether 21, as shown in Scheme 1.6.
5  
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Scheme 1.6.  Synthesis of Schöllkopf bis-lactim ether 21 
 
The bis-lactim ether 21 could then be subjected to diastereoselective alkylation 
with a range of alkyl halides, with the presence of the relatively large isopropyl 
group leading to alkylation taking place preferentially from the opposite face of the 
anion  of  21,  generated  by  deprotonation  with  n-butyllithium  (Scheme  1.7).  
Completion of the -amino acid targets was then achieved by hydrolysis of ether 22 
with dilute acid, which gives initially the methyl ester derivative of the -amino 
acids 23, which could then be converted to the -amino acids by hydrolysis with 
either acid or base. 
 
N
N
OMe
OMe
N
N
OMe
OMe
R   (i) nBuLi
(ii) R X
0.25 M HCl
H2N
OMe
O
R
21 22 23  
Scheme 1.7.  Diastereoselective alkylation of Schöllkopf bis-lactim ether 21 
 
Selected  results  for  the  alkylation  and  hydrolysis  steps  are  highlighted  below  in 
Table 1, with enantiomeric excess values determined for methyl esters 23. 
 
  
 
16 
Alkylating agent  Yield of 22 (%)  Yield of 23 (%)  e.e. of ester 23 (%) 
BrCH2C6H5  81  73  91-95 
Br(CH2)6CH3  62  75  75-80 
BrCH2-3,4-(OCH3)2C6H3  91  78  85 
BrCH2-CH=CH-C6H5  90  89  >95 
Table 1.  Results of alkylation of bis-lactim ether 21 
 
While relatively high yields and levels of enantioselectivity were encountered using 
this approach, the requirement for additional steps to both incorporate and remove 
the chiral auxiliary lead to a less efficient synthetic route than catalytic procedures. 
 
 
1.1.3 Previous syntheses of ,-disubstituted -amino acids 
In recent years, much literature has been published which discusses methods for 
the synthesis of ,-disubstituted -amino acids using a number of approaches for 
the  functionalisation  of  -amino  acid  derivatives.
14  These  include  the 
diastereoselective  alkylation  of  oxazinones  derived  from  asymmetric  Strecker 
reaction products,
15 and the asymmetric alkylation of -amino acid enolates.
16 
 
Another approach which has proven to be applicable to the synthesis of both -
amino  acids  and  ,-disubstituted  -amino  acids  is  the  use  of  Overman 
rearrangement chemistry to generate protected allylic amines, which can be readily 
converted  to  -amino  acid  targets.    The  Overman  rearrangement  is  a  well-
established reaction which has been shown to have wide scope for the generation of 
a large variety of allylic amines and importantly, the stereochemical outcome of 
these reactions can be controlled. 
 
  
1.2 The Overman rearrangement 
 
1.2.1 [3,3]-Sigmatropic rearrangements 
[3,3]-Sigmatropic  rearrangements,  such  as  the  Claisen  rearrangement  shown  in 
Scheme 1.8, are a class of pericyclic reaction in which a sigma bond moves from the  
 
17 
1 position to the relative 3 position at each of its ends.  Rearrangements of this 
type proceed in a concerted manner, via a highly ordered 6-membered transition 
state.
17 
 
O R O R H 1
2
3
1
2
3
1
2
3
1
2
3
24 25  
Scheme 1.8.  [3,3]-Sigmatropic rearrangement 
 
As with all pericyclic reactions, [3,3]-sigmatropic rearrangement reactions obey the 
Woodward-Hoffmann rules,
18 which state that: 
  A ground-state (thermal) pericyclic reaction is symmetry-allowed when the 
total number of (4q+2)s and (4r)a components is odd 
  A pericyclic reaction in the first electronically excited state (photochemical) 
is symmetry-allowed when the total number of (4q+2)s and (4r)a components 
is even 
 
Here,  ‘component’  refers  to  a  bond  or  orbital  which  takes  part  in  a  pericyclic 
reaction.  The letters q and r here are simply integers.  The letter s stands for 
suprafacial, with a suprafacial component forming new bonds on the same face at 
both ends.  The letter a represents antarafacial, and an antarafacial component 
forms new bonds on opposite faces at both ends. 
 
In the case of [3,3]-sigmatropic rearrangements, three components are involved in 
the reaction: two nonconjugated  bonds, and one  bond which joins these.  Each 
of these components contributes two electons, and is assigned according to Figure 
4.
19,20 
 
O R
2
2
2
 
Figure 4.  Assignment of components in [3,3]-sigmatropic rearrangement 
  
 
18 
By  drawing  a  three-dimensional  representation  of  the  orbitals  involved  in  the 
reaction,  it  can  be  determined  if  each  of  these  components  is  a  suprafacial  or 
antarafacial component, as shown in Figure 5. 
 
2a
2a
2s
 
Figure 5.  Orbitals involved in [3,3]-sigmatropic rearrangement 
 
Therefore in the case of [3,3]-sigmatropic rearrangement reactions, there is one 
component  which  satisfies  the  (4q+2)s  formula  (2s),  and  no  components  which 
satisfy (4r)a.  This gives a total of 1,  which is odd, and hence [3,3]-sigmatropic 
rearrangements  in  the  ground  state  are  symmetry-allowed  according  to  the 
Woodward-Hoffmann rules. 
 
 
1.2.2 The Claisen rearrangement 
The  Claisen  rearrangement  was  the  first  example  of  a  [3,3]-sigmatropic 
rearrangement, originally reported in the literature in 1912.
21  Claisen found that 
aromatic allylic ethers 26 were able to rearrange to substituted phenol derivatives 
28 when heated to 200 °C, as shown in Scheme 1.9. 
 
O
200 °C
O
H
OH
tautomerism
85%
26 27 28  
Scheme 1.9.  Aromatic Claisen rearrangement 
 
Following this result, efforts were focussed on developing an aliphatic variant of 
the Claisen rearrangement, involving the [3,3]-sigmatropic rearrangement of allylic 
vinyl ethers 24 to ,-unsaturated carbonyl compounds 25 (Scheme 1.10).
22  The  
 
19 
driving force of this reaction is the formation of a new carbon-oxygen double bond 
at the expense of a weaker carbon-carbon double bond.  
 
O R O R
heat or
metal
catalyst H
24 25  
Scheme 1.10.  Aliphatic Claisen rearrangement 
 
Further variations of the Claisen rearrangement were subsequently developed to 
allow the formation of functional groups other than aldehydes.  These include the 
Johnson-Claisen rearrangement for the generation of esters 30,
23 the Eschenmoser-
Claisen rearrangement of N,O-ketene acetals 31 to amides 32,
24 and the all-carbon 
version  of  the  Claisen  rearrangement,  known  as  the  Cope  rearrangement
25  as 
summarised in Scheme 1.11.   
 
MeO O R MeO O R
Me2N O R Me2N O R
Johnson-Claisen rearrangement
Eschenmoser-Claisen rearrangement
Cope rearrangement
R R
29 30
31 32
33 34
 
Scheme 1.11.  Variations of the Claisen rearrangement 
 
A  further  analogous  reaction  to  the  Claisen  rearrangement  was  reported  in  the 
literature by Mumm and Möller, who first discussed the rearrangement of allylic 
imidates 35, shown in Scheme 1.12.
26 
  
 
20 
NH
O R
HN
O R heat
35 36  
Scheme 1.12.  Rearrangement of allylic imidates 
 
While  this  rearrangement  provides  a  potentially  useful  method  for  accessing 
protected allylic amines from derivatives of more readily available allylic alcohols, 
the  generation  of  the  allylic  imidate  intermediates  and  their  subsequent 
rearrangement are often slow and tend to require high temperatures to proceed.  
As a result of these elevated temperatures, decomposition of the imidates prior to 
rearrangement is a potential issue. 
 
 
1.2.3 History of the Overman rearrangement 
In  1974,  Professor  Larry  Overman  first  reported  a  subtype  of  the  imidate 
rearrangement  which  involved  the  [3,3]-sigmatropic  rearrangement  of  allylic 
trichloroacetimidates 37 to allylic trichloroacetamides 38, as outlined in Scheme 
1.13.
27 
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Scheme 1.13.  [3,3]-Sigmatropic rearrangement of allylic trichloroacetimidates 
 
Now referred  to  as the Overman rearrangement,  these reactions were shown to 
proceed in high yield under either thermal reaction conditions, or using mercury(II) 
catalysis.  Selected results from Overman’s original paper are shown in Scheme 1.14.  
Note  that  the  failure  of  the  mercury(II)-catalysed  rearrangement  of  the  2-
cyclohexen-1-yl acetimidate 43 can be attributed to the preference for nucleophilic 
attack by nitrogen at the C-2 position as opposed to the required C-3 attack. 
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Scheme 1.14.  First reported examples of Overman rearrangement 
 
Following the publication of these results, the Overman rearrangement has proved 
popular as it provides an effective method for the 1,3-transposition of alcohol and 
amine functionality which does not require particularly harsh conditions.  Hydrolysis 
of the trichloroacetamides to corresponding free amines can also be easily achieved, 
and hence the Overman rearrangement has found utility in the synthesis of many 
important classes of molecules, such as amino sugars, nucleotides, N-heterocycles 
and amino acids.
28 
 
Importantly,  generation  of  the  allylic  trichloroacetimidate  substrates  37  for  the 
Overman  rearrangement  is  very  straightforward  from  the  corresponding  allylic 
alcohols  45,  which  are  treated  with  trichloroacetonitrile  in  the  presence  of  a 
catalytic  quantity  of  base
29,30  such  as  sodium  hydride  or  1,8-
diazabicyclo[5.4.0]undec-7-ene, as shown in Scheme 1.15.
31  Generally, the allylic 
trichloroacetimidates  are  used  immediately  after  formation,  with  simple 
purification by filtration through a short plug of silica capable of providing the pure 
allylic trichloroacetimidates required. 
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Scheme 1.15.  Synthesis of allylic trichloroacetimidates 
 
The use of allylic trifluoroacetimidates in Overman rearrangements has also been 
reported and in some cases, an increased reaction rate has been observed for the 
rearrangement  of  these  substrates.    However,  formation  of  the  required  allylic 
trifluoroacetimidate  substrates  is  significantly  more  challenging  than  allylic 
trichloroacetimidates,  often  requiring  the  use  of  the  highly  toxic  gas, 
trifluoroacetonitrile.    Therefore,  allylic  trifluoroacetimidates  have  not  found 
comparably widespread utility as rearrangement substrates.
32,33 
 
 
1.2.4 Thermal Overman rearrangements 
The  reaction  conditions  required  for  a  thermal  Overman  rearrangement  initially 
involved simply dissolving the trichloroacetimidate substrate in an aprotic,  high-
boiling  point  solvent  such  as  toluene  or  xylene,  and  heating  under  reflux  until 
completion.   
 
Allylic  trichloroacetimidates  derived  from  primary,  secondary  and  tertiary-
substituted allylic alcohols have all been shown to be applicable to the Overman 
rearrangement,  and  an  increase  in  reaction  rate  is  observed  with  increasing 
substitution.  Primary substituted systems tend to require temperatures of 140 °C 
and 4–24 hours, while the tertiary variants can rearrange at 80 °C in a few hours.
34 
 
In  1998,  an  important  modification  was  made  to  standard  thermal  Overman 
rearrangement conditions when Isobe and co-workers reported that the addition of 
a small quantity of potassium carbonate to the reaction mixture generally improves 
product yields.
35  The higher yields can be attributed to the neutralisation of acid 
that  may  be  generated  at  the  high  temperatures  encountered  during  thermal  
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rearrangement  conditions,  which in turn  can lead  to  decomposition  of the acid-
sensitive trichloroacetimidate. 
 
One  particular  example  which  highlights  this  improvement  involved  the  thermal 
Overman rearrangement of allylic trichloroacetimidate 46, shown in Scheme 1.16.  
With no potassium carbonate present, this reaction initially proceeded in 74% yield 
over 2 steps from the allylic alcohol, although this drastically lowered by around 
50% upon scale-up.  Addition of potassium carbonate (2 mg/ mL of solvent) led to 
the generation of the trichloroacetamide product 47 in a yield of 90%, which was 
reproducible on scaling the reaction up to using 10 g of the allylic alcohol starting 
material. 
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Scheme 1.16.  Isobe modification of thermal rearrangement conditions 
 
As  previously  mentioned,  the  involvement  of  a  6-membered  transition  state 
dictates  the  stereochemical  outcome  of  Overman  rearrangement  reactions.  
Selectivity exists for the formation of allylic trichloroacetamides with E geometry 
across  the  allylic  double  bond,  as  a  result  of  the  large  trichloromethyl  group 
occupying  an  axial  position  in  the  chair-like  transition  state.    1,3-Diaxial 
interactions are minimised when the hydrogen atom is placed in an axial position, 
with  the  larger  R  group  equatorial,  as  shown  in  Figure  6.
34    Thus,  allylic 
trichloroacetimidates derived from both E- and Z-allylic alcohols show a high level 
of preference for the formation of E-products in the vast majority of cases, with 
the  main  exception  being  tertiary  substituted  alcohols  with  two  similarly-sized 
substitutents on the -carbon.  It is worth noting that the substrates derived from 
allylic  alcohols  with  Z-geometry  require  longer  reaction  times  and  /  or  higher 
reaction temperatures in comparison to the E allylic alcohols.  
 
24 
HN
CCl3
H
R
O HN
CCl3
H
R
O
O
R
HN
CCl3
48 49  
Figure 6.  Preferred Overman rearrangement transition state leading to E-product 
 
One of the most attractive features of using a [3,3]-sigmatropic rearrangement to 
access  protected  allylic  amines  is  that  complete  transfer  of  chirality  between 
stereocentres is observed as a direct result of the well-ordered transition state.  
Therefore, in the case of an enantiomerically enriched sample of a secondary or 
tertiary allylic alcohol, the level of enantiomeric excess will be carried through to 
the  trichloroacetamide  product.    This  was  first  discussed  in  the  literature  by 
Yamamoto  et  al.,  who  converted  allylic  alcohol  50  to  the  corresponding  allylic 
trichloroacetimidate 51 which was subjected to a thermal Overman rearrangement, 
as shown in Scheme 1.17.  Comparison of optical rotation values of rearrangement 
product derivatives and 
1H NMR spectroscopic analysis using chiral shift reagents 
allowed the group to confirm that the allylic alcohol starting material 50 had an 
optical purity of 45±2%, while the rearrangement product 52 was 45.6% optically 
pure.  This result served to show that a complete transfer of chirality is achieved in 
rearrangements of this type, and additionally provided evidence for progress of the 
rearrangement via a chair-like transition state.
36 
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Scheme 1.17.  Chirality transfer in secondary allylic trichloroacetimidates 
 
The  complete  transfer  of  chirality  is  not  limited  to  only  E-allylic 
trichloroacetimidates,  but  is  also  observed  in  the  thermal  rearrangement  of  the 
equivalent compounds with Z-geometry such as 54 as discussed by Bloch and co-
workers in 1999, highlighted in Scheme 1.18.
37  
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Scheme 1.18.  Chirality transfer in rearrangement of Z-allylic trichloroacetimidates 
 
In examples where an additional stereogenic centre is present in the rearrangement 
substrate,  diastereoselectivity  in  formation  of  the  new  C-N  bond  is  possible, 
although this greatly depends on the substituents present.  However, the use of 
metal catalysis in Overman rearrangements can allow much greater control of the 
stereochemical outcome of such reactions. 
 
 
1.2.5 Metal-catalysed Overman rearrangements 
As  previously  discussed,  Overman  published  details  of  the  first  metal-catalysed 
[3,3]-sigmatropic rearrangements of allylic trichloroacetimidates in 1974.
27  Here, 
he showed that the presence of catalytic mercuric trifluoroacetate (Hg(O2CCF3)2) 
allowed  these  reactions  to  successfully  proceed  at  room  temperature  or  below, 
often within minutes owing to a proposed enhancement in rate calculated to be 
over 1 × 10
12 in comparison to the corresponding thermal reactions.
34 
 
Following this observation, the use of alternative metal catalysts was studied, and 
it was subsequently discovered  that palladium(II) catalysis was also applicable.
38  
The  most  commonly  used  palladium(II)  catalysts  in  Overman  rearrangement 
chemistry now are PdCl2(CH3CN)2 and PdCl2(PhCN)2, which are typically present in 
loadings  of  approximately  4  to  8  mol%.    These  catalysts  are  soluble  in  aprotic 
solvents such as tetrahydrofuran and toluene, which are  often used during these 
rearrangements. 
 
In  the  presence  of  a  metal  catalyst,  the  Overman  rearrangement  is  thought  to 
proceed  via  a  cyclisation-induced  mechanism,  as  shown  in  Figure  7.    Here,  the  
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metal centre coordinates to the alkene and promotes cyclisation via nucleophilic 
attack by nitrogen.  Collapse of the 6-membered ring then generates the carbonyl, 
and  movement  of  the  allylic  system  gives  the  desired  allylic  trichloroacetamide 
product.
39  
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Figure 7.  Mechanism of metal-catalysed Overman rearrangement 
 
As  with  the  thermal  Overman  rearrangement,  the  progression  of  the  metal-
catalysed  variant  through  a  6-membered  intermediate  means  that  the 
stereochemical outcome of the reaction is once again controlled. 
 
In  1992,  Metz  and  co-workers  discussed  the  palladium(II)-catalysed  Overman 
rearrangement of a range of secondary allylic trichloroacetimidates, and found that 
as in the case of thermal rearrangements of these compounds, the products were 
formed with complete selectivity for E geometry across the double bond, and with 
complete transfer of chirality between the stereogenic centres (Scheme 1.19).
40  It 
is worth noting that the rearrangement of 56 was also attempted under thermal 
conditions,  and  the  desired  product  was  isolated  in  a  yield  of  61%,  although  a 
reaction time of 8 hours in toluene heating under reflux was required. 
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Scheme 1.19.  Palladium(II)-catalysed rearrangement of secondary allylic trichloroacetimidates 
 
As in the case of thermal rearrangements, metal-catalysed Overman rearrangments 
can  proceed  with  some  degree  of  diastereoselectivity  depending  on  the 
substitutents  present  as  a  result  of  steric  control.    However,  one  of  the  most 
attractive  features  associated  with  the  use  of  metal  catalysts  in  Overman 
rearrangements is their potential to coordinate to not only the alkene,  but also 
certain groups present in the vicinal position, such as protected amines.  This can 
have a marked effect on the diastereoselectivity observed in these reactions.  For 
example, Gonda et al. reported the results of both the thermal and palladium(II)-
catalysed  rearrangement  of  allylic  trichloroacetimidate  60,  as  shown  in  Scheme 
1.20.
41 
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Scheme 1.20.  Diastereoselective Overman rearrangement 
 
These results showed that the presence of a metal catalyst greatly enhanced the 
diastereoselectivity  of  this  rearrangement  reaction,  and  it  was  believed  that  
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coordination  of  the  palladium  centre  was  occurring  to  both  the  alkene  and  the 
protected nitrogen, thus directing the rearrangement via the transition state shown 
in  Figure  8,  resulting  in  the  observed  preference  for  formation  of  the 
diastereoisomer anti-61. 
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Figure 8.  Source of diastereoselectivity in palladium(II)-catalysed rearrangement 
 
 
1.2.6 Enantioselective metal-catalysed Overman rearrangements 
One of the greatest advancements in metal-catalysed Overman rearrangements has 
been the development of chiral palladium(II) catalysts capable of conducting the 
Overman rearrangement of allylic trichloroacetimidates derived from primary allylic 
alcohols  in  an  enantioselective  manner.    This  is  possible  because  direct 
coordination of the palladium centre to the rearrangement substrate occurs during 
the reaction. 
 
In 1997,  Overman and co-workers  discussed  the first application of palladium(II) 
diamine  catalysts  such  as  A  to  the  enantioselective  rearrangement  of  allylic 
imidates, shown in Scheme 1.21.
42  While the rearrangement of N-arylbenzimidate 
62 proceeded in moderate yield and with an encouraging level of enantioselectivity, 
catalyst  A  failed  to  promote  rearrangement  of  the  corresponding  allylic 
trichloroacetimidate in the same manner.  It was believed that this was due to a 
strong  coordination  between  the  trichloroacetimidate’s  nitrogen  atom  and  the 
cationic  palladium  complex  which  led  to  a  competing  elimination  of 
trichloroacetamide. 
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Scheme 1.21.  First enantioselective Overman rearrangement catalyst 
 
Following  this  result,  Donde  and  Overman  studied  the  rearrangement  of  similar 
allylic  N-arylbenzimidates  using  a  selection  of  ferrocenyloxazoline  palladacyclic 
(FOP) catalysts.
43  These rearrangements proved successful, proceeding with much 
improved enantiomeric excess values of up to 96% in the products.  One drawback 
to  this  work  is  that  the  N-arylbenzamide  products  are  not  particularly  useful 
synthetic  intermediates,  as  their  conversion  to  the  corresponding  desired  allylic 
amines is not easily achieved. 
 
A key paper published by Overman and co-workers in 2003 discussed the results of a 
screen of chiral palladium(II) catalysts B–I (Figure 9), including the FOP catalysts B 
and  C  for  the  enantioselective  rearrangement  of  allylic  N-
aryltrifluoroacetimidates.
44 
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Figure 9.  Asymmetric rearrangement catalysts 
 
These catalysts were applied to rearrangement reactions involving a selection of 
substrates with both E and Z geometry in the double bond.  The catalysts were used 
in a loading of 5 mol%, and the trifluoroacetate-bridged examples C, E and G were 
generated by treatment of the corresponding halides (B,D and F) with 4 equivalents 
(relative to the halide-bridged precursors) of AgOCOCF3.  Catalysts H and I were 
activated by TlOTf (4 equivalents) prior to use.  The formation and rearrangement 
of the N-aryltrifluoroacetimidates 65 is outlined in Scheme 1.22.  
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Scheme 1.22.  Formation and rearrangement of allylic N-aryltrifluoroacetimidates  
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Preliminary  results  in  this  study  showed  that  the  coboltocenyl  oxazolidine 
palladacycle  (COP)  complex  E  successfully  catalysed  the  rearrangement  of 
substrates with either E- or Z-geometry in high yield and with the best levels of 
enantioselectivity  in  this  catalyst  screen.    The  FOP  catalyst  C  also  achieved 
promising results with the substrate (when R = 
npropyl), as summarised in Table 2. 
 
Catalyst  Substrate Geometry  Yield (%)  e.e. (%) / configuration 
C  E  88  76/S 
C  Z  21  87/R 
E  E  84  84/S 
E  Z  71  94/R 
G  E  43  86/S 
G  Z  19  88/R 
H  E  49  82/S 
H  Z  15  67/R 
I  E  66  48/S 
I  Z  13  42/R 
Table 2.  Results of catalyst screen 
 
A further study also showed that the chloride-bridged COP catalyst (COP-Cl) D was 
capable of achieving comparable product yields and high enantioselectivity even 
when not activated with AgOCOCF3, as had been used previously with catalysts B, D, 
and F.  This was a particularly positive result, as it improves the efficiency of these 
rearrangement reactions, allowing the direct use of a stable catalyst. 
 
A  final  investigation  in  this  paper  compared  the  use  of  the  unactivated  COP-Cl 
catalyst  D  and  its  activated  trifluoroacetate  derivative  E  with  a  number  of 
rearrangement substrates.  It was found that while product yields and enantiomeric 
excess values were high in each instance with both catalysts, there was a slight 
advantage in applying COP E to the rearrangement of substrates with Z-geometry 
across the double bond and COP-Cl D to examples with E-geometry. 
 
Following these encouraging results, Anderson and Overman showed that the COP-
Cl catalyst D could also be successfully applied to the enantioselective Overman  
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rearrangement of allylic trichloroacetimidates 67 to the synthetically useful allylic 
trichloroacetamides 68, as shown in Scheme 1.23.
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Scheme 1.23.  COP-Cl catalysed rearrangement of allylic trichloroacetimidates 
 
A range of allylic trichloroacetimidate substrates 67 with varying R groups present 
were subjected to Overman rearrangement in the presence of 5 mol% of COP-Cl D.  
Excellent  product  yields  and  enantioselectivity  levels  were  achieved  in  the 
rearrangement  of  allylic  trichloroacetimidates  with  E-geometry,  while  the 
rearrangement  of  Z-allylic  trichloroacetimidates  was  not  favoured.    It  was  also 
found that the optimum reaction temperature for the use of this catalyst was 38 °C, 
which resulted in the highest product yields.  These results are summarised in Table 
3. 
 
R  Geometry  Temperature  Yield (%)  e.e. (%) / configuration 
npropyl  E  r.t.  80  94/S 
npropyl  E  38 °C  99  95/S 
npropyl  Z  38 °C  17  71/R 
cyclohexyl  E  38 °C  82  96/S 
CH2CH2Ph  E  38 °C  93  93/S 
tbutyl  E  38 °C  7  unknown 
(CH2)2COMe  E  38 °C  98  95/S 
(CH2)2COMe  E  r.t.  80  94/S 
(CH2)3NBn(Boc)  E  38 °C  96  95/S 
(CH2)3NBn(Boc)  E  r.t.  87  95/S 
Table 3.  COP-Cl catalysed Overman rearrangement results 
 
These  results  exemplify  the  excellent  utility  of  the  COP-Cl  catalyst  D  in  the 
enantioselective  generation  of  allylic  trichloroacetamides,  which  are  extremely 
useful  synthetic  intermediates  as  they  are  readily  deprotected  to  form  the 
corresponding allylic amines. 
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Following  on  from  the  publication  of  the  results  discussed  above,  the  COP-Cl 
catalysts  D  and  J,  commonly  referred  to  as  (S)-(+)-COP-Cl  and  (R)-(-)COP-Cl 
respectively  (Figure  10)  have  become  popular,  and  hence  are  now  available 
commercially,  in  addition  to  some  similar  derivatives  capable  of  promoting 
Overman rearrangement reactions enantioselectively. 
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Figure 10.  Commercially available asymmetric Overman rearrangement catalysts 
 
 
1.2.7 The Overman rearrangement applied to -amino acid synthesis 
As the Overman rearrangement has proved to be a reliable method of introducing 
amine functionality in a stereoselective manner, it has found utility in the synthesis 
of a range of natural products including -amino acids in literature examples. 
 
Vyas and co-workers reported in 1984 the introduction of the key amine group of 
(±)-acivicin 75 by way of a thermal Overman rearrangement, carried out on the 
trichloroacetimidate derivative of the diol 69.  The presence of the second hydroxyl 
group allows eventual completion of the -amino acid functionality by oxidation to 
a carboxylic acid (Scheme 1.24).
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Scheme 1.24.  Vyas synthesis of (±)-acivicin 
 
In  2002,  Walsh  and  co-workers  applied  the  thermal  Overman  rearrangement 
reaction to the formation of a range of allylic amines, which were then converted 
to protected -amino acid targets by means of an oxidative cleavage of the alkene, 
followed  by  trichloroacetamide  hydrolysis  (Scheme  1.25).
47    The  allylic  alcohol 
substrates for the rearrangement were synthesised via the asymmetric vinylation of 
aldehydes.  The vinylzinc reagents 77 were formed from a range of commercially 
available terminal alkynes 76 and their subsequent addition to benzaldehyde was 
conducted  in  the  presence  of  an  enantiomerically  pure  isoborneol-based  amino 
alcohol  ligand  known  as  (-)-MIB,  which  generated  the  allylic  alcohols  78  with 
enantiomeric excess values ranging from 93% to 97%.  These allylic alcohols were 
then  subjected  to  a  standard  thermal  Overman  rearrangement,  generating  the 
corresponding protected allylic amides 79, which proceeded with conservation of  
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the high enantiomeric excess values in all cases except when R = cyclopropyl, which 
saw a decrease from 95% in the alcohol to 89% in the trichloroacetamide.  Finally, 
oxidative cleavage of the double bond led to the completion of protected -amino 
acids 80 or the corresponding methyl esters 81, as shown in Scheme 1.25. 
 
 
 
Scheme 1.25.  Walsh approach to -amino acids 
 
The rearrangement step applied in this route allowed the generation of a range of 
relatively sterically hindered allylic trichloroacetamides in good to excellent yield, 
generally  requiring  heating  under  reflux  for  just  1–2  hours.    Selected  yields  are 
summarised in Table 4. 
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Trichloroacetamide  Yield (%)  e.e. (%) 
Ph
NH
CCl3
O
 
64  95 (99
a) 
Ph
NH
CCl3
O
 
93  89 
Ph
NH
CCl3
O
 
96  95 (99
a) 
Ph
NH
CCl3
O
 
90  96 (99
a) 
Ph
NH
CCl3
O
 
83  97 (99
a) 
Ph
NH
CCl3
O
Cl 
66  93
a 
                             
a e.e. value after recrystallisation 
Table 4.  Overman rearrangement results 
 
Within  the  Sutherland  research  group,  previous  projects  have  investigated  the 
application  of  metal-catalysed  Overman  rearrangements  to  the  synthesis  of  -
hydroxy--amino acids.
48  The methodology, outlined in Scheme 1.26, involved the 
generation of allylic alcohols by a chiral pool approach, with a Horner-Wadsworth-
Emmons reaction utilised to introduce the required double bond.  The presence of 
the  methoxymethyl  (MOM)-protected  hydroxyl  not  only  provides  the  required 
hydroxyl  group  in  the  -position  of  the  final  amino  acid  products,  but  is  also  
 
37 
capable  of  directing  the  Overman  rearrangement  step  to  proceed  in  a  highly 
diastereoselective manner. 
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Scheme 1.26.  Synthesis of -hydroxy -amino acids 
 
During the Overman rearrangement stage, it was essential to achieve a high level of 
selectivity  for  the  required  diastereoisomer  anti-89.    The  presence  of  the  MOM  
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protected hydroxyl group  on  allylic trichloroacetimidate 88 allowed a substrate-
directed rearrangement to take place, where palladium co-ordinates to the alkene 
and also two oxygen atoms, which directs co-ordination to one face, as shown in 
the transition state in Figure 11, leading to selective formation of the anti-product 
diastereoisomer. 
 
R
O
CCl3
HN
O
R
O
CCl3
HN
OMOM
-Pd(II) Pd(II)
O
O
HN
Cl3C
H
R O
O
[Pd]
88 anti-89  
Figure 11.  Directing effect of MOM group in Overman rearrangement 
 
In the cases where R = CH3, the rearrangement proceeded in 64% yield and with an 
anti : syn ratio of 10 : 1.  However, in examples where steric bulk was greater in 
this position, the slower rate of rearrangement allowed a competing reaction to 
proceed, where palladium(0) catalysed an undesired allylic substitution reaction.  
Helpfully,  the  addition  of  p-benzoquinone,  a  mild  oxidant  which  converts 
palladium(0) to palladium(II) prevented formation of this by-product.  The results of 
the  rearrangement  step,  which  then  proceeded  in  good  yield  and  with  high 
diastereoselectivity, are summarised in Table 5. 
 
R  Additive  Yield (%)  anti : syn 
CH3  none  64  10 : 1 
iBu  p-benzoquinone  73  14 : 1 
PhCH2  p-benzoquinone  70  12 : 1 
PhCH2CH2  p-benzoquinone  69  9 : 1 
Table 5.  Overman rearrangement results 
 
Following the successful rearrangement chemistry, completion of the desired amino 
acid targets was achieved in high yield by oxidation of the alkene and removal of 
the protecting groups (Scheme 1.26). 
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In  1996,  Larchevêque  and  co-workers  reported  the  application  of  the  Overman 
rearrangement to the generation of ,-disubstituted -amino acids and -amino 
aldehydes, synthesised via trisubstituted monoprotected allylic diols 93.
49  Here, 
the required allylic diols are synthesised by treatment of an -hydroxy aldehyde 92 
with a vinylic organometallic reagent.  In order to generate the required amino acid 
enantiomers,  control of the  stereochemistry of the  hydroxyl  group  of the  allylic 
alcohol  was  essential.    Helpfully,  the  addition  of  the  organometallic  reagents 
proceeded not only in good yield, but also with high syn : anti ratios greater than 
92:8  in  all  but  one  instance.  Conversion  of  these  intermediates  to  the 
corresponding  allylic  trichloroacetimidates  94  and  subsequent  Overman 
rearrangement installed the required quaternary substituted carbon centre of the 
allylic amines.  Ozonolysis of the alkene, oxidation of the aldehyde intermediate to 
the  required  carboxylic  acid  and  then  trichloroacetamide  hydrolysis  completed 
formation of the amino acid targets 98, as shown in Scheme 1.27. 
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Scheme 1.27.  Larchevêque approach to ,-disubstituted -amino acids  
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In the development of this methodology, the thermal Overman rearrangement step 
was  conducted  with  a  variety  of  R  groups  present.    The  yields  achieved  for  a 
selection of the allylic trichloroacetamides 95 are summarised in Table 6 below.  In 
each  case,  only  a  single  product  diastereoisomer  was  detected  by 
1H  NMR 
spectroscopic analysis. 
 
R1  R2  R3  Yield (%) 
Ph 
nBu  Me  98 
iPr  Me 
nBu  62 
iPr  Me  Et  60 
iPr  Ph  Me  70 
Table 6.  Results of thermal Overman rearrangement step 
 
It is worth noting that attempts were made to conduct the rearrangement step in 
the  presence  of  mercury(II)  and  palladium(II)  catalysts,  although  the  desired 
products were not isolated and instead, elimination of the trichloroacetamides was 
occurring to generate dienes. 
 
This  route  represents  a  highly  stereoselective  method  for  accessing  ,-
disubstituted -amino acids which relies on the Overman rearrangement proceeding 
with  complete  chirality  transfer  to  give  enantiomerically  pure  -amino  acid 
products. 
 
The Overman rearrangement represents an excellent reaction which provides access 
to a large array of protected allylic amines which have widespread utility in organic 
synthesis.   Importantly, the stereochemical outcome of these reactions is highly 
controlled  and  predictable.    Additionally,  the  substrates  required  are  easily 
generated from allylic alcohols, which are common synthetic intermediates.  The 
conversion of protected allylic amines to -amino acids has proven successful in a 
number of literature examples, as outlined above and hence the investigation of 
methodology for the enantioselective synthesis of allylic alcohols could provide an 
efficient method for the generation of a variety of -amino acid targets. 
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1.3 Proposed Research 
 
The  aim  of  this  research  project  was  to  develop  new  methodology  for  the 
stereoselective synthesis of a range of -amino acids.  The route studied should be 
flexible enough to allow the eventual generation of  both -amino acid and ,-
disubstituted  -amino  acid  targets  with  a  variety  of  side  chains  which  can  be 
accessed in a fast, efficient manner. 
 
The strategy under investigation here can be considered in three distinct stages, 
summarised in Scheme 1.28.  Firstly, a range of di- and tri-substituted chiral allylic 
alcohols 99 would be generated enantioselectively.  These would then be subjected 
to Overman rearrangement chemistry to convert them to allylic trichloroacetamides 
100.  Finally, oxidative cleavage of the allylic double bond and amide hydrolysis 
would complete the formation of the desired -amino acid targets 98. 
 
R1
R2
R3
OH
R1
NH
CCl3
O
R3
R2
NH2
R3
R2
HO
O
(i) Cl3CCN
(ii) [3,3]-
sigmatropic 
rearrangement
(i) NaIO4
RuCl3·xH2O
(ii) acid
or base
99 98 100  
Scheme 1.28.  Proposed synthetic strategy 
 
The  proposed  method  for  the  generation  of  chiral  allylic  alcohols  is  outlined  in 
Scheme 1.29, and relies on chemistry published by Evans and Leffray whereby a 
vinyl sulfone derivative such as 103 is subjected to an asymmetric dihydroxylation.  
This installs the desired configuration at the alcohol’s stereogenic centre and the 
presence  of  the  -hydroxyl  group  promotes  a  spontaneous  1,2-elimination  to 
generate the corresponding aldehyde 104 in situ.  This could then be trapped with 
a  range  of  phosphonium  salts  or  phosphonate  esters  under  Wittig  or  Horner-
Wadsworth-Emmons  (HWE)  olefination  conditions  respectively  to  complete  the 
formation of di- or tri-substituted allylic alcohols.
50 
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Scheme 1.29.  Proposed synthesis of substituted chiral allylic alcohols 
 
In order to transform these allylic alcohols to the corresponding protected allylic 
amines, Overman rearrangement chemistry would be employed.  The alcohols 106 
could  be  easily  converted  to  allylic  trichloroacetimidates  107,  which  are  the 
necessary substrates for the [3,3]-sigmatropic rearrangement, as shown in Scheme 
1.30. 
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Scheme 1.30.  Conversion of allylic alcohols to allylic trichloroacetamides 
 
From these allylic trichloroacetamides 108, the desired -amino acid targets can 
be generated by carrying out a ruthenium-catalysed oxidation of the allylic double 
bond to introduce the required carboxylic acid functionality, followed by hydrolysis  
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of the trichloroacetamide group under acidic or basic conditions as highlighted in 
Scheme 1.28. 
 
In order to develop the methodology proposed, initial studies would focus on the 
generation  of  -amino  acids  before  being  applied  to  the  more  challenging  ,-
disubstituted examples. 
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2.0 Results and Discussion 
 
2.1 Synthesis of -amino acids via organophosphorus olefinations 
 
2.1.1 Synthesis of chiral allylic alcohols via dihydroxylation and olefination 
The  first  step  in  the  proposed  synthesis  of  substituted  chiral  allylic  alcohols 
involved  generation  of  the  vinyl  sulfone  derivative  103  via  a  cross-metathesis 
reaction  between  the  terminal  alkene  4-phenyl-1-butene  101  and  phenyl  vinyl 
sulfone  102  in  the  presence  of  Grubbs  2
nd  generation  catalyst  K  as  outlined  in 
Scheme 2.1. 
 
This reaction was carried out according to a literature procedure published by Grela 
and Bieniek, using a 2:1 ratio of phenyl vinyl sulfone 102 : 4-phenyl-1-butene 101 
in the presence of 5 mol% of catalyst K.
51  Under these conditions, the reaction 
reached  completion  in  6  hours.    However,  repeated  purification  of  the  crude 
reaction product by silica column chromatography failed to adequately separate the 
desired  product  103  from  excess  phenyl  vinyl  sulfone  102.    In  an  attempt  to 
prevent the requirement for separation of these two components, the reaction was 
repeated with 4-phenyl-1-butene in excess (1.5 equivalents).  However, this did not 
reach completion and unreacted phenyl vinyl sulfone remained after 46 h.  Finally, 
the  cross-metathesis  reaction  was  run  using  a  1:1  ratio  of  the  terminal  alkene 
partners and a total catalyst loading of 6 mol%, which on a small scale (0.1 g of 
phenyl  vinyl  sulfone)  led  to  the  successful  formation  and  isolation  of  the  clean 
product 103 in 77% yield.  However, when the same conditions were applied on a 
larger scale (1.4 g of phenyl vinyl sulfone), the reaction required repeated additions 
of  both  4-phenyl-1-butene  and  Grubbs  2
nd  generation  catalyst  K,  despite  which 
traces of phenyl vinyl sulfone still remained after an extended reaction time which 
again could not be removed by column chromatography. 
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Scheme 2.1.  Cross-metathesis of 4-phenyl-1-butene and phenyl vinyl sulfone 
 
Due  to  the  significant  problems  associated  with  the  isolation  of  vinyl  sulfone 
derivative 103, it was decided to substitute 4-phenyl-1-pentene with an alternative 
alkene bearing an inert side chain which would give a product with polarity that 
differs enough from that of phenyl vinyl sulfone, thus allowing separation of the 
two by chromatography.  As the side chain introduced here will be cleaved later in 
the route, a variety of groups could be present in this position with no effect on the 
eventual targets.  Therefore, 4,4-dimethyl-1-pentene 109 was subjected to cross-
metathesis with phenyl vinyl sulfone using the original Grela and Bieniek conditions 
(Scheme 2.2).  As expected, the reaction successfully reached completion and this 
time  the  polarity  of  cross-metathesis  product  110  differed  enough  from  that  of 
phenyl vinyl sulfone 112 to allow successful separation of the two components by 
silica column chromatography, leading to isolation of the desired product  110 in 
67% yield.  As the tert-butyl substituted vinyl sulfone 110 was easily synthesised, 
this was used for a study of the next stage of the proposed route. 
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Scheme 2.2.  Cross-metathesis of 4,4-dimethyl-1-pentene and phenyl vinyl sulfone 
 
Introduction of the required hydroxyl group and allylic double bond was attempted 
using  a  combined  Sharpless  asymmetric  dihydroxylation  and  Horner-Wadsworth-
Emmons olefination approach previously described by Evans and Leffray.
50 
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The  Sharpless  asymmetric  dihydroxylation  was  first  reported  in  1988,  and  fully 
developed  reaction  conditions  were  outlined  by  Sharpless  and  co-workers  in 
1992.
52,53  The reaction achieves the cis-vicinal dihydroxylation of alkenes, capable 
of proceeding with enantiomeric excess values greater than 90% in the product diols.  
Two pre-mixed, commercially available reagent powders known as AD-mix- and 
AD-mix- are most commonly  used.   They both  contain a  chiral ligand  and give 
opposing  stereochemical  outcomes,  which  are  based  on  the  size  of  the  alkene 
substitutents as summarised in Figure 12. 
 
RM
H RL
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RL = large group
OH HO
RL H
RM RS
OH HO
RL H
RM RS
AD-mix-
AD-mix-
 
Figure 12.  Stereochemical outcome of Sharpless asymmetric dihydroxylation 
 
The AD-mixes contain the following components: 
  catalytic potassium osmate (K[OsO2(OH)4]), a non-volatile source of osmium 
tetroxide, the required oxidant 
  stoichiometric potassium ferricyanide (K3Fe(CN)6), used to oxidise the H2OsO4 
by-product back to reactive osmium tetroxide, making the reaction catalytic 
with respect to the expensive, toxic osmium reagent 
  potassium carbonate (K2CO3) which maintains the reaction pH 
  (DHQ)2PHAL (in AD-mix-) or (DHQD)2-PHAL (in AD-mix-), enantiomerically-
pure  cinchona  alkaloid  ligands  which  provide  the  chiral  environment 
necessary for an enantioselective reduction (Figure 13) 
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Figure 13.  Sharpless asymmetric dihydroxylation ligands 
 
In addition to the required AD-mix, the reactions are generally carried out in the 
presence  of  methanesulfonamide,  which  increases  the  rate  of  hydrolysis  of  the 
osmate ester intermediates. 
 
The large cinchona alkaloid ligands such as (DHQ)2-PHAL and (DHQD)2-PHAL provide 
a chiral environment in which the dihydroxylation takes place in U-shaped binding 
pocket.
54  From the results of applying the Sharpless asymmetric dihydroxylation to 
a  wide  range  of  substrates,  a  mnemonic  has  been  developed  which  provides  a 
model of the catalyst active site and can be used to predict the stereochemical 
outcome of a Sharpless dihydroxylation (Figure 14).
53 
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Figure 14.  Mnemonic for prediction of enantioselectivity  
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The vinyl sulfone 110, with RL = sulfone, was treated with AD-mix- to achieve the 
desired  enantioselectivity  and  dihydroxylation  of  the  alkene  should  lead  to  a 
spontaneous  1,2-elimination,  generating  the  -hydroxy  aldehyde  110  in  situ.  
Addition  of  a  solution  of  deprotonated  triethyl  phosphonoacetate  under  Horner-
Wadsworth-Emmons conditions should then give the desired allylic alcohol 112 in a 
single  step,  as  shown  in  Scheme  2.3.    Unfortunately  when  this  reaction  was 
attempted  under  the  Evans  and  Leffray  conditions,  none  of  the  desired  allylic 
alcohol product 112 was detected after the olefination step.  In fact, only the vinyl 
sulfone starting material 110 was found to be present in the crude reaction product, 
indicating that the reaction had failed at the dihydroxylation stage.  
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Scheme 2.3.  Dihydroxylation/ Horner-Wadsworth-Emmons olefination 
 
It was thought that the failure of this reaction could be attributed to the presence 
of  the  bulky  tert-butyl  group preventing  access  of  the  substrate  to the catalyst 
active site.  To assess this hypothesis, the same reaction was carried out on phenyl-
substituted  vinyl  sulfone  103,  as  shown  in  Scheme  2.4.    Using  the  phenyl-
substituted substrate  103, the reaction proved successful and the desired allylic 
alcohol product 113 was isolated in 24% yield. 
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Scheme 2.4.  Dihydroxylation/ Horner-Wadsworth-Emmons olefination 
 
Due  to  the  problems  associated  with  the  purification  of  the  vinyl  sulfone 
intermediate 103 and the low yield of the subsequent dihydroxylation/olefination 
reaction, it was decided that an alternative synthesis of allylic alcohols should be 
investigated. 
 
 
2.1.2 Synthesis of chiral allylic alcohols via chiral pool approach 
The alternative approach to allylic alcohols adopted is shown in Scheme 2.5, and 
relies on a combined Swern oxidation and Horner-Wadsworth-Emmons olefination to 
install the allylic double bond.  This time, the required hydroxyl group is in place in 
the starting material (S)-ethyl lactate 114, which is cheap and readily available. 
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Scheme 2.5.  Proposed alternative synthesis of allylic alcohols 
 
The  first  step  in  this  route  involved  a  simple  hydroxyl  protection  using  tert-
butyldiphenylchlorosilane  in  the  presence  of  imidazole  according  to  a  literature 
procedure, as shown in Scheme 2.6.
55  This reaction proceeded successfully, giving 
ether 115 in 81% yield.  This was followed by reduction of the ethyl ester to the 
corresponding  primary  alcohol  116.    Initially,  this  was  attempted  using  2.2 
equivalents of diisobutylaluminium hydride solution however the product yield was 
a relatively low 33% and it appeared that loss of the silyl group was occurring during 
the  reaction.    A  literature  procedure  published  by  Duffield  and  Pettit  which 
describes the reduction of ester 115 to alcohol 116 was then trialled using borane-
tetrahydrofuran  complex  solution,  and  this  successfully  generated  the  desired 
product in 84% yield.
56 
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Scheme 2.6.  Synthesis of monoprotected diol 116  
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In order to introduce the allylic double bond and a potentially wide variety of side 
chains,  the  primary  alcohol  116  was  subjected  to  a  Swern  oxidation  to  the 
corresponding  aldehyde,
57  which  could  then  be  trapped  with  a  range  of 
phosphonate  esters,  forming  a  new  carbon-carbon  double  bond.    This  type  of 
strategy  has  been  successfully  utilised  within  the  research  group  many  times 
previously,  and  the  conditions  are  well-established.
58,59    The  Swern  oxidation 
product simply requires concentration in vacuo before being treated with a solution 
of the deprotonated phosphonate ester, providing the protected allylic alcohol in a 
fast, efficient manner. 
 
The first phosphonate ester used for the investigation of the olefination step was 
triethyl phosphonoacetate.  In order to promote the selective formation of the E-
alkene product, the Masamune Roush variation of the Horner-Wadsworth-Emmons 
olefination was employed.
60  The proposed mechanism for the Horner-Wadsworth-
Emmons  olefination is  shown in Scheme  2.7.   The lithium cation  present in the 
reaction mixture coordinates between the two oxygen atoms of the phosphonate 
ester, and acts as a Lewis acid to facilitate its deprotonation.  The deprotonated 
ester is stabilised both by this coordination, and by resonance and so the acidic 
proton can be removed by 1,8-diazabicyclo[5.4.0]undec-7-ene.  These conditions 
are  particularly  mild  and  can  be  applied  to  the  olefination  of  a  wide  range  of 
substrates, including those where sensitivity to strong bases such as butyllithium is 
an issue. 
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Scheme 2.7.  Mechanism of Horner-Wadsworth-Emmons olefination 
 
The  stereochemical  outcome  of  this  olefination  is  determined  by  the 
stereochemistry  achieved  in  the  4-membered  oxaphosphetane  ring  intermediate.  
Here, there are two options possible, where the ester group and the R group can be 
in  either  a  syn  or  anti  relationship  with  one  another.    As  the  formation  of  the 
oxaphosphetane ring is a reversible process, the thermodynamic product is favoured 
which  here  is  the  anti  stereoisomer  with  minimal  steric  clash  between  the 
relatively  bulky  ester  and  R  groups.    Subsequent  decomposition  of  the  anti 
oxaphosphetane ring leads to the E alkene product, as shown in Scheme 2.8.
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Scheme 2.8.  Origin of stereoselectivity in Horner-Wadsworth-Emmons reaction 
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This approach proved successful and gave the desired product 119 in a yield of 79% 
over the two steps from alcohol 116 (Scheme 2.9).  Only the desired E-alkene was 
observed by 
1H NMR spectroscopic analysis of the product, indicated by a coupling 
constant of 15.5 Hz in the signals arising from the alkene protons. 
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Scheme 2.9.  Swern oxidation and Horner-Wadsworth-Emmons olefination 
 
As previously reported in the literature, compounds bearing electron-withdrawing 
sidechains such as esters in conjugation with the alkene tend to be unsuccessful 
substrates  for  Overman  rearrangement  chemistry,  although  the  allylic 
trichloroacetimidate formation step is known to proceed as normal.
62  It has been 
shown that the presence of an electron-withdrawing group in conjugation with the 
alkene such as in 120 leads to the possibility of a conjugate addition taking place 
from the trichloroacetimidate nitrogen atom to form the corresponding oxazoline 
122,  as  shown  in  Scheme  2.10.    This  process  competes  with  the  desired  [3,3]-
sigmatropic  rearrangement,  and  in  general,  very  little  of  the  rearrangement 
product 121 is observed.
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Scheme 2.10.  Competing reaction pathways with conjugated ester 
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In order to overcome this potential problem, manipulation of the ester side chain 
was required.  Conversion of the ester to a protected hydroxyl group would lead to 
generation of a substrate suitable for investigation of the Overman rearrangement 
chemistry.  First, ester 119 was reduced to the corresponding alcohol 123 using 2.2 
equivalents  of  diisobutylaluminium  hydride,  a  reaction  which  proceeded  in  97% 
without the need for purification (Scheme 2.11). 
 
OEt
O
OTBDPS
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OTBDPS DIBAL-H
Et2O
-78 °C to r.t.
97% 119 123  
Scheme 2.11.  Diisobutylaluminium hydride reduction 
 
Protection of the free hydroxyl group was then required, and the methoxymethyl  
(MOM)  protecting  group  was  selected  as  orthogonal  deprotection  conditions  are 
required for this and the already–installed silyl group which required removal in the 
next  synthetic  step,  as  shown  in  Scheme  2.12.    Alcohol  123  was  treated  with 
bromomethyl methyl ether in the presence of Hünig’s base to give ether 124 in 82% 
yield, while the removal of the silyl protecting group was achieved in 73% yield 
using tetra-n-butylammonium fluoride. 
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Scheme 2.12.  Generation of allylic alcohol 125 
 
 
2.1.3  Conversion of allylic alcohol to allylic trichloroacetamide 
With  the  first  allylic  alcohol  125  in  hand,  it  was  then  possible  to  conduct  an 
investigation of the formation of allylic trichloroacetimidate 126 and its subsequent 
Overman rearrangement to allylic trichloroacetamide 127, as shown in Scheme 2.13.  
Synthesis  of  the  allylic  trichloroacetimidate  was  carried  out  successfully  using  
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trichloroacetonitrile in the presence of base.  As these compounds are relatively 
unstable, the reaction product was immediately subjected to rearrangement.   
 
OMOM
OH
Cl3CCN
DBU
CH2Cl2
0 °C to r.t.
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O
CCl3
NH
 or
catalyst
OMOM
O
CCl3
NH
125 126 127
Scheme 2.13.  Synthesis and rearrangement of allylic trichloroacetimidate 126 
 
In  order  to  determine  the  optimum  method  for  carrying  out  the  Overman 
rearrangement, four sets of reaction conditions including both thermal and metal-
catalysed  variants  were  tested.    In  addition  to  the  standard  palladium(II) 
rearrangement catalyst bis(acetonitrile)palladium(II) chloride, platinum(II) chloride 
and gold(III) chloride were also screened, as both literature precedent and studies 
within  our  group  have  indicated  that  these  could  be  successfully  applied  to 
Overman rearrangement reactions.
64,65  The results are summarised below in Table 
7.  Note that the product yields quoted are over two steps from the allylic alcohol 
125. 
 
Reaction conditions  Product Yield (%) 
K2CO3, p-xylene, 140 °C, 15 h  66 
PdCl2(CH3CN)2 (10 mol%), toluene, r.t., 15 h  51 
PtCl2 (15 mol%), THF, r.t., 135 h  34 
AuCl3 (15 mol%), THF, r.t.  No reaction 
Table 7.  Results of Overman rearrangement study 
 
The results of this study showed that the reaction was successfully achieved under 
both thermal reaction conditions and palladium(II) catalysis, with both approaches 
generating the allylic trichloroacetamide in good yield.  When platinum(II) catalysis 
was trialled, a relatively high loading and longer reaction time were required, to 
attain only a moderate product yield.  The gold(III) catalyst failed to promote the 
rearrangement,  and  no  product  was  detected  after  192  h.    The  use  of  thermal 
rearrangement  conditions  led  to  a  significantly  cleaner  reaction  profile  than 
utilising palladium(II) catalysis, explaining the lower product yield observed. 
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2.1.4 Completion of -amino acid target 
With the protected amine functionality in place, it was then possible to introduce 
the required carboxylic acid group by use of an oxidative cleavage of the allylic 
double  bond.    This  was  to  be  achieved  under  conditions  originally  published  by 
Sharpless  and  co-workers  where  sodium  periodate  is  used  in  the  presence  of  a 
ruthenium(III) catalyst to install a carboxylic acid group on each carbon originating 
from the alkene.
66  The catalytic cycle involved in this reaction is outlined below in 
Figure 15.
67  Here, periodate oxidises ruthenium(III) chloride to ruthenium tetroxide, 
which enters the catalytic cycle and dihydroxylates the alkene.  This diol is then 
cleaved  by  periodate  to  form  two  aldehyde  intermediates,  which  are  then 
converted to carboxylic acids by ruthenium tetroxide, which itself is reformed by 
oxidation. 
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Figure 15.  Proposed catalytic cycle of Sharpless oxidative cleavage 
 
When these conditions were applied to the oxidation of trichloroacetamide  127, 
the desired carboxylic acid product 128 was successfully generated with a crude 
yield of 77% (Scheme 2.14).  In this instance, the carboxylic acid by-product formed 
is acetic acid, which was removed upon work-up. 
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Scheme 2.14.  Oxidative cleavage of alkene 
 
Following  this,  removal  of  both  the  trichloroacetamide  and  methoxymethyl 
protecting groups was required in order to complete the synthesis of the first -
amino  acid  target.    Helpfully,  it  was  possible  to  achieve  this  simultaneously  by 
heating the carboxylic acid 128 in 6 M hydrochloric acid under reflux, as shown in 
Scheme 2.15.  Using this approach, the amino acid target, D-serine 129 was formed 
in quantitative yield, and isolated as the hydrochloride salt. 
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Scheme 2.15.  Completion of -amino acid target 
 
 
2.1.5  Attempted synthesis of further allylic alcohol intermediates 
As  the  chemistry  required  to  synthesise  the  first  amino  acid  target  had  been 
developed, attempts were made to apply the methodology to the synthesis of a 
number of other -amino acids with a variety of side chains.  These groups would 
be introduced during the Horner-Wadsworth-Emmons step by treating the aldehyde 
with different phosphonate esters.  If inert alkyl side chains were added at this 
stage,  no  further  manipulation  would  be  required  before  the  Overman 
rearrangement step and hence the final -amino acid targets could be generated 
rapidly. 
 
The  next  phosphonate  ester  to  be  applied  to  the  olefination  step  was  diethyl 
phenylethyl phosphonate, shown in Scheme 2.16.  Alcohol 116 was again oxidised  
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to the corresponding aldehyde as previously discussed and this was to be treated 
with a solution of the deprotonated phosphonate ester. 
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Scheme 2.16.  Swern oxidation and Horner-Wadsworth-Emmons olefination 
 
As there is no electron-withdrawing group in the phosphonate ester side chain, co-
ordination to a metal cation would be possible only to the P=O bond, and would not 
be expected to significantly aid deprotonation in this instance, and so it was likely 
that  a  stronger  base  than  DBU  would  be  required.    Therefore,  a  search  of  the 
literature  was  conducted  to  find  conditions  which  would  be  suitable  for  the 
deprotonation of alkyl-substituted phosphonate esters.  The success of this search 
was limited, and the closest matching procedures were those which involved the 
use of phosphonate esters bearing unsaturated alkyl groups. 
 
The  olefination  was  initially  attempted  using  lithium  bis(trimethylsilyl)amide 
according to a procedure described by Trost and Gunzner,
68 although none of the 
desired  alkene  130  was  isolated  upon  purification.    Next,  the  reaction  was 
repeated using lithium diisopropylamide as the base, which was generated in situ 
from  diisoproylamine  and  butyllithium.
69  Again,  the  reaction  failed  and  so  an 
attempt  was  made  to  carry  out  the  olefination  under  the  Masamune  Roush 
conditions previously discussed although as expected, none of the desired product 
was observed.
60  It was then considered that perhaps using the aldehyde as a crude 
product of the Swern oxidation step was impeding the progress of the reaction, and 
so  an  attempt  was  made  to  remove  the  residual  triethylamine  by  carrying  out 
washes with water and 2 M hydrochloric acid before addition of the phosphonate 
ester,  the  deprotonation  of  which  had  again  been  attempted  using  lithium 
diisopropylamide.  Unfortunately, this reaction failed to yield the desired product.  
These results are summarised in Table 8. 
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Conditions  Outcome 
LiHMDS, THF, -78 °C to r.t.  No product isolated 
nBuLi, 
iPr2NH, THF, -78 °C to r.t.  No product isolated 
LiCl, DBU, CH3CN, r.t.  No product isolated 
nBuLi, iPr2NH, THF, -78 °C; aldehyde worked up   No product isolated 
Table 8.  Attempted Horner-Wadsworth-Emmons olefination 
 
The failure of these attempted olefinations was considered to be a result of the 
lack of an electron-witdrawing sidechain on the phosphonate ester, and indeed in 
1966,  Corey  and  Kwiatkowski  showed  that  while  the  deprotonation  of  these 
phosphonates  and  their  subsequent  attack  of  aldehydes  is  possible,  it  is  the 
elimination of phosphate via the oxaphosphetane ring which fails (see mechanism in 
Scheme  2.7).    It  is  thought  that  an  electon-withdrawing  group  is  required  to 
dissipate a negative charge which builds up on the carbon - to phosphorus in the 4-
membered transition state, therefore allowing rapid elimination to proceed.
70 
 
These results showed that the methodology developed within this project would not 
prove flexible enough for the synthesis of the wide range of -mono- and ,-di-
substituted  -amino  acids  required  bearing  alkyl  functionality  and  therefore,  an 
alternative approach was investigated in which the reactivity of the components 
involved in the olefination step was reversed.   
 
The new method involved an attempt to convert the alcohol intermediate 116 to 
the corresponding tributylphosphonium salt 132 via the iodide 131, as shown in 
Scheme 2.17.  The phosphonium salt 132 could then be used in E-selective Wittig 
olefination  reactions  with  a  range  of  aldehydes,  which  are  readily  available 
commercially.  This would introduce the allylic double bond and desired side chain.  
The iodination was carried out according to a literature procedure described by 
Garegg and Samuelsson, and the desired product 131 was isolated in 96% yield.
71   
However,  when  this  was  treated  with  tributylphosphine,  none  of  the  desired 
phosphonium salt was detected by 
1H NMR spectroscopic analysis of the reaction 
mixture after 4 days.  It was believed that the approach of tributylphosphine to the 
substrate  may  have  been  sterically  hindered  by  the  presence  of  the  large  silyl 
protecting group.  
1H NMR spectroscopic analysis also indicated that oxidation of  
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tributylphosphine to tributylphosphine oxide was occurring during the course of the 
reaction, and degassing the reaction mixture did not help the reaction to proceed 
successfully. 
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Scheme 2.17.  Attempted synthesis of phosphonium salt 132 
 
A final attempt was then made to introduce the required alkene and various side 
chains to the alcohol intermediate 116.  If the alcohol could be converted to a 
terminal alkene, this could be subjected to cross-metathesis chemistry with some 
simple terminal alkene partners to generate the desired protected allylic alcohol 
substrates. 
 
Scheme  2.18  shows  the  method  attempted  for  the  generation  of  the  desired 
terminal  alkene  133  via  Swern  oxidation  and  Wittig  methylenation,  which  was 
carried  out  according  to  a  literature  procedure  described  by  Schmidt  and 
Sattelkau.
72  Unfortunately, this methylenation proved unsuccessful and none of the 
desired product 133 was isolated.  It was believed that the presence of the strong 
butyllithium base was perhaps causing decomposition of the aldehyde intermediate 
by loss of the silyl protecting group.  
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Scheme 2.18.  Attempted generation of terminal alkene 133 
 
As  several  approaches  based  on  organophosphorus  olefinations  had  failed  to 
incorporate the required alkene and side chains to the alcohol intermediate 116, 
the decision was made to focus efforts on an alternative strategy for the synthesis  
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of  the  desired  range  of  allylic  alcohols  which  would  prove  flexible  enough  to 
introduce many side chains without the need for harsh reaction conditions. 
 
 
2.2  Synthesis of -amino acids via cross-metathesis 
 
2.2.1  Proposed route to allylic alcohols 
The new approach proposed for the synthesis of allylic alcohols, outlined in Scheme 
2.19,  focuses  on  the  use  of  cross-metathesis  chemistry  with  a  common  enone 
intermediate to incorporate the required side chain substitution on the eventual 
allylic double bond.  Due to the large number of both mono- and di-substituted 
terminal alkenes available commercially, this strategy would potentially allow the 
eventual  generation  of  a  wide  variety  of  di-  and  tri-substituted  allylic  alcohol 
intermediates. 
 
In order  to install the hydroxyl group,  a  1,2-reduction  of  the  carbonyl  could  be 
carried out and crucially, the stereochemistry at this centre can be controlled if the 
reaction is carried out in an appropriate chiral environment. 
 
As before, the proposed methodology would be developed initially for the synthesis 
of -amino acids before later application to the generation of targets bearing ,-
disubstitution. 
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Scheme 2.19.  Proposed synthesis of allylic alcohols 
 
 
2.2.2  Synthesis of enone intermediates via cross-metathesis 
The  first  aim  of  this  route  was  to  synthesise  a  simple  enone  to  be  used  as  a 
substrate for cross-metathesis with the various terminal alkene partners.  As the 
oxidative cleavage reaction later in the synthesis removes the alkyl portion of this 
enone,  the  use  of  almost  any  inert  group  should  be  appropriate.    Here,  a 
phenylethyl group was selected as it should not be capable of reacting under any of 
the  conditions  it  will  be  subjected  to,  and  provides  a  simple 
1H  NMR  pattern, 
making analysis of subsequent intermediates straightforward.  The starting material 
required, hydrocinnamic acid, is also relatively cheap and readily available. 
 
Crucial  to  the  generation  of  the  required  enone  intermediate  136  is  the 
introduction  of  a  vinyl  group  to  hydrocinnamic  acid.    A  problem  commonly 
encountered  in  the  alkylation  of  carboxylic  acid  derivatives  with  organometallic 
reagents to form ketones is the propensity of the reaction products to undergo a 
second  alkylation,  generating  the  corresponding  tertiary  alcohol,  as  shown  in 
Scheme 2.20.  Often, complex mixtures of starting material, ketone, and tertiary 
alcohol are detected after reaction. 
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Scheme 2.20.  Nucleophilic alkylation of carboxylic acid derivatives 
 
In 1981, Weinreb showed that formation of the undesired tertiary alcohol can be 
minimised if the alkylation is carried out on an N-methoxy-N-methyl amide, which 
are easily generated from the corresponding carboxylic acid derivative and amine.  
The methoxy oxygen atom here coordinates to the organometallic reagent (Figure 
16), stabilising the tetrahedral intermediate formed upon the first addition.  This 
intermediate does not collapse to the ketone product until quenched by acid during 
the work-up, thus preventing attack by a second equivalent of the organometallic 
reagent.
73 
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Figure 16.  Weinreb amide coordination 
 
While the use of Weinreb amides has proven successful in circumventing the issue 
of  tertiary  alcohol  formation,  the  cost  of  starting  materials  required  for  amide 
formation is relatively high.  In 1997, Martín et al. reported the use of morpholine 
amides  as  substrates  for  alkylation  by  organometallic  reagents  to  generate 
ketones.
74  Morpholine itself is a very cheap amine and can be used to easily form 
amides.  The oxygen atom present in the morpholine ring is able to stabilise the 
tetrahedral intermediate formed during alkylation in a similar way to the Weinreb 
amides, and studies have shown that the alkylation reactions proceed in relatively 
high yield with minimal tertiary alcohol formation.  Indeed, Martín’s paper reported  
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the synthesis of the enone 136 required for this project, and hence this approach 
was adopted here. 
 
As shown in Scheme 2.21, the desired morpholine amide 135 was generated easily 
via  the  corresponding  acid  chloride  139  which  was  formed  by  simply  stirring 
hydrocinnamic acid 134 in neat thionyl chloride.  As the acid chloride is likely to be 
very reactive and  sensitive to hydrolysis,  no purification  was carried out  at  this 
stage, and the crude product was immediately treated with morpholine to give the 
amide 135 in an excellent yield of 99% over the two steps. 
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Scheme 2.21.  Synthesis of morpholine amide 135 
 
Conversion of the morpholine amide 135 to the key enone intermediate 136 was 
carried  out  according  to  the  conditions  outlined  in  the  Martín  paper,  using 
vinylmagnesium  bromide,  as  shown  in  Scheme  2.22.    Helpfully,  this  Grignard 
reagent is commercially available as a solution in tetrahydrofuran.  The alkylation 
was carried out with a highest yield of 74%, although on a number of repeats of this 
experiment, this high yield proved somewhat inconsistent.  It was found that low 
product yields obtainedin some instances could be attributed to the formation of 
the  double-alkylated  tertiary  alcohol.    In  order  to  limit  the  formation  of  this 
undesired  by-product  and  achieve  consistently  high  yields  of  enone  136,  the 
reaction  time  was  kept  to  1  hour  or  less  to  limit  the  possibility  of  the  second 
alkylation taking place. 
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Scheme 2.22.  Formation of key enone intermediate 136  
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With the key enone intermediate 136 successfully synthesised, introduction of the 
eventual  -amino  acid  side  chains  was  achieved  via  cross-metathesis  chemistry, 
which is very well established in the literature.
75,76  Cross-metathesis has proved 
very popular in recent years, as it represents a simple method for the generation of 
new carbon-carbon double bonds which does not require harsh conditions, and is 
relatively atom-economical as only small loadings of the catalyst are required.  The 
cross-metathesis  of  two  monosubstituted  alkene  partners  also  proceeds  with 
selectivity for the E-alkene product, which is desired in this project. 
 
A number of catalysts have been developed which can promote alkene metathesis 
reactions  including  ring-closing  metathesis,  cross-metathesis  and  ring-opening 
metathesis.  The most commonly-encountered catalyst applied to cross-metathesis 
is Grubbs second generation catalyst K (Figure 17), first discussed in the literature 
in 1999.
77 
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Figure 17.  Grubbs 2
nd generation catalyst for cross-metathesis 
 
This catalyst acts as a source of a metal-carbene complex, and this undergoes a 
[2+2]-cycloaddition  with  the  first  alkene  partner  to  form  a  4-membered 
metallocyclobutane.  Collapse of this generates an alkene by-product (ethane in the 
methathesis of two terminal alkenes) and a new metal-carbene which is able to 
react  with  the  second alkene  partner, forming another metallocyclobutane from 
which the desired metathesis product is generated.  Note that in the first cycle, the 
phenyl group will be present on the metal-carbene complex, and this will be lost in 
the first alkene by-product in place of ethene.  This widely-accepted mechanism for 
the  cross-metathesis  of  two  alkenes  was  first  proposed  in  1970  by  Hérisson  and 
Chauvin and is shown in Figure 18.
78 
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Figure 18.  Mechanism of alkene cross-metathesis 
 
A paper published by Grubbs and co-workers in 2003 categorised the various types 
of  olefins  which  can  undergo  cross-metathesis  according  to  their  ability  to 
homodimerise in the presence of a particular metathesis catalyst.
79  Four ‘types’ of 
olefins  were  discussed,  ranging  from  type  I,  which  undergo  homodimerisation 
rapidly, type II which homodimerise slowly, to type III which do not homodimerise, 
and finally type IV which fail to undergo cross-metathesis themselves but do not 
interfere with the metathesis catalyst’s activity.  The categories essentially relate 
to the order of reactivity of the olefin partners, with type I being the most reactive 
to cross-metathesis. 
 
According to this classification, the enone intermediate 136 is a type II olefin in 
reactions  catalysed  by  Grubbs  2
nd  generation  catalyst  K,  while  simple  terminal 
alkenes such as the metathesis partners used in this project are of type I.  Grubbs’ 
paper states that cross-metathesis reactions between an olefin of type I and one of 
type II should successfully lead to a selective heterodimerisation of the two alkene 
partners.   This is  due  to the fact  that although  homodimerisation  of  the  type I 
alkene is possible, the homodimer itself can undergo a second metathesis reaction 
with the type II olefin to generate the desired product (Figure 19).  
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Figure 19.  Selectivity in cross-metathesis between type I and type II olefins 
 
The first terminal alkene partner selected for metathesis with enone 136 was 1-
hexene,  which  provided  a  simple  alkyl  chain  for  initial  development  of  the 
methodology.    The  first  of  these  cross-metathesis  reactions  was  carried  out 
according  to  standard  conditions.
80  In  the  presence  of  Grubbs  2
nd  generation 
catalyst K (4 mol%), the substituted enone 140 was successfully generated in 75% 
yield, as shown in Scheme 2.23.   
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Scheme 2.23.  Cross-metathesis of enone 136 with 1-hexene 
 
Importantly, this reaction proceeded with complete selectivity for the desired E-
alkene product, and none of the alkene with Z-geometry was detected by 
1H NMR 
spectroscopic analysis of the crude reaction product, as indicated by an observed 
coupling constant value of J = 15.8 Hz in the two signals derived from the alkene 
protons, which are shown in Figure 20. 
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Figure 20. 
1H NMR spectroscopy signals derived from alkene protons of 140 
 
As this cross-metathesis reaction proceeded in a straightforward manner with a high 
product yield, the same key enone intermediate was subjected to these reaction 
conditions with three other terminal alkene partners,  as shown in Scheme  2.24.  
These  reactions  achieved  product  yields  ranging  from  a  moderate  47%  to  58%, 
observed for the tert-butyl substituted example 142.  The reaction involving the 
synthesis  of  nitrile-substituted  trichloroacetamide  143  proved  sluggish,  and 
required repeated additions of catalyst (total catalyst loading = 9 mol%) to achieve 
complete consumption of the enone starting material 136. 
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Scheme 2.24.  Cross-metathesis reaction with additional alkene partners 
 
An  additional  -amino  acid  target,  which  bears  a  stereogenic  centre  in  the  -
position was also selected for synthesis and in order to introduce the required side 
chain, a cross metathesis reaction between enone 136 and a protected derivative 
of (S)-(+)-4-penten-2-ol 144 was necessary.  Protection of the hydroxyl group was 
first needed and the methoxymethyl group was selected as a suitable choice.  (S)-
(+)-4-penten-2-ol  144  was  therefore  subjected  to  standard  MOM  protection 
conditions using bromomethyl methyl ether in the presence of base, as shown in 
Scheme 2.25.  
1H NMR spectroscopic analysis of the crude product showed that the 
required alkene 145 had been successfully generated in 89% crude yield, with only 
minor  impurities  present.    However  when  purification  by  silica  column 
chromatography was attempted, decomposition of the product occurred, and none 
of the required product was isolated in a pure form. 
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Scheme 2.25.  Attempted MOM protection of (S)-(+)-4-penten-2-ol 
 
An alternative protection strategy was then selected for (S)-(+)-4-penten-2-ol 144, 
and silyl protection was deemed appropriate, as it would be capable of resisting the 
reaction conditions involved  with  the route under development.   Therefore,  the 
alcohol  was  treated  with  tert-butyldimethylsilyl  chloride  in  the  presence  of 
imidazole according to a literature procedure by Overman and Rishton, as shown in 
Scheme 2.26.
81  However, neither the desired protected product 146 or starting 
material alcohol were identified upon work-up.  The protection was then attempted 
using triethylamine and 4-di(methylamino)pyridine, as described in the literature by 
Kalivretenos et al., and this time the desired protected alcohol was generated in 
52% yield.
82 
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Scheme 2.26.  Silyl protection of (S)-(+)-4-penten-2-ol 
 
The  silyloxy-substituted  terminal  alkene  146  was  then  subjected  to  cross-
metathesis  with  enone  136  using  the  standard  reaction  conditions,  as  shown  in 
Scheme 2.27.  Although a slightly increased loading of Grubbs catalyst K (5 mol%) 
was required, the reaction proceeded successfully with an excellent yield of 89%. 
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Scheme 2.27.  Cross metathesis of enone 136 with silyloxy-substituted terminal alkene 146 
 
 
2.2.3  Enantioselective ketone reductions to generate allylic alcohols 
In order to complete the generation of the desired allylic alcohol intermediates, 
reduction  of  the  enone  carbonyl  groups  was  required.    This  could  be  achieved 
enantioselectively by employing CBS protocol.  The CBS reduction, named after its 
developers Corey, Bakshi and Shibata, was developed in the late 1980s and involves 
a 1,2-reduction of ketones to alcohols in the presence of an enantiomerically pure 
oxazaborolidine  catalyst  of  the  type  shown  in  Figure  21  and  a  borane  reducing 
agent.
83,84  These oxazaborolidine catalysts are capable of achieving the reduction 
of simple ketones in excellent yield attaining enantiomeric excess values greater 
than 90% in the alcohol products. 
 
N B
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H Ph
Ph
R  
Figure 21.  Typical CBS oxazaborolidine catalyst 
 
Both enantiomers of these oxazaborolidine catalysts are available commercially and 
as  expected,  opposite  enantiomers  of  oxazaborolidine  lead  to  generation  of 
opposite  allylic  alcohol  product  enantiomers.    The  product  enantiomer  formed 
preferentially  can  be  predicted  (Figure  22).    It  can  be  seen  that  a  highly 
enantioselective reduction is possible when there is a significant difference in size 
between the groups on either side of the carbonyl.  With the enone substrates 140–
143 and 147 used in this project, there is not a particularly significant difference in  
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the size between these groups although it has been shown that in general, a vinylic 
double bond will generally behave as the large group in these reductions.
85 
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Figure 22.  Prediction of enantiomeric outcome of CBS reduction 
 
The source of enantioselectivity observed in the CBS reduction can be understood 
by consideration of the reaction mechanism, a simplified version of which is shown 
in Figure 23.
86  The active reducing agent here is formed when borane coordinates 
to  the  oxazaborolidine  nitrogen.    The  ketone  substrate  then  coordinates  to  the 
boron  atom  within  the  oxazaborolidine  bicycle,  the  Lewis  acidity  of  which  is 
increased by the initial coordination of borane to nitrogen.  The ketone binds in a 
manner which minimises steric interaction between the large substituent and the 
oxazaborolidine, with the large substituent placed in a pseudoequatorial position in 
the 6-membered transition state.  This coordination then allows the hydride from 
borane to be delivered preferentially to one face of the ketone. 
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Figure 23.  Source of enantioselectivity with (S)-(-)-2-methyl-CBS-oxazaborolidine 
 
In order to find the optimal conditions for this CBS reduction, a study was carried 
out to determine the effect of altering the loading of the CBS catalyst on both the  
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yield and enantiomeric excess of the product.  The butyl-substituted enone 140 was 
selected as a standard substrate for the reduction reactions with (S)-(-)-2-methyl-
CBS-oxazaborolidine,  selected as the catalyst to favour formation of the desired 
(R)-enantiomer of the allylic alcohol 148, as shown in Scheme 2.28. 
 
Ph
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BH3·THF
(S)-(-)-2-methyl-
CBS-oxazaborolidine
THF, -20 °C 140 148  
Scheme 2.28.  CBS reduction of enone 140 
 
This  reduction  reaction  was  attempted  under  standard  conditions  discussed  by 
Evans and Morken in the literature, and initially carried out in the presence of 0.2 
equivalents of the CBS oxazaborolidine catalyst.
87  This was subsequently increased 
to  0.5  equivalents  in  a  repeat  of  the  reduction,  and  finally  to  a  stoichiometric 
quantity of the oxazaborolidine.  The product yields were high in each instance, 
although the enantiomeric excess values were shown to improve significantly with 
increasing equivalents of oxazaborolidine, as shown in Table 9.  Comparison of []D 
values to literature data confirmed the formation of the required (R)-enantiomer of 
the allylic alcohol. 
 
Equivalents of oxazaborolidine  Yield (%)  e.e (%) 
0.2  57  31 
0.5  100  71 
1.0  99  84 
Table 9.  Results of CBS reduction study 
 
The  enantiomeric  excess  values  quoted  here  were  determined  by  chiral  HPLC 
analysis, using a Chiralcel IB column.  In order to determine HPLC conditions for the 
separation of enantiomers of the enol products, a racemic sample of each of these 
was  required.    These  enol  racemates  were  generated  by  carrying  out  a 
straightforward reduction using diisobutylaluminium hydride, as shown in Scheme 
2.29. 
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Scheme 2.29.  Racemic reduction of enone intermediates 
 
The  results  of  the  catalyst  screen  showed  that  the  highest  enantiomeric  excess 
values  in  the  product  are  observed  when  a  stoichiometric  quantity  of  the  CBS 
oxazaborolidine is used.  As the enantioselectivity established in the CBS reduction 
is  carried  through  to  the  eventual  amino  acid  target,  it  is  crucial  that  high 
enantiomeric excess values are attained at this stage.  Therefore, it was decided 
that  a  stoichiometric  quantity  of  CBS  oxazaborolidine  should  be  utilised  in  the 
reduction of the remaining enone intermediates, as shown in Scheme 2.30.  High 
yields were achieved for each of these reduction reactions, with moderate to high 
levels  of  enantioselectivity  observed.   
1H  and 
13C  NMR  spectroscopic  analysis  of 
alcohol 152, with comparison to the diisobutylaluminium hydride-reduced sample, 
indicated that only a single diastereoisomer of the product was detectable. 
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Scheme 2.30.  CBS reduction of remaining enone intermediates 
 
While the CBS reduction was successfully achieved to synthesise all of the desired 
allylic alcohols, this strategy is slightly lacking in efficiency, as it requires the CBS 
enantioselective reduction and also racemic diisobutylaluminium hydride reduction 
of each individual enone synthesised in addition to subsequent chiral HPLC analysis 
of all these reaction products.  An alternative approach was therefore considered, 
where the 1,2-reduction of the enone functionality was carried out on key enone 
intermediate  136  prior  to  cross-metathesis  with  the  various  terminal  alkene 
partners.  This would mean that chiral HPLC analysis would only be required once, 
as the stereogenic centre would not be affected by the cross-metathesis chemistry.  
Using  the  reduction  conditions  employed  previously,  both  the  racemic  and 
enantioselective reductions were carried out on enone  136, proceeding in yields 
comparable to previous examples as shown in Scheme 2.31.  It is worth mentioning 
that an initial attempt to carry out the reduction of enone 136 to racemic alcohol  
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rac-153 using sodium borohydride had resulted in a 1:1 ratio of the desired product 
and the product with a fully reduced alcohol with further reduction of the carbon-
carbon double bond, the result of a 1,4-addition of hydride to enone 136. 
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Scheme 2.31.  Reduction of enone 136 
 
With the reduction of enone 136 successfully achieved, the racemic sample was 
utilised in a test cross-metathesis reaction with 1-hexene, as shown in Scheme 2.32.  
According to literature precedent, the cross-metathesis of enol partners should be 
possible to achieve, with enols falling into the Type II category according to Grubbs’ 
classification.
79  However, when this reaction was attempted, none of the desired 
product rac-153 was detected by 
1H NMR spectroscopic analysis upon purification. 
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Scheme 2.32.  Cross metathesis of alcohol rac-153 with 1-hexene 
 
As this cross-metathesis failed, it was decided to continue with the original strategy 
of carrying out the cross-metathesis prior to the reduction step. 
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2.2.4 Conversion of allylic alcohols to allylic trichloroacetimidates 
With the desired allylic alcohols successfully synthesised, a study of the Overman 
rearrangement chemistry was then carried out.  As discussed previously, the [3,3]-
sigmatropic rearrangement of allylic trichloroacetimidates derived from secondary 
alcohols is  possible  under  both  thermal conditions  and metal  catalysis,  although 
thermal rearrangements tend to give a cleaner reaction profile and hence higher 
yields. 
 
The  butyl-substituted  enol  148  was  initially  used  as  the  substrate  for 
trichloroacetimidate formation and subsequent Overman rearrangement, as shown 
in Scheme 2.33.   
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Scheme 2.33.  Conversion of enol 148 to trichloroacetimidate and Overman rearrangement 
 
Initially,  the  trichloroacetimidate  formation  was  carried  out  using  the  reaction 
conditions  discussed  in  chapter  2.1.    On  the  first  attempt  of  this  reaction,  the 
acetimidate  formation  was  stirred  at  room  temperature  for  9  h,  and  this  was 
followed  by  a  PdCl2(CH3CN)2-catalysed  rearrangement.    The  yield  of 
trichloroacetamide 155 was a relatively disappointing 37% in this instance, and the 
presence of some remaining unreacted allylic alcohol starting material cited as the 
reason for this.  Therefore, the trichloroacetimidate formation step for alcohol 148 
and  the  remaining  examples  was  allowed  to  stir  at  room  temperature  for  24  h 
before  subjecting  to  the  rearrangement  conditions.    When  this  rearrangement  
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chemistry  was  repeated  in  combination  with  the  longer  acetimidate  formation 
reaction, a slightly increased product yield of 41% was attained, although repeated 
purification by silica column chromatography failed to separate the desired product 
from minor impurities present. 
 
The rearrangement reaction was then carried out under thermal reaction conditions.  
Again, the acetimidate formation was allowed to stir at room temperature for 24 h.  
Using  this  approach,  a  much  cleaner  reaction  product  was  observed,  and  upon 
purification, a 67% product yield was achieved (Scheme 2.34). 
 
The conditions employed for the synthesis of allylic trichloroacetamide 155 were 
then  applied  to  conversion  of  the  remaining  allylic  alcohols,  as  shown  below  in 
Scheme 2.34.  All of these reactions were carried out in high yield.  Note that the 
product  yields  quoted  below  are  over  two  steps  from  the  corresponding  allylic 
alcohols. 
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Scheme 2.34.  Synthesis of allylic trichloroacetamides 155–159 
 
 
2.2.5  Completion of -amino acid targets 
With the desired protected amine functionality in place, it was then possible to 
introduce the carboxylic acid group required in the final amino acid targets.  In 
order to achieve this, Sharpless oxidation conditions were employed to cleave the 
alkene using ruthenium(III) catalysis.
66  The reaction was initially carried out on 
allylic trichloroacetamide 155, as shown in Scheme 2.35, generating the desired  
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product 160 and hydrocinnamic acid 134 as a by-product.  Attempts to separate 
these two reaction components by silica column chromatography proved difficult 
due to their ability to form hydrogen bonds with the stationary phase, and resulted 
in a relatively low product yield of 29%. 
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Scheme 2.35.  Oxidative cleavage of allylic trichloroacetamide 155 
 
As separation of the two acid products was problematic, it was decided to subject 
the crude reaction product to a simple esterification to generate the corresponding 
methyl  esters,  which  would  be  significantly  easier  to  purify  by  column 
chromatography.  This method was successfully applied to the generation of esters 
155-158, as shown in Scheme 2.36.  Again, the product yields quoted are over 2 
steps from the allylic trichloroacetamides. 
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Scheme 2.36.  Oxidative cleavage and esterification 
 
During one instance of carrying out this oxidation and esterification on the nitrile-
substituted trichloroacetamide 158, additional ruthenium trichloride hydrate (2.5 
mol%) and sodium periodate (1 equivalent) were added after a reaction time of 18 h, 
as TLC analysis at this stage appeared to show the presence of residual starting 
material.  Upon purification after the esterification step, a significant by-product 
was isolated.  Analysis indicated that the nitrile group had undergone hydrolysis to 
the  corresponding  carboxylic  acid  during  the  oxidative  cleavage  reaction,  and 
subsequent  esterification  led  to  the  formation  of  the  diester  165,  which  was  
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isolated  in  35%  yield  (Figure  24).    The  presence  of  this  diester  resulted  in  a 
significantly lower yield of 17% of the desired ester 164. 
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Figure 24.  Diester by-product 
 
Problems  were  encountered  in  the  oxidative  cleavage  of  silyloxy-substituted 
trichloroacetamide  159.    When  subjected  to  the  Sharpless  oxidation  and 
esterification, none of the desired ester 166 was formed, and a complex product 
mixture  was  observed  by 
1H  NMR  spectroscopic  analysis.    At  this  stage,  it  was 
believed that this was perhaps due to loss of the silyl protecting group occurring 
during  the  esterification  step  where  relatively  harsh  reaction  conditions  are 
encountered  and  HCl  is  generated.    Therefore,  the  oxidation  was  repeated 
according  to  the  Sharpless  protocol,  although  this  was  followed  by  a  milder 
esterfication procedure utilising (trimethylsilyl)diazomethane as shown in Scheme 
2.37.  The desired ester product 166 was isolated upon purification, although in a 
disappointing yield of just 16% over the 2 steps.  This result suggested that the 
oxidative  cleavage  step  was  problematic  with  the  silyloxy-substituted  substrate.  
This was confirmed when attempts to purify the cleaved carboxylic acid directly 
from the Sharpless oxidation step without esterification failed. 
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Scheme 2.37.  Attempted generation of ester 166 
 
Alternative  methods  for  the  oxidative  cleavage  of  the  alkene  159  were  then 
investigated,  the  first  of  which  was  ozonolysis  in  the  presence  of  a  methanolic 
solution  of  sodium  hydroxide  in  an  attempt  to  carry  out  the  oxidation  and 
esterification in a single reaction.  The conditions applied were described in the 
literature by Marshall and Garofalo (Scheme 2.38), and resulted in the successful 
isolation of the desired ester 166 in a modest 25% yield upon purification.
88 
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Scheme 2.38.  Ozonolysis of trichloroacetamide 159 
 
A  literature  procedure  published  by  Ranu  et  al.
89  which  uses  tert-
butylhydroperoxide in the presence of a Lewis acid catalyst was then trialled as this 
uses relatively mild conditions, and was followed by the mild TMS-diazomethane 
esterification as shown in Scheme 2.39.  However, none of the desired ester 166 
was isolated and a proportion of the unreacted starting material 159 remained in 
the  crude  product.    Finally,  conditions  published  by  Figueiredo  et  al.  were 
employed, and the oxidation was carried out using potassium permanganate and  
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sodium periodate.
90  When followed by the same TMS-diazomethane esterification, 
ester 166 was isolated in a satisfactory yield of 30% over the two steps. 
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Scheme 2.39.  Alternative oxidations of trichloroacetamide 159 
 
In order to complete the synthesis of the -amino acid targets, removal of both the 
trichloroacetamide  group  and  the  methyl  ester  was  required  for  each  example.  
This  was  achieved  by  heating  the  ester  intermediates  under  reflux  in  6  M 
hydrochloric acid, as shown in Scheme 2.40.  In the case of the silyloxy substituted 
compound 166, it was found that the silyl protecting group was also removed as 
desired under these reaction conditions.  Upon workup however, it was found that 
lactonisation  had  occurred  also  and  so  in  order  to  reopen  the  lactone  ring, 
purification was carried out using an ion exchange column.  This gave the -amino 
acid target 170 in a yield of 71%. 
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Scheme 2.40.  Completion of -amino acid targets 
 
As the nitrile functionality on ester 164 is sensitive to hydrolysis in the presence of 
6 M hydrochloric acid, an alternative strategy was utilised for its deprotection.  An 
attempt was made  to hydrolyse  the methyl ester and  trichloroacetamide groups 
simultaneously  in  the  presence  of  base,  which  would  hopefully  leave  the  nitrile 
group intact.  Lithium hydroxide was employed, as shown in Scheme 2.41, although 
it  was  found  that  while  ester  hydrolysis  was  successful,  the  trichloroacetamide 
groups remained unreacted.  Therefore the acid intermediate 171 was reacted with 
6 M HCl under reflux and as expected, hydrolysis of the trichloroacetamide group 
occurred.  The harsh reaction conditions led to conversion of the nitrile group to 
the corresponding amide 172, which was formed in quantitative yield over the two 
steps. 
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Scheme 2.41.  Deprotection of trichloroacetamide 164 
 
It was also possible to complete the synthesis of an additional -amino acid target 
173  from  the  diester  165,  isolated  as  a  by-product  during  the  oxidative 
cleavage/esterification step as previously described.  This was achieved as above by 
treating  the  diester  with  acid  under  reflux,  as  shown  in  Scheme  2.42,  and  the 
target L-aminoadipic acid 173 was generated in quantitative yield. 
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Scheme 2.42.  Completion of diacid 173 
 
At this stage, the new methodology for the generation of -amino acids had been 
successfully developed.  Importantly, the introduction of a variety of side chains 
was  possible  during  the  mild  cross-metathesis  conditions,  and  the  use  of  an 
asymmetric ketone reduction to form the required chiral allylic alcohols meant that 
access  to  either  product  enantiomer  would  be  possible  by  application  of  both 
enantiomers of the commercially-available CBS oxazaborolidine reagent.  A study of 
conditions  required  for  the  Overman  rearrangement  conditions  and  subsequent 
conversion  to  -amino  acids  led  to  the  completed  synthesis  of  the  target  
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compounds 167–170 and 172 in an efficient, stereoselective manner from simple 
starting materials. 
 
 
2.2.6  Synthesis of trisubstituted enone via cross-metathesis 
With -amino acid targets 167–170 and 172 successfully completed, the developed 
methodology was applied to the attempted synthesis of ,-disubstituted examples.  
This  could  be  achieved  by  using  disubstituted  terminal  alkenes  in  the  cross-
metathesis reaction  with  the  enone intermediate  136.   For  this approach  to  be 
successful,  this  cross-metathesis  has  to  proceed  in  good  yield  and  with  a  high 
degree of E/Z-selectivity.  In 1999, Chatterjee and Grubbs published details of the 
synthesis of trisubstituted alkenes via cross-metathesis and showed that Grubbs 2
nd 
generation  catalyst  K succeeded in promoting  these reactions  with a number of 
examples where one of the substituents on the disubstituted alkene partner is a 
methyl  group.
80  The  reactions  discussed  proceeded  in  good  yield  and  with 
moderate levels of E:Z selectivity, the highest being a 4:1 product ratio. 
 
Under  Grubbs’  classification  of  olefin  cross-metathesis  partners,  simple  2,2-
disubstituted olefins belong to the type III category when Grubbs 2
nd generation 
catalyst K is used.
79  Type III olefins are less reactive than type II partners, and are 
not susceptible to homodimerisation.  This reduced reactivity, attributed to steric 
hindrance, means that often a relatively high excess of the terminal alkene partner 
is required to attain a high yield of the desired heterocoupled product.  This excess 
can help to prevent the formation of the type II homodimer, which would be unable 
to undergo a second metathesis with the type III olefin. 
 
Enone  intermediate  136  was  subjected  to  cross-metathesis  with  2,2-dimethyl 
pentene, as shown in Scheme 2.43 and both the product yield and E/Z selectivity 
were noted using a range of conditions. 
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Scheme 2.43.  Cross-metathesis to form trisubstituted alkenes 
 
Initially, the standard reaction conditions applied to the synthesis of enone 140 
were  employed,  using  5  mol%  of  Grubbs  2
nd  generation  catalyst.    However,  the 
reaction  was  slow  and  required  additional  2-methyl-1-pentene  and  Grubbs  2
nd 
generation catalyst K, although a very poor yield product yield of 6% was achieved 
(Table 10, entry 1).  Repeats of this reaction using higher catalyst loadings and 
increased reaction temperatures were also attempted, with limited improvement in 
product yield.  Use of a copper(I) chloride co-catalyst was also trialled, as literature 
precedent indicated that this can improve reaction turnover.  However, this failed 
to  yield  any  of  the  desired  alkene  product  (entry  4).
91  The  most  significant 
improvement came in changing the cross-metathesis catalyst to Hoveyda-Grubbs 2
nd 
generation catalyst L (Figure 25), with reaction time significantly decreased and 
improvement  in  both  yield  and  E/Z-selectivity  observed  (entry  5).    Further 
investigation showed that this catalyst provides the highest yield of trisubstituted 
alkene  174  when  the  reaction  is  carried  out  at  45  °C,  allowing  lower  catalyst 
loadings to be used. 
 
Entry  Catalyst (initial/ 
total loading, mol%) 
Solvent  Temperature 
(°C) 
Time 
(h) 
Yield 
(%) 
E : Z 
1  K (5/15)  CH2Cl2  45  190   6  1.7 : 1 
2  K (20/25)  CH2Cl2  45  72  25  3 : 2 
3  K (20/25)  toluene  80  88  31  1.2 : 1 
4  K (5/10) + CuI (10)  CH2Cl2  45  71  0  _ 
5  L (20)  toluene  80  24  41  2 : 1 
6  L (5/10)  toluene  80  354  18  1.2 : 1 
7  L (10/22.5)  toluene  80  162  23  2.2 : 1 
8  L (5/6)  CH2Cl2  45  72  53  1.7 : 1 
Table 10.  Results of cross-metathesis study 
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Figure 25.  Hoveyda-Grubbs 2
nd generation catalyst L for cross-metathesis 
 
Confirmation of the geometry of the alkene products was achieved using 
1H NMR 
spectroscopic analysis by the nuclear Overhauser effect.  Selective irradiation of 
the 
1H NMR signal arising from the alkene proton at 5.97 ppm provided the ability to 
distinguish  between  the  E  and  Z  product  isomers.    In  the  E-isomer,  the  alkene 
proton should interact through space with the CH2 group of carbon-3, while the Z-
isomer’s alkene proton should interact with the methyl group substituent of the 
double bond, as indicated in Figure 26. 
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Figure 26.  Anticipated through-space interaction with alkene protons 
 
These experiments confirmed that the major isomer formed in each attempt of the 
reaction was, as expected, the E-isomer, and the spectra from this study are shown 
below in Figure 27 (E-isomer) and Figure 28 (Z-isomer). 
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Figure 27.  nOe spectrum for E-174 
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Figure 28.  nOe spectrum for Z-174 
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2.2.7  Installation of quaternary centre via Overman rearrangement 
With the limited quantities of trisubstituted alkene E-174 synthesised, its reduction 
to allylic alcohol 175 was carried out.  As before, this was attempted using the CBS 
asymmetric reduction protocol and  proceeded in  quantitative yield,  as shown in 
Scheme 2.44.  Again, chiral HPLC analysis was carried out with comparison to a 
racemic sample of the allylic alcohol (synthesised in 54% via DIBAL-H reduction), 
and this indicated an enantiomeric excess value of 46% in the CBS reduction product. 
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Scheme 2.44.  Asymmetric reduction of trisubstituted enone E-174 
 
Conversion of allylic alcohol 175 to the corresponding allylic trichloroacetimidate 
176  was  then  attempted  using  the  standard  conditions  previously  discussed.  
However, the additional methyl group introduced additional steric bulk across the 
alkene relative to the disubstituted examples and significantly lowered the reaction 
rates.    Therefore,  acetimidate  formation  required  additional  reaction  time  and 
eventually heating under reflux to promote consumption of the starting material 
175. 
 
The  rearrangement  step  was  also  initially  attempted  under  thermal  conditions 
although  again,  the  presence  of  the  additional  methyl  group  meant  that  longer 
reaction times were applied.  However, none of the desired product was isolated in 
the first attempts at this reaction.  The use of palladium catalysis also failed to 
promote the rearrangement.  Finally, the reaction was attempted by heating the 
allylic trichloroacetimidate 175 at 130 °C in toluene in a sealed reaction tube.  In 
this  instance,  it  appeared  that  a  small  quantity  of  the  desired  rearrangement 
product 177 had formed, although only in a disappointing yield of 11% over the 2 
steps (Scheme 2.45). 
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Scheme 2.45.  Overman rearrangement to form quaternary centre 
 
Although the attempted synthesis of an ,-disubstituted -amino acid target was 
met with limited success, it was hoped that the methodology developed could be 
applied to the synthesis of more complex -amino acid targets. 
 
 
2.2.8  Attempted synthesis of orthogonally-protected meso-diaminopimelic acid 
An investigation was undertaken to use the chemistry developed for the generation 
of an  orthogonally protected  derivative  178 of diaminopimelic acid  179,  a non-
proteinogenic diamino diacid (Figure 29). 
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Figure 29.  Protected meso-diaminopimelic acid derivative and meso-diaminopimelic acid 
 
meso-Diaminopimelic acid (meso-DAP) 179 is found as a component of bacterial cell 
walls, and is a precursor in the biosynthesis of  L-lysine.
92  Therefore, compounds 
similar in structure to meso-DAP have the potential for exhibiting antibiotic activity  
 
93 
by inhibiting this biosynthetic pathway and preventing bacterial cell wall formation.  
Rapid generation of meso-DAP analogues could be aided with the generation of a 
synthetically useful orthogonally-protected derivative such as  178, as this would 
allow the individual manipulation of the functional groups. 
 
The planned synthesis of 178 involved the generation of a chiral allylic alcohol 185 
via cross-metathesis and CBS reduction, which could again be subjected to Overman 
rearrangement to introduce one of the required protected amine groups.  Sharpless 
oxidation  followed  by  esterification  would  complete  the  synthesis  of  178  by 
installing the second ester group.  The steps proposed to complete the synthesis of 
the target compound are outlined below in Scheme 2.46.  The starting material is 
Cbz-protected lysine, which is commercially available as a single enantiomer and 
provides one of the required protected amines and an ester found in the eventual 
target compound. 
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Scheme 2.46.  Cross-metathesis approach to target 178 
 
The first reaction required for this route was a conversion of Cbz-L-lysine to the 
corresponding primary alcohol, and this was carried out according to a literature 
procedure by Bence and Crooks using sodium nitroferricyanide, as shown in Scheme 
2.47.
93  The crude  product  of this reaction was  then  subjected to  esterification  
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under standard conditions, and the desired methyl ester 182 was isolated in a yield 
of 53% over the 2 steps. 
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Scheme 2.47.  Synthesis of primary alcohol 182 
 
Primary alcohol 182 was treated under standard Swern oxidation conditions, and 
the  crude  aldehyde  187  was  reacted  with  a  solution  of  deprotonated 
methyltriphenylphosphonium  bromide  (1.5  equivalents),  which  had  been  treated 
with potassium bis(trimethylsilyl)amide (1.3 equivalents).
94  Unfortunately after the 
olefination  reaction  mixture  had  been  stirred  overnight,  none  of  the  desired 
terminal alkene 183 was isolated (Scheme 2.48). 
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Scheme 2.48.  Swern oxidation and methylenation  
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In order to establish whether this reaction had failed at the Swern oxidation step, 
or during methylenation, the oxidation was carried out a second time, although this 
attempt  was  followed  by  olefination  with  triethyl  phosphonoacetate  under 
Masamune Roush conditions which had previously been shown to successfully react 
with crude aldehydes synthesised in the same manner.
58  The test reaction carried 
out is shown in Scheme 2.49, and successfully generated -unsaturated ester 188 
in a yield of 47% over the 2 steps. 
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Scheme 2.49.  Test Horner-Wadsworth-Emmons olefination 
 
The  successful  outcome  of  this  HWE  olefination  confirms  that  it  is  possible  to 
generate aldehyde 187 using a Swern oxidation, and it was the methylenation of 
this  intermediate  that  was  proving  problematic.    The  Swern  oxidation  and 
methylenation  procedure  was  therefore  repeated,  increasing  the  equivalents  of 
phosphonium salt from 1.5 to 5.0 and equivalents of the KHMDS base from 1.3 to 
5.0.  A fresh bottle of KHMDS was also purchased, although the highest yield of 
terminal alkene 183 isolated using this was just 26% (Scheme 2.50).  Changing the 
base used to potassium tert-butoxide failed to lead to the formation of any of the 
product. 
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Scheme 2.50.  Improved methylenation of aldehyde 187 
 
An alternative method was then investigated for the desired methylenation reaction.  
Nysted  reagent
95,  a  zinc-based  reagent  used  for  the  methylenation  of  carbonyl 
compounds, was used to treat aldehyde 187, which was again generated via the 
Swern oxidation of alcohol 182.  The methylenation was carried out using Nysted 
reagent  in  the  presence  of  boron  trifluoride  diethyl  etherate  according  to  a 
literature procedure by Matsubara et al., as shown in Scheme 2.51.
96  Unfortunately, 
despite attempting this reaction several times, none of the desired alkene 183 was 
isolated. 
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Scheme 2.51.  Attempted Nysted methylenation of aldehyde 187 
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As none of the attempts described above were successful in generating alkene 183 
in  the  high  yield  required  for  the  eventual  synthesis  of  orthogonally-protected 
meso-diaminopimelic acid 178, work in this area was discontinued. 
 
 
2.3 Towards the stereoselective synthesis of capreomycidine 
 
2.3.1 Properties of capreomycidine-containing compounds 
(2S,3R)-Capreomycidine  189  is  a  non-proteinogenic  -amino  acid  with  a  cyclic 
structure incorporating a guanidine group (Figure 30). 
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Figure 30.  (2S,3R)-Capreomycidine 189 
 
(2S,3R)-Capreomycidine 189 is a component of the families of capreomycins and 
the related tuberactinomycins, both of which are cyclic pentapeptides (Figure 31).  
Capreomycins  have  been  shown  to  exhibit  biological  activity  against  strains  of 
Mycobacterium tuberculosis which have proved resistant to other antibiotics.
97  It 
has been shown that the capreomycidine unit within these structures is necessary 
for the biological activity exhibited.
98 
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Figure 31.  Structures of capreomycins and tuberactinomycins 
 
In  addition  to  the  significant  biological  activity  of  (2S,3R)-capreomycidine-
containing  compounds,  its  diastereoisomer  (2S,3S)-capreomycidine  190  (also 
referred  to  as  epi-capreomycidine)  is  also  found  incorporated  into  complex 
structures such as muraymycin A1 (Figure 32) which inhibits a key enzyme involved 
in peptidoglycan biosynthesis in bacteria.
99 
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Figure 32.  Muraymycin A1, inhibitor of peptidoglycan biosynthesis 
 
Previous approaches to the synthesis of (2S,3R)-capreomycidine 189 and (2S,3S)-
capreomycidine 190 include the use of kinetic resolution
100 and chiral auxiliaries.
97  
The development of a stereoselective, efficient route suitable for the generation of 
large  quantities  of  these  amino  acids  could  aid  the  generation  of  a  range  of 
compounds with attractive biological activity.   
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2.3.2 Proposed synthetic route to (2S,3R)-capreomycidine 
Initial efforts would focus on the synthesis of (2S,3R)-capreomycidine 189, using 
the  steps  outlined  in  Scheme  2.52.  A  key  step  involved  in  this  route  is  the 
stereoselective  introduction  of  a  hydroxyl  group  to  an  enolate  derived  from 
protected  L-aspartic  acid  192,  which  is  achieved  using  Davis’  oxaziridine  193.  
Protection of this group is followed by reduction of the methyl ester to primary 
alcohol 196, which is then subjected to a Swern oxidation/olefination reaction to 
introduce  the  required  nitro  group,  which  could  be  converted  to  amine  198  by 
hydrogenation.  Introduction of a protected guanidine unit, followed by a key ring 
closure step and deprotection would then generate the desired target compound. 
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Scheme 2.52.  Proposed synthesis of (2S,3R)-capreomycidine 189  
 
101 
2.3.3 Generation of alcohol via stereoselective hydroxylation 
The first steps of this proposed route involved the protection of L-aspartic acid 191.  
As shown in Scheme 2.53, a single reaction can be used to protect both carboxylic 
acid groups as methyl esters and the amine with a Boc group.  This was carried out 
according to a procedure previously used within the Sutherland research group and 
gave the protected product 192 in 82% yield.
101 
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Scheme 2.53.  Protection of L-aspartic acid 
 
The next step in the route involved the stereoselective introduction of a hydroxyl 
group onto the methylene group of diester  192.  This was to be achieved using 
Davis’ oxaziridine 193, an electrophilic source of oxygen which was first applied to 
the synthesis of -hydroxy carbonyl compounds in 1984.
102  The oxaziridine reagent 
itself was synthesised in 2 steps from commercially available starting materials, as 
outlined in Scheme 2.54.
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Scheme 2.54.  Synthesis of Davis’ oxaziridine 193  
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Attempts were then made to carry out the hydroxylation reaction using oxaziridine 
193,  as  shown  in  Scheme  2.55.    The  procedure  was  carried  out  according  to  a 
literature  procedure  published  by  O’Brien  and  co-workers  whereby  the  enolate 
derivative of diester 192 was formed by treatment with base before addition of the 
oxaziridine  reagent.    The  presence  of  the  large  Boc  group  on  nitrogen  should 
prevent access of the oxaziridine from the top face, and hence the hydroxyl group 
should be added in an anti relationship with this protected amine.
104  Unfortunately, 
the first attempts at this reaction failed to yield any of the desired alcohol product 
anti-194.  Increasing the reaction time from 1 hour to 2 hours led to the isolation 
of the alcohol product in a low yield of just 9%.  However, analysis of the reaction 
product indicated that the hydroxyl group had the undesired syn relationship with 
the protected amine.  The reaction time was then increased further to 6 hours at -
78 °C, followed by stirring overnight at room temperature.  While this led to the 
generation of the anti product anti-194, which was isolated in 20% yield, there was 
still significant formation of the syn product, this time formed in 19% yield.  Further 
repeats of this reaction failed to lead to the generation of significant quantities of 
the desired product, and the ratio of syn:anti products was inconsistent, varying 
from  1:1  to  approximately  3:1.    Therefore,  this  approach  did  not  allow  the 
generation of significant quantities of the anti alcohol product to continue with the 
investigation of this route. 
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Scheme 2.55.  Stereoselective hydroxylation of 192 
 
The  failure  of  this  hydroxylation  reaction  on  a  number  of  attempts  led  to  the 
proposal of an alternative approach to the synthesis of (2S,3R)-capreomycidine 189. 
 
 
 
  
 
103 
2.3.4 Alternative proposed synthesis of (2S,3R)-capreomycidine 
The  alternative  route,  shown  in  Scheme  2.56  makes  use  of  the  Overman 
rearrangement  of  an  allylic  trichloroacetimidate  as  a  key  step.    This  time,  the 
allylic trichloroacetimidate is derived from a primary allylic alcohol and therefore 
control of the stereochemical outcome of the rearrangement reaction is necessary.  
This can be achieved using a chiral Pd catalyst, which will allow the reaction to 
proceed in an enantioselective manner.  A particularly attractive feature of this 
approach  is  the  use  of  either  (S)-(+)-COP-Cl  D  or  (R)-(-)-COP-Cl  J  as  the 
rearrangement  catalyst,  which  should  allow  the  installation  of  opposing 
stereochemistry at C-3 centre, thus meaning that this route has the potential to 
lead  to  the  eventual  synthesis  of  (2S,3R)-capreomycidine  189  or  (2S,3S)-
capreomycidine  190.    Introduction  of  the  protected  guanidine  unit, followed  by 
hydroboration and oxidation of the terminal alkene would give a primary alcohol 
which could undergo mesylation to give the substrate required for a ring closure 
reaction to form the cyclic amino acid core.  Finally, removal of the protecting 
groups  would  give  the  desired  capreomycidine  target.    The  starting  material 
required for this route is D-serine 129, which is again cheap and readily-available 
and  has  the  required  stereochemistry  for  one  of  the  stereocentres  already 
established. 
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Scheme 2.56.  Proposed alternative synthesis of (2S,3R)-capreomycidine 189 
 
 
2.3.5 Protection of D-serine 
The initial steps of this route are concerned with the complete protection of  D-
serine 129.  The amine is protected with a Boc group, while the carboxylic acid can 
be protected as the methyl ester.  Finally, the free hydroxyl can be protected as a 
silyl  ether.    These  protection  reactions  were  carried  out  in  a  straightforward  
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manner using conditions published by Nicolaou and co-workers, as shown below in 
Scheme 2.57.
105  The required ester 212 was synthesised in a total yield of 75% over 
the 3 steps.  Helpfully, purification was not required until after the silyl protection 
step, and so this chemistry was able to provide the desired protected derivative of 
D-serine in a fast, efficient manner. 
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Scheme 2.57.  Protection of D-serine 
 
 
2.3.6 Generation of allylic alcohol intermediate 
In order to generate the desired allylic alcohol 206, an olefination reaction with 
triethyl phosphonoacetate would be used to install the necessary C=C double bond.  
To achieve this, conversion of the methyl ester 212 to the corresponding aldehyde 
was required, and attempts were made to achieve this using diisobutylaluminium 
hydride.  In theory, the use of one equivalent of diisubutylaluminium hydride should 
cause a single reduction of the methyl ester 212 to the aldehyde 213. 
 
The reduction was attempted using one equivalent of diisobutylaluminium hydride, 
and the crude product of the reaction was immediately treated with a solution of 
deprotonated  triethyl  phosphonoacetate  in  an  attempt  to  generate  the  ,-
unsaturated ester 205, as shown in Scheme 2.58.  However upon work-up, none of 
the desired product was found to have formed, and mostly the methyl ester starting 
material 212 from the reduction step remained.  Several further attempts using this  
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approach, with the reaction time increased from 1.5 hours to 18 hours, failed to 
complete the conversion of ester 212 to aldehyde 213 cleanly. 
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Scheme 2.58.  Attempted DIBAL-H reduction and Horner-Wadsworth-Emmons olefination 
 
As the reduction step was failing to generate the desired aldehyde intermediate, it 
was decided to alter this approach to one which involved chemistry which was well-
established within the group for the formation of similar compounds.  As shown in 
Scheme 2.59 below, this required first of all the generation of the primary alcohol 
204, which could then be subjected to a combined Swern oxidation and Horner-
Wadsworth-Emmons olefination reaction, as discussed previously within this thesis.  
Again, the reduction could be achieved using diisobutylaluminium hydride, although 
this time 2.2 equivalents of this reducing agent was employed to fully reduce the 
methyl ester 212 to primary alcohol 204.  As expected, this reaction successfully 
generated the required alcohol 204 in 46% yield. 
 
MeO
O
OTBDMS
NHBoc
OTBDMS
NHBoc
HO
DIBAL-H (1.0 M)
Et2O, -78 °C
46% 212 204  
Scheme 2.59.  Reduction of methyl ester to primary alcohol 
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The primary alcohol 204 was then subjected to a Swern oxidation reaction, and the 
crude  product  of  this  was  immediately  treated  with  a  solution  of  deprotonated 
triethyl  phosphonoacetate  to  complete  the  olefination.    This  took  place  under 
Masamune-Roush conditions, as outlined in Scheme 2.60.
60  The reaction outlined 
here  proved  successful,  and  the  desired  ,-unsaturated  ester  product  205  was 
formed in 76% yield, with a high E/Z ratio of 13:1.  Helpfully, separation of the two 
geometric isomers was straightforward via silica column chromatography. 
 
HO OTBDMS
NHBoc
H
NHBoc
O
oxalyl chloride
DMSO, Et3N
CH2Cl2
-78 °C to r.t.
OTBDMS
NHBoc
EtO
O
P
O
EtO OEt
O
OEt
LiCl, DBU
CH3CN, r.t.
76% (2 steps)
OTBDMS
204 213
205
 
Scheme 2.60.  Swern oxidation and HWE olefination 
 
In  order  to  complete  the  formation  of  the  desired  allylic  alcohol  substrate,  a 
reduction of the ethyl ester 205 was carried out.  As diisobutylaluminum hydride 
had  proven  to  successfully  achieve  the  reduction  of  esters  to  primary  alcohols 
within this and previous projects, this was initially selected as the reducing agent, 
as  shown  in  Scheme  2.61.    Unfortunately,  none  of  the  desired  allylic  alcohol 
product was isolated.  It was thought that a 1,4-reduction of the allylic double bond 
may have been occurring under these conditions. 
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OTBDMS
NHBoc
O
HO OTBDMS
NHBoc
DIBAL-H (1.0 M)
Et2O
-78 °C, then r.t.
× EtO
205 206  
Scheme 2.61.  Attempted reduction to allylic alcohol 
 
This  particular  issue  encountered  with  the  1,2-reduction  of  -amino-,-
unsaturated esters of this type has previously been discussed in the literature, and 
is thought to be attributed to the coordination of diisobutylaluminium to the Boc 
protecting group and the alkene, increases the susceptibility of the ester to 1,4-
reduction.  Moriwake et al. showed that this undesired reduction can be prevented 
if  the  unsaturated  ester  is  treated  with  a  Lewis  acid  such  as  boron  trifluoride 
diethyl etherate before addition of diisobutylaluminium hydride.  The Boc group’s 
oxygen atom coordinates to the Lewis acid, while diisobutylaluminium hydride can 
coordinate only to the ester carbonyl group, promoting the desired 1,2-reduction. 
 
These alternative reaction conditions were therefore applied to the formation of 
allylic  alcohol  206,  as  shown  below  in  Scheme  2.62,  and  this  time  successfully 
generated the desired product in 78% yield.
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OTBDMS
NHBoc
O
HO OTBDMS
NHBoc
BF3·OEt2
DIBAL-H (1.0 M)
Et2O, -78 °C
78%
EtO
205 206  
Scheme 2.62.  Improved reduction to allylic alcohol 
 
 
2.3.7 Investigation of Overman rearrangement conditions 
With  the  allylic  alcohol  in  hand,  it  was  then  possible  to  investigate  the 
stereoselective Overman rearrangement step.  As shown in Scheme 2.63, the allylic 
trichloroacetimidate  formation  step  was  carried  out  as  previously  described, 
although as a primary alcohol was involved this time, the reaction time required 
was just 5 hours. 
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OH
OTBDMS
NHBoc
O
NHBoc
CCl3
NH
O
OTBDMS
NHBoc
CCl3
NH O
OTBDMS
NHBoc
CCl3
NH
+
Cl3CCN
DBU
CH2Cl2
0 °C to r.t.
conditions
(Table 10)
OTBDMS
206
syn-207 anti-207
214
 
Scheme 2.63.  Synthesis and Overman rearrangement of allylic trichloroacetimidate 214 
 
From the allylic trichloroacetimidate 214, a range of reaction conditions were used 
to  promote  the  Overman  rearrangement  and  both  product  yield  and  ratio  of 
syn:anti-product diastereoisomers were noted (Table 11). 
 
Initially,  (S)-(+)-COP-Cl  was  used  as,  according  to  literature  precedent,  this  was 
expected to furnish the desired product diastereoisomer syn-207.  For a thorough 
investigation of this reaction, the same rearrangement was carried out this time in 
the presence of (R)-(-)-COP-Cl in an attempt to install the opposite stereochemistry, 
henceforth  generating  the  anti-product  diastereomer  anti-207.    However,  upon 
comparison of the 
1H NMR spectra of the major products of both of these reactions, 
it was discovered that the same product diastereomer had preferentially formed in 
the presence of both of these catalysts, which was an unexpected observation. 
 
The  rearrangement  was  also  carried  out  using  the  achiral  Pd(II)  catalyst, 
PdCl2(CH3CN)2  and  again,  the  same  product  diastereoisomer  was  formed  in 
preference.    The  rearrangement  was  also  carried  out  under  thermal  conditions, 
heating at 140 °C in p-xylene with a small amount of potassium carbonate present.  
Little to no stereoselectivity for the rearrangement reaction under these conditions 
should be observed, and indeed a 1:1 ratio of both diastereomers was detected by 
1H NMR spectroscopic analysis.  Separation of these diastereoisomers was possible  
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by silica column chromatography, and gave individual samples of both products.  
Further  analysis  and  comparison  to  literature  data  confirmed  that  the 
diastereoisomer formed preferentially in each of the metal-catalysed reactions was 
in fact the anti-diastereoisomer.
41 
 
Conditions  Catalyst loading  Time (h)  Yield (%)  anti : syn 
(S)-(+)-COP-Cl, CH2Cl2, 38 °C  8 mol%  161  76  4.7 : 1 
(R)-(-)-COP-Cl, CH2Cl2, 38 °C  9 mol%  162  58  6 : 1 
K2CO3, p-xylene, 140 °C  N/A  140  67  1 : 1 
PdCl2(CH3CN)2, CH2Cl2, 38 °C  10 mol%  24  53  11 : 1 
Table 11.  Results of Overman rearrangement study 
 
These unexpected results suggest that some factor is interfering with the expected 
progression of these rearrangement reactions, as it had been predicted that the (S)-
(+)-COP-Cl  catalyst  D  and  (R)-(-)-COP-Cl  catalyst  J  should  be  selective  for  the 
formation of opposite product diastereoisomers, which is not the observed outcome.  
The levels of diastereoselectivity are not as high as may have been anticipated, and 
also very long reaction times were required in the presence of these catalysts.  It 
was  thought  that  the  presence  of  the  two  bulky  protecting  groups  on  the 
rearrangement  substrate  214  may  have  hindered  the  approach  of  these  large 
catalysts  in  the  expected  manner,  thus  leading  to  the  observed  stereochemical 
outcome in the rearrangement step. 
 
At this stage, it was decided to take forward the anti-207 and continue with the 
proposed  route  in  an  attempt  to  develop  the  methodology  for  the  synthesis  of 
(2S,3S)-capreomycidine  190,  which  itself  is  found  in  as  a  component  of  many 
compounds which exhibit antibacterial activity.  From the results of this reaction 
study shown in Table 10, it can be seen that while the (S)-(+)-COP-Cl D catalysed 
reaction gives the overall highest product yield, the highest diastereomeric ratio 
product  is  achieved  when  the  simple  PdCl2(CH3CN)2  catalyst  is  utilised.    The 
reaction time is also significantly lower here compared to when the larger chiral 
catalysts are used, and so when this rearrangement reaction was carried out on a 
larger scale, this catalyst was selected to achieve the desired product efficiently. 
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Formation of  compounds such as  207 via Overman rearrangement  chemistry has 
previously been discussed in the literature by Gonda  et al.
41  Selectivity for the 
formation of the anti product diastereoisomer in the presence of PdCl2(CH3CN)2 can 
be explained by co-ordination of palladium(II) to the amine nitrogen atom which 
promotes the progress of the rearrangement via the transition state shown in Figure 
8 in chapter 1.2. 
 
 
2.3.8 Removal of trichloroacetyl group 
In  order  to  introduce  the  required  protected  guanidine  unit,  hydrolysis  of  the 
trichloroacetyl while leaving the two other protecting groups intact was necessary.  
This  was  initially  attempted  using  sodium  hydroxide,  as  shown  in  Scheme  2.64.  
Unfortunately, the hydrolysis of the trichloroacetamide failed to proceed at room 
temperature after 4 days, and the unreacted starting material was recovered.  The 
reaction was repeated, this time with heating to 65 °C although again no reaction 
occurred. 
 
O
OTBDMS
NHBoc
CCl3
NH
OTBDMS
NHBoc
NH2
2 M NaOH
r.t. ×
anti-207 215  
Scheme 2.64.  Attempted hydrolysis of trichloroacetyl group 
 
An  alternative  approach  was  then  adopted  for  the  removal  of  the 
trichloroacetamide  group,  this  time  by  reduction.    Sodium  borohydride  was 
employed, as shown in Scheme 2.65.  These conditions were expected to readily 
generate  amine  215,  although  the  reduction  proved  to  be  slow,  and  required 
stirring for 5 days.  Despite the long reaction time, the product yield was relatively 
low at 23%. 
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O
OTBDMS
NHBoc
CCl3
NH
OTBDMS
NHBoc
NH2 NaBH4
EtOH, r.t.
23%
anti-207 215  
Scheme 2.65.  Removal of trichloroacetyl group by reduction 
 
As  small  quantities  of  the  amine  215  were  generated  via  this  method,  only  a 
preliminary investigation into the introduction of the protected guanidine unit was 
conducted, implementing reaction conditions used within the group previously as 
outlined in Scheme 2.66.
107,108,109  Unfortunately, none of the desired product was 
detected. 
 
OTBDMS
NHBoc
NH2
OTBDMS
NHBoc
NH
NBoc
BocHN
BocHN N
NBoc
N
iPr2NEt
MeOH, r.t. ×
216 215  
Scheme 2.66.  Attempted introduction of guanidine unit 
 
At this stage, time restrictions unfortunately dictated that further development of 
this synthetic route is not currently possible.  However, successful generation of the 
late-stage  amine  intermediate  215  was  achieved  and  therefore,  further 
investigation of this route would be desirable.  The use of a stronger reducing agent 
could  improve  the  formation  of  the  required  amine  215  and  as  the  chemistry 
required for introduction of the Boc-protected guanidine unit is known within the 
literature, so would be expected to successfully generate the intermediate required 
for the ring-closing step.  Following this, relatively straightforward chemistry can 
be applied to complete the formation of the desired (2S,3S)-capreomycidine target 
190 as described in Scheme 2.56. 
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2.4 Conclusions 
 
During the course of this research project, new methodology has been developed 
for the synthesis of chiral allylic alcohols which could be utilised in the generation 
of -amino acid targets.  Initial studies investigated the use of organophosphorus 
olefination  reagents  for  allylic  alcohol  generation  and  while  the  scope  of  this 
methodology was  limited,  an investigation  of Overman rearrangement  conditions 
was conducted to determine the optimum method for the conversion of secondary 
allylic alcohol 125 to allylic trichloroacetamide 127.  -Amino acid target D-serine 
129  was  then  formed  by  oxidative  cleavage  of  the  double  bond,  followed  by 
hydrolysis of the trichloroacetamide under acidic conditions (Scheme 2.67). 
 
OEt
O
OH (i) TBDPSCl
imidazole
(ii) DIBAL-H
OH
OTBDPS (i) oxalyl chloride
DMSO, Et3N
(ii) triethyl 
phosphonoacetate
OTBDPS
OH
114
116
119
O
OEt
OMOM
(i) DIBAL-H
(ii) MOMBr
(iii) Bu4N+F-
O
OMOM
CCl3
NH
(i) Cl3CCN
DBU
(ii) 
(i) NaIO4
RuCl3·xH2O
(ii) HCl
HO OH
NH2
O
129 127 125  
Scheme 2.67.  Synthesis of D-serine via organophosphorus olefination chemistry 
 
An  alternative  approach  was  then  investigated  for  the  synthesis  of  chiral  allylic 
alcohols which has improved flexibility for the generation of a range of alcohols 
with various side chains in place.  This involved the cross-metathesis of enone 136 
with  terminal  alkene  partners,  followed  by  asymmetric  CBS-catalysed  ketone 
reduction (Scheme 2.68). 
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Scheme 2.68.  Alternative methodology developed for chiral allylic alcohol generation 
 
Again,  the  Overman  rearrangement  was  employed  to  generate  allylic 
trichloroacetamides  which  was  followed  by  oxidative  cleavage  and  hydrolysis  as 
shown in Scheme 2.67  to furnished  -amino  acid targets 167–170 and 172 in a 
highly efficient manner, with good product yields encountered during the key steps 
of the route.  Importantly, the use of Overman rearrangement chemistry allows the 
levels of enantiomeric excess established during CBS reduction to be transferred 
directly to the allylic trichloroacetamides, and hence to the eventual -amino acid 
targets. 
 
HO
O
NH2
HO
Ph
O
NH2
HO
O
NH2
HO
O
NH2 OH
168 169
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O
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Attempts were then made to apply the successfully developed methodology to the 
generation of some more complex  -amino acid targets, including a target bearing 
quaternary-substitution on the -carbon atom, formed via a trisubstituted allylic 
alcohol  175  which  was  again  generated  from  a  cross-metathesis  reaction  with 
enone 136, followed by CBS reduction.  Initial results indicated that installation of 
the required quaternary centre is possible using a thermal Overman rearrangement 
reaction (Scheme 2.69). 
  
 
115 
OH O
(i) 2-methyl-
1-pentene,
Grubbs
catalyst K
(ii) CBS
reduction
Ph Ph Ph
NH O
(i) Cl3CCN
DBU, 
(ii) K2CO3
toluene, 
CCl3
136 175
177  
Scheme 2.69.  Introduction of quaternary centre via Overman rearrangment 
 
Finally, a late-stage intermediate anti-207 which can be applied to the eventual 
synthesis of (2S,3S)-capreomycidine  190 was generated  using  Horner-Wadsworth-
Emmons  olefination  chemistry  to  form  the  double  bond,  and  a  metal-catalysed 
Overman  rearrangement  to  introduce  the  trichloroacetamide  functionality  in  a 
diastereoselective manner.  The intermediate was successfully formed in 9 steps 
from  D-serine,  again  encountering  high  yields  in  many  of  the  reactions  required 
(Scheme 2.10).  Future work conducted in this area should allow the generation of 
the  desired  (2S,3S)-capreomycidine  target  190  following  the  steps  outlined  in 
Scheme 2.56. 
 
OTBDMS
NHBoc
NH2
CO2H
NH2
NH HN
NH
190
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HO
O
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Scheme 2.70.  Generation of intermediate anti-207 
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3.0 Experimental 
 
General Experimental Information 
Reactions  were  carried  out  in  oven-  or  flame-dried  glassware  under  an  argon 
atmosphere unless otherwise stated.  Starting materials and reagents were obtained 
from commercial sources and used as received.  Lithium chloride was oven-dried for 
at least 12 hours prior to use.  Dry solvents were purified using a PureSolv 500 MD 
solvent purification system.  Flash column chromatography was carried out using 
Fisher matrix silica 60.  Macherey-Nagel aluminium-backed plates pre-coated with 
silica gel 60 (UV254) were used for thin layer chromatography, and were visualised 
by  staining  with  potassium  permanganate.   
1H  NMR  and 
13C  NMR  spectra  were 
recorded on a Bruker DPX 400 spectrometer with chemical shift values in parts per 
million relative to tetramethylsilane (H 0.00 and C 0.0) or residual chloroform (H 
7.28 and C 77.2) as standard.  Proton and carbon assignments are based on two-
dimensional COSY and DEPT experiments respectively.  Mass spectra were obtained 
using a JEOL JMS-700 spectrometer.  Infrared spectra were obtained neat using a 
Shimadzu IRPrestige-21 spectrometer or using sodium chloride plates on a JASCO 
FTIR 410 spectrometer.  Optical rotations were determined as solutions irradiating 
with the sodium D line ( = 589 nm) using an AA series Automatic polarimeter.  []D 
values are given in units 10
-1 degcm
2g
-1.  Chiral HPLC was performed on a Hewlett 
Packard Agilent 1100 Series instrument  and  was  calibrated with  the appropriate 
racemic sample mixture. 
 
General  Procedure  1:    Cross-metathesis  of  5-phenylpent-1-en-3-one 114  with 
terminal alkene partners 
O
R
Grubbs 2nd
generation catalyst K
CH2Cl2, 45 °C
O
R
 
The terminal alkene partner was added to a stirred solution of 5-phenylpent-1-en-3-
one  114  in  dichloromethane,  followed  by  a  solution  of  Grubbs  2
nd  generation 
catalyst (4 mol%) in dichloromethane.  The resulting reaction mixture was heated to 
45 °C and allowed to stir under reflux until complete consumption of 5-phenylpent- 
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1-en-3-one  114  was  detected  by  TLC  analysis.    The  reaction  mixture  was  then 
allowed to cool to room temperature and concentrated in vacuo.  Purification was 
carried out by silica column chromatography to give the desired enone product. 
 
 
General Procedure 2:  Enantioselective CBS oxazaborolidine-catalysed reduction 
of enones to allylic alcohols 
R
O
R
OH
(S)-(-)-2-Methyl-CBS-
oxazaborolidine (1.0 M)
BH3·THF (1.0 M)
THF, -20 °C
 
A stirred solution of  the enone intermediate in tetrahydrofuran was cooled  to  -
20 °C before (S)-(-)-2-methyl-CBS-oxazaborolidine solution (1.0 M in toluene) was 
added,  followed  by  borane  tetrahydrofuran  complex  solution  (1.0  M  in 
tetrahydrofuran).  The resulting reaction mixture was then stirred at -20 °C for 2.5 
h  before  being  quenched  by  the  slow  addition  of  methanol  (15  mL).    Once  gas 
evolution ceased, the mixture was concentrated in vacuo and then purified by silica 
column chromatography to give the desired allylic alcohol product. 
 
 
General  Procedure  3:    Reduction  of  enones  to  allylic  alcohols  using 
diisobutylaluminium hydride 
O
R
DIBAL-H (1.0 M)
toluene, 0 °C
OH
R
 
A  stirred  solution  of  the  enone  (1.0  eq)  in  toluene  was  cooled  to  0  °C  before 
diisobutylaluminium hydride solution (1.0 M in hexanes, 1.5 eq) was added dropwise.  
The resulting reaction mixture was allowed to stir at 0 °C for 3 h before being 
quenched by the addition of methanol (20 mL) and filtered through a pad of Celite
®, 
which  was  washed  with  warm  methanol  (50  mL).    The  combined  filtrates  were 
concentrated  in  vacuo,  and  purification  was  carried  out  by  silica  column 
chromatography to give the desired allylic alcohol product. 
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General  Procedure  4:  Conversion  of  allylic  alcohol  to  allylic 
trichloroacetimidate 
OH
R
O
R
CCl3
NH Cl3CCN
DBU
CH2Cl2
0 °C, then r.t.  
A stirred solution of the allylic alcohol (1.0 eq) in dichloromethane was cooled to 
0 °C  before  1,8-diazabicyclo[5.4.0]undec-7-ene (0.5  eq)  was  added,  followed by 
trichloroacetonitrile (1.5 eq).  The reaction mixture was allowed to stir at 0 °C for 
0.2 h, and then at room temperature for 24 h before being filtered through a short 
plug of silica, which was washed with diethyl ether (50 mL).  The combined filtrates 
were concentrated in vacuo to give the desired crude allylic trichloroacetimidate, 
which was used without further purification. 
 
 
General Procedure 5:  Overman rearrangement of allylic trichloroacetimidate to 
allylic trichloroacetamide (thermal conditions) 
R
O
CCl3
NH
R
NH
CCl3
O
K2CO3
p-xylene
140 °C
 
The  crude  allylic  trichloroacetimidate  (1.0  eq)  was  dissolved  in  p-xylene,  and 
potassium carbonate (0.003 g per mL of solvent) was added.  The reaction mixture 
was heated to 140 °C and stirred under reflux overnight before being allowed to 
cool to room temperature and then concentrated in vacuo.  Purification was carried 
out by silica column chromatography to give the desired allylic trichloroacetamide 
product. 
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General  Procedure  6:  Oxidative  cleavage  of  allylic  double  bond  and 
esterification 
NH
R
CCl3
O
R
MeO
O
NH
CCl3
O
(i) NaIO4
RuCl3·xH2O
CH3CN/CCl4/H2O
r.t.
(ii) SOCl2
MeOH, 65 °C  
The  allylic  trichloroacetamide  (1.0  eq)  was  dissolved  in  acetonitrile  and  carbon 
tetrachloride and to this stirred solution,  sodium periodate (4.1 eq,  dissolved in 
water) was added.  Ruthenium(III) chloride hydrate (0.1 eq) was then added, and 
the  reaction  mixture  was  stirred  at  room  temperature  for  22  h  before  being 
partitioned between water (100 mL) and dichloromethane (100 mL).  The organic 
phase was dried (MgSO4), filtered, and concentrated in vacuo.  The residue was 
then dissolved in methanol, and the solution cooled to 0 °C before thionyl chloride 
(5.0 eq) was added dropwise.  The resulting reaction mixture was stirred at 0 °C for 
0.1  h  and  then  heated  to 65 °C and stirred  under reflux for 22 h  before  being 
allowed to cool to room temperature and concentrated in vacuo.  The residue was 
partitioned between a saturated aqueous solution of sodium hydrogen carbonate 
(30 mL) and ethyl acetate (30 mL) and the organic phase was dried (MgSO4), filtered, 
and  concentrated  in  vacuo.    Purification  was  carried  out  by  silica  column 
chromatography to give the desired methyl ester. 
 
 
General Procedure 7:  Deprotection to generate -amino acid targets 
MeO
R
O
NH
CCl3
O
HO
O
R
NH2 6 M HCl
reflux
·HCl
 
The methyl ester (1.0 eq) was dissolved in 6 M hydrochloric acid, and the resulting 
reaction mixture was heated under reflux overnight before being allowed to cool to 
room  temperature.    Water  (20  mL)  and  diethyl  ether  (30  mL)  were  added,  the 
layers were separated, and the aqueous phase was concentrated in vacuo to give 
the desired -amino acid product as the hydrochloride salt. 
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(E)-4-Phenyl-1-(phenylsulfonyl)-1-butene
110 
S
O O
1
2
3
4
103  
Grubbs  2
nd  generation  catalyst  K  (0.025  g,  0.03  mmol,  dissolved  in  5  mL  of 
dichloromethane) was added to a stirred solution of 4-phenyl-1-butene 101 (0.089 
mL,  0.59  mmol)  and  phenyl  vinyl  sulfone  102  (0.100  g,  0.59  mmol)  in 
dichloromethane (15 mL).  The reaction mixture was heated to 45 °C and stirred 
under reflux for 20 h before further 4-phenyl-1-butene (0.018 mL, 0.12 mmol) and 
Grubbs  2
nd  generation  catalyst  K  (0.005  g,  0.006  mmol,  dissolved  in  2  mL  of 
dichloromethane) were added. The reaction mixture was stirred under reflux for a 
further 2.5 h before being allowed to cool to room temperature and concentrated 
in vacuo.  Purification was carried out by silica column chromatography, and elution 
with  7:43  diethyl  ether/petroleum  ether  gave  (E)-4-phenyl-1-(phenylsulfonyl)-1-
butene 103 as a pale yellow oil (0.124 g, 77%).  max/cm
-1 (NaCl) 3060 (CH), 3027 
(CH), 2926 (CH), 1626 (C=C), 1496, 1446, 1317, 1146, 1087, 822, 750; H (400 MHz, 
CDCl3) 2.52–2.60 (2H, m, 3-H2), 2.77 (2H, t, J 7.6 Hz, 4-H2), 6.29 (1H, dt, J 15.0, 1.5 
Hz, 1-H), 7.01 (1H, dt, J 15.0, 6.9 Hz, 2-H), 7.09–7.14 (2H, m, 2 × ArH), 7.15–7.21 
(1H, m, ArH), 7.22–7.28 (2H, m, 2 × ArH), 7.49–7.56 (2H, m, 2 × ArH), 7.58–7.64 (1H, 
m, ArH), 7.79–7.84 (2H, m, 2 × ArH); C (100 MHz, CDCl3) 33.3 (CH2), 34.0 (CH2), 
126.5 (CH), 127.7 (2 × CH), 128.5 (2 × CH), 128.7 (2 × CH), 129.3 (2 × CH), 131.2 
(CH),  133.4  (CH),  140.1  (C),  140.7  (C),  146.1  (CH);  m/z  (CI)  273.0952  (MH
+. 
C16H17O2S requires 273.0949), 259 (11%), 245 (5), 183 (10), 130 (13), 91 (10), 69 (9). 
 
 
(E)-4,4-Dimethyl-1-(phenylsulfonyl)-1-pentene 
S
O O
1
2
3
4
5
110  
Grubbs  2
nd  generation  catalyst  K  (0.200  g,  0.24  mmol,  dissolved  in  20  mL  of 
dichloromethane) was added to a stirred solution of 4,4-dimethyl-1-pentene 109 
(1.17  mL,  8.15  mmol)  and  phenyl  vinyl  sulfone  102  (2.74  g,  16.3  mmol)  in  
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dichloromethane (100 mL).  The reaction mixture was heated to 45 °C and allowed 
to stir under reflux for 23 h.  Further Grubbs 2
nd generation catalyst K (0.143 g, 
0.17  mmol,  dissolved  in  10  mL  of  dichloromethane)  was  then  added  and  the 
reaction was again stirred under reflux for 27 h before being concentrated in vacuo.  
Purification was carried out by silica column chromatography, and elution with 1:7 
diethyl  ether/petroleum  ether  gave  (E)-4,4-dimethyl-1-(phenylsulfonyl)-1-pentene 
110 as a colourless oil (1.31 g, 67%).  max/cm
-1 (NaCl) 3062 (CH), 2958 (CH), 1631 
(C=C), 1475, 1446, 1367, 1317, 1146, 1087, 976, 822, 753 cm
-1; H (400 MHz, CDCl3) 
0.92 (9H, s, C(CH3)3), 2.11 (2H, dd, J 7.9, 1.2 Hz, 3-H2), 6.30 (1H, dt, J 15.0, 1.2 Hz, 
1-H), 7.01 (1H, dt, J 15.0, 7.9 Hz, 2-H), 7.50–7.57 (2H, m, 2 × ArH), 7.58–7.64 (1H, 
m, ArH), 7.85–7.91 (2H, m, 2 × ArH); C (100 MHz, CDCl3) 29.3 (3 × CH3), 31.6 (C), 
45.7 (CH2), 127.5 (2 × CH), 129.2 (2 × CH), 132.0 (CH), 133.2 (CH), 140.7 (C), 144.9 
(CH); m/z (CI) 239.1104 (MH
+. C13H19O2S requires 239.1106), 69 (6%). 
 
 
Ethyl (2E,4S)-4-hydroxy-6-phenylhex-2-enoate 
OEt
O
OH
2
3
4
5
6
113  
(E)-4-Phenyl-1-(phenylsulfonyl)-1-butene 103 (0.100 g, 0.37 mmol) was dissolved in 
tert-butanol (2 mL) and water (2 mL) and to the stirred solution, AD-mix- (1.47 g) 
was added, followed by methanesulfonamide (0.044 g, 0.46 mmol).  The reaction 
mixture was stirred at room temperature, in air, for 50 h and then water (25 mL) 
and  dichloromethane  (25  mL)  were  added  to  the  flask.    The  resulting  biphasic 
mixture  was  stirred  at  room  temperature  for  0.5  h  and  then  the  layers  were 
separated.  The organic layers were further extracted using dichloromethane (4 × 
10  mL)  and  the  combined  organic  phases  were  dried  (MgSO4),  filtered,  and 
concentrated in vacuo to give the desired aldehyde intermediate.  Meanwhile, in a 
separate flask, sodium hydride (60% dispersion in mineral oil, 0.015 g, 0.37 mmol) 
was added to a stirred solution of triethyl phosphonoacetate (0.080 mL, 0.40 mmol) 
in tetrahydrofuran (5 mL).  The mixture was stirred at room temperature for 0.5 h 
and then the crude aldehyde (dissolved in 2 mL of tetrahydrofuran) was added.  The  
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resulting reaction mixture was then allowed to stir at room temperature for 67 h 
before being partitioned between water (20 mL) and diethyl ether (20 mL).  The 
layers were separated and the organic layers were further extracted using diethyl 
ether (3 × 10 mL).  The combined organic phases were then dried (MgSO4), filtered, 
and  concentrated  in  vacuo.    Purification  was  carried  out  by  silica  column 
chromatography, and elution with 3:17 ethyl acetate/petroleum ether gave ethyl 
(2E,4S)-4-hydroxy-6-phenylhex-2-enoate  113  as  a  colourless  oil  (0.021  g,  24%).  
max/cm
-1 (NaCl) 3448 (OH), 2928 (CH), 1717 (CO), 1656 (C=C), 1454, 1369, 1306, 
1179, 1034, 981, 750; []D
21 + 23.8 (c 1.5, CHCl3); H (400 MHz, CDCl3) 1.29 (3H, t, J 
7.1 Hz, OCH2CH3), 1.72–1.81 (1H, br s, OH), 1.83–1.99 (2H, m, 5-H2), 2.68–2.83 (2H, 
m, 6-H2), 4.20 (2H, q, J 7.1 Hz, OCH2CH3), 4.28–4.37 (1H, m, 4-H), 6.05 (1H, dd, J 
15.7, 1.6 Hz, 2-H), 6.96 (1H, dd, J 15.7, 4.9 Hz, 3-H), 7.17–7.33 (5H, m, 5 × ArH); C 
(100 MHz, CDCl3) 14.2 (CH3), 31.4 (CH2), 38.0 (CH2), 60.5 (CH2), 70.3 (CH), 120.4 
(CH), 126.1 (CH), 128.4 (2 × CH), 128.5 (2 × CH), 141.2 (C), 149.8 (CH), 166.5 (C); 
m/z (CI) 235.1337 (MH
+. C14H19O3 requires 235.1334), 235 (MH
+, 100%), 217 (55), 189 
(64), 171 (8), 143 (25), 131 (15), 105 (15), 91 (39), 73 (5). 
 
 
Ethyl (2S)-2-(tert-butyldiphenylsilyloxy)propanoate
111 
OEt
O
O
Si
2
3
115
 
To a stirred solution of ethyl L-lactate 114 (4.83 mL, 42.3 mmol) in tetrahydrofuran 
(50  mL),  imidazole  (4.32  g,  63.5  mmol)  was  added,  followed  by  tert-
butyldiphenylchlorosilane (13.0 mL,  50.7  mmol), upon which a white precipitate 
formed.  The reaction mixture was allowed to stir at room temperature for 22 h 
before  being  filtered,  and  the  solid  washed  with  ethyl  acetate  (20  mL).    The 
combined  filtrates  were  concentrated  in  vacuo  and  the  resulting  residue  was 
partitioned between water (200 mL) and ethyl acetate (200 mL).  The layers were 
separated  and  the  organic  phase  was  washed  further  with  water  (2  ×  150  mL)  
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before being dried (MgSO4), filtered, and concentrated in vacuo.  Purification was 
carried  out  by  silica  column  chromatography,  and  elution  with  1:19  ethyl 
acetate/petroleum  ether  gave  ethyl  (2S)-2-(tert-butyldiphenylsilyloxy)propanoate 
115 as a colourless oil (12.28 g, 81%).  max/cm
-1 (NaCl) 2933 (CH), 2858 (CH), 1753 
(CO), 1428, 1137, 703; []D
25 -42.6 (c 1.0, CHCl3) (lit.
111 []D -41.1 (c 2.0, CHCl3)); H 
(400 MHz, CDCl3) 1.09 (9H, s, SiC(CH3)3), 1.15 (3H, t, J 7.1 Hz, OCH2CH3), 1.37 (3H, 
d, J 6.7 Hz, 3-H3), 4.02 (2H, qd, J 7.1, 1.0 Hz, OCH2CH3), 4.26 (1H, q, J 6.7 Hz, 2-H), 
7.32–7.47 (6H, m, 6 × ArH), 7.62–7.71 (4H, m, 4 × ArH); C (100 MHz, CDCl3) 14.0 
(CH3), 19.2 (C), 21.3 (CH3), 26.8 (3 × CH3), 60.6 (CH2), 68.9 (CH), 127.5 (2 × CH), 
127.6 (2 × CH), 129.7 (2 × CH), 133.2 (C), 133.6 (C), 135.7 (2 × CH), 135.9 (2 × CH), 
173.8 (C); m/z (CI) 299 (MH
+-C(CH3)3, 24%), 279 (100), 251 (15), 69 (7). 
 
 
(2S)-2-(tert-butyldiphenylsilyloxy)propan-1-ol
56 
OH
O
Si
1
2
3
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Borane tetrahydrofuran complex solution (1.0 M in tetrahydrofuran, 24.0 mL, 24.0 
mmol)  was  slowly  added  to  a  stirred  solution  of  ethyl  (2S)-2-(tert-
butyldiphenylsilyloxy)propanoate  115 (3.80 g, 10.7 mmol) in tetrahydrofuran (15 
mL).  The reaction mixture was heated to 65 °C and stirred under reflux for 22 h 
before being allowed to cool to room temperature.  Further borane tetrahydrofuran 
complex solution (1.0 M in tetrahydrofuran, 3.20 mL, 3.20 mmol) was added, and 
the reaction was heated to 65 °C and stirred under reflux for 5 h before being 
allowed to cool to room temperature and quenched by the addition of water (30 
mL).    The  tetrahydrofuran  was  removed  in  vacuo,  and  the  organic  layers  were 
extracted using dichloromethane (3 × 50 mL).  The combined organic phases were 
then  dried  (MgSO4),  filtered,  and  concentrated  in  vacuo  to  give  (2S)-2-(tert-
butyldiphenylsilyloxy)propan-1-ol 116 as a pale yellow oil (2.82 g, 84%).  max/cm
-1 
(NaCl) 3386 (OH), 2931 (CH), 2858 (CH), 1427, 1111, 1047, 702; []D
25 +26.7 (c 1.0,  
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CHCl3); H (400 MHz, CDCl3) 1.05 (3H, d, J 6.3 Hz, 3-H3), 1.07 (9H, s, SiC(CH3)3), 
1.92 (1H, t, J 6.4 Hz, OH), 3.39–3.46 (1H, m, 1-HH), 3.48–3.55 (1H, m, 1-HH), 3.91–
4.00 (1H, m, 2-H), 7.35–7.47 (6H, m, 6 × ArH), 7.65–7.71 (4H, m, 4 × ArH); C (100 
MHz, CDCl3) 19.2 (C), 19.6 (CH3), 27.0 (3 × CH3), 68.2 (CH2), 70.2 (CH), 127.6 (2 × 
CH), 127.8 (2 × CH), 129.7 (CH), 129.8 (CH), 133.8 (C), 134.0 (C), 135.7 (2 × CH), 
135.8 (2 × CH); m/z (CI) 257 (MH
+-C(CH3)3, 18%), 237 (100), 71 (7). 
 
 
Ethyl (2E,4S)-4-(tert-butyldiphenylsilyloxy)pent-2-enoate
112 
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A stirred solution of oxalyl chloride (0.65 mL, 7.63 mmol) in dichloromethane (55 
mL) was cooled to -78 °C before dimethylsulfoxide (1.10 mL, 15.5 mmol) was added 
dropwise.    The  mixture  was  stirred  at  -78  °C  for  0.25  h  and  then  (2S)-2-(tert-
butyldiphenylsilyloxy)propan-1-ol  116  (2.00  g,  6.36  mmol,  dissolved  in  5  mL  of 
dichloromethane) was added.  The reaction was stirred again at -78 °C for 0.25 h 
before  triethylamine  (4.50  mL,  32.3  mmol)  was  added.    The  resulting  reaction 
mixture was stirred at -78 °C for 1.25 h, and then at room temperature for 4 h 
before being concentrated in vacuo to give the desired crude aldehyde, which was 
used without further purification.  Meanwhile, in a separate flask, lithium chloride 
(0.674  g,  15.9  mmol)  was  suspended  in  acetonitrile  (60  mL)  and  1,8-
diazabicyclo[5.4.0]undec-7-ene  (2.40  mL,  16.0  mmol)  was  added,  followed  by 
triethyl phosphonoacetate (3.20 mL, 16.1 mmol).  The mixture was stirred at room 
temperature for 1 h before being added to the crude aldehyde, and the resulting 
reaction mixture was allowed to stir at room temperature for 22 h before being 
quenched by the addition of a saturated aqueous solution of ammonium chloride 
(100  mL).    The  organic  solvent  was  removed  in  vacuo,  and  the  residue  was 
partitioned between ethyl acetate (150 mL) and water (50 mL).  The layers were 
separated, and the organic layers were further extracted using ethyl acetate (3 ×  
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150  mL).    The  combined  organic  phases  were  then  dried  (MgSO4),  filtered,  and 
concentrated  in  vacuo.    Purification  was  carried  out  by  silica  column 
chromatography, and elution with 2:23 ethyl acetate/petroleum ether gave ethyl 
(2E,4S)-4-(tert-butyldiphenylsilyloxy)pent-2-enoate 119 as a colourless oil (1.91 g, 
79%).  max/cm
-1 (NaCl) 3071 (CH), 2932 (CH), 2858 (CH), 1720 (CO), 1660 (C=C), 
1428, 1273, 1157, 1112, 979, 703; []D
25 -42.2 (c 1.0, CHCl3) (lit.
112 []D
20 -40.0 (c 
2.0, CHCl3)); H (400 MHz, CDCl3) 1.08 (9H, s, SiC(CH3)3), 1.12 (3H, d, J 6.5 Hz, 5-H3), 
1.30 (3H, t, J 7.1 Hz, OCH2CH3), 4.13–4.26 (2H, m, OCH2CH3), 4.41–4.50 (1H, m, 4-
H), 6.01 (1H, dd, J 15.5, 1.6 Hz, 2-H), 6.90 (1H, dd, J 15.5, 4.4 Hz, 3-H), 7.33–7.47 
(6H, m, 6 × ArH), 7.60–7.71 (4H, m, 4 × ArH); C (100 MHz, CDCl3) 14.3 (CH3), 19.3 
(C), 23.3 (CH3), 27.0 (3 × CH3), 60.3 (CH2), 68.6 (CH), 119.1 (CH), 127.6 (4 × CH), 
129.8 (2 × CH), 133.4 (C), 134.0 (C), 135.7 (2 × CH), 135.8 (2 × CH), 151.5 (CH), 
166.9 (C); m/z (EI) 382.1963 (M
+. C23H30O3Si requires 382.1964), 325 (100%), 227 
(47), 199 (77), 175 (33), 135 (13), 123 (10), 77 (14). 
 
 
(2E,4S)-4-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol
113 
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A stirred solution of ethyl (2E,4S)-4-(tert-butyldiphenylsilyloxy)pent-2-enoate 119 
(1.80  g,  4.71  mmol)  in  diethyl  ether  (20  mL)  was  cooled  to  -78  °C  before 
diisobutylaluminium hydride solution (1.0 M in hexanes, 10.5 mL, 10.5 mmol) was 
added dropwise.  The reaction mixture was allowed to stir at room temperature for 
5  h  before  being  cooled  to  0  °C  and  quenched  by  the  addition  of  a  saturated 
aqueous solution of ammonium chloride (40 mL).  Further diethyl ether (40 mL) was 
added, and the biphasic mixture was warmed to room temperature and stirred for 
1.5 h before being filtered through a pad of Celite
®.  The collected solids were 
washed with diethyl ether (400 mL) and the combined filtrates were dried (MgSO4), 
filtered,  and  concentrated  in  vacuo  to  give  (2E,4S)-4-(tert- 
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butyldiphenylsilyloxy)pent-2-en-1-ol 123 as a colourless oil (1.56 g, 97%).  max/cm
-1 
(NaCl) 3340 (OH), 2929 (CH), 2857 (CH), 1427, 1111, 1075, 997, 701; []D
21 -20.8 (c 
0.5, CHCl3) (lit.
113 []D
21 -21.2 (c 2.1, CH2Cl2)); H (400 MHz, CDCl3) 0.99 (1H, t, J 5.7 
Hz, OH), 1.06 (9H, s, SiC(CH3)3), 1.17 (3H, d, J 6.3 Hz, 5-H3), 3.99 (2H, t, J 5.7 Hz, 
1-H2), 4.29–4.38 (1H, m, 4-H), 5.55 (1H, dt, J 15.5, 5.7 Hz, 2-H), 5.65 (1H, dd, J 
15.5, 5.6 Hz, 3-H), 7.32–7.46 (6H, m, 6 × ArH), 7.63–7.71 (4H, m, 4 × ArH); C (100 
MHz, CDCl3) 19.2 (C), 24.2 (CH3), 27.0 (3 × CH3), 63.2 (CH2), 70.0 (CH), 127.4 (2 × 
CH), 127.5 (2 × CH), 127.7 (CH), 129.5 (CH), 129.6 (CH), 134.3 (C), 134.4 (C), 135.9 
(2 × CH), 136.0 (2 × CH), 136.1 (CH); m/z (CI) 323 (100%), 283 (33), 257 (19), 239 
(18), 199 (40), 179 (15), 69 (10). 
 
 
(2E,4S)-4-(tert-butyldiphenylsilyloxy)-1-(methoxymethoxy)pent-2-ene 
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O
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A stirred solution of (2E,4S)-4-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol 123 (1.24 g, 
3.64  mmol)  in  dichloromethane  (40  mL)  was  cooled  to  0  °C  before 
diisopropylethylamine (1.00 mL, 5.74 mmol) was added, followed by bromomethyl 
methyl ether (0.357 mL, 4.37 mmol).  The reaction mixture was allowed to stir at 
0 °C for 0.75 h and then heated to 45 °C and stirred under reflux for 26 h before 
being  cooled  to  room  temperature  and  quenched  by  the  addition  of  2  M 
hydrochloric acid (100 mL).  Dichloromethane (100 mL) was added, and the layers 
were separated.  The organic layers were extracted further with dichloromethane 
(50  mL),  and  the  combined  organic  phases  were  dried  (MgSO4),  filtered,  and 
concentrated  in  vacuo.    Purification  was  carried  out  by  silica  column 
chromatography, and elution with 1:19 ethyl acetate/petroleum ether gave (2E,4S)-
4-(tert-butyldiphenylsilyloxy)-1-(methoxymethoxy)pent-2-ene  124  as  a  colourless 
oil (1.16 g, 82%).  max/cm
-1 (NaCl) 2931 (CH), 2858 (CH), 1472, 1428, 1368, 1149, 
1110,  1048,  703;  []D
21  -31.8  (c  1.0,  CHCl3);  H  (400  MHz,  CDCl3)  1.06  (9H,  s,  
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SiC(CH3)3), 1.14 (3H, d, J 6.0 Hz, 5-H3), 3.35 (3H, s, OCH2OCH3), 3.98 (2H, d, J 5.6 
Hz, 1-H2), 4.32 (1H, quin, J 6.0 Hz, 4-H), 4.59 (2H, s, OCH2OCH3), 5.58 (1H, dt, J 
15.4, 5.6, 2-H), 5.73 (1H, dd, J 15.4, 6.0 Hz, 3-H), 7.33–7.44 (6H, m, 6 × ArH), 7.65–
7.69 (4H, m, 4 × ArH); C (100 MHz, CDCl3) 19.2 (C), 24.2 (CH3), 27.0 (3 × CH3), 55.2 
(CH3), 67.2 (CH2), 69.5 (CH), 95.4 (CH2), 124.6 (CH), 127.4 (2 × CH), 127.5 (2 × CH), 
129.5 (CH), 129.6 (CH), 134.1 (C), 134.5 (C), 135.8 (2 × CH), 135.9 (2 × CH), 137.5 
(CH); m/z (CI) 365 (8%), 323 (91), 297 (100), 277 (22), 253 (19), 213 (77), 199 (20), 
183 (10), 153 (8), 129 (29), 91 (20), 69 (17). 
 
 
(2E,4S)-1-Methoxymethoxypent-2-en-4-ol 
O O
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A  stirred  solution  of  (2E,4S)-4-(tert-butyldiphenylsilyloxy)-1-
(methoxymethoxy)pent-2-ene 124 (2.60 g, 6.76 mmol) in tetrahydrofuran (60 mL) 
was  cooled  to  0  °C  before  tetra-n-butylammonium  fluoride  solution  (1.0  M  in 
tetrahydrofuran, 8.10 mL, 8.10 mmol) was added dropwise.  The reaction mixture 
was stirred at 0 °C for 0.2 h and then at room temperature for 18 h before being 
cooled again to 0 °C and further tetra-n-butylammonium fluoride solution (1.0 M in 
tetrahydrofuran,  1.50  mL,  1.50  mmol)  was  added.    The  reaction  mixture  was 
allowed to stir at 0 °C for 0.1 h and then at room temperature for a further 5 h 
before being concentrated in vacuo.  The residue was partitioned between water 
(100 mL) and  ethyl  acetate (100 mL)  and  the  organic  phase  was  dried (MgSO4), 
filtered, and concentrated in vacuo.  Purification was carried out by silica column 
chromatography, and elution with 2:3 ethyl acetate/petroleum ether gave (2E,4S)-
1-methoxymethoxypent-2-en-4-ol 125 as a colourless oil (0.718 g, 73%).  max/cm
-1 
(NaCl)  3421  (OH),  2931  (CH),  1655  (C=C),  1451,  1371,  1041;  []D
26  +6.9  (c  1.0, 
CHCl3); H (400 MHz, CDCl3) 1.29 (3H, d, J 6.2 Hz, 5-H3), 1.60 (1H, br s, OH), 3.38 
(3H, s, OCH2OCH3), 4.06 (2H, d, J 5.2 Hz, 1-H2), 4.35 (1H, quin, J 6.2 Hz, 4-H), 4.65 
(2H, s, OCH2OCH3), 5.72–5.87 (2H, m, 2-H and 3-H); C (100 MHz, CDCl3) 23.2 (CH3),  
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55.3 (CH3), 67.2 (CH2), 68.2 (CH), 95.7 (CH2), 125.8 (CH), 137.3 (CH); m/z (EI) 127 
(38%), 97 (33), 83 (100), 57 (70), 45 (87). 
 
 
(2S,3E)-1-(Methoxymethoxy)-2-(trichloromethylcarbonylamino)pent-3-ene  (via 
thermal rearrangement) 
O O
NH
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A stirred  solution of  (2E,4S)-1-methoxymethoxypent-2-en-4-ol  125 (0.200 g, 1.37 
mmol)  in  dichloromethane  (10  mL)  was  cooled  to  0  °C  before  1,8-
diazabicyclo[5.4.0]undec-7-ene  (0.051  mL,  0.34  mmol)  was  added,  followed  by 
trichloroacetonitrile (0.210 mL, 2.09 mmol).  The reaction mixture was allowed to 
stir at room temperature for 6.5 h before being filtered through a short plug of 
silica, which was washed with diethyl ether (200 mL).  The combined filtrates were 
concentrated  in  vacuo  to  give  the  desired  allylic  trichloroacetimidate  126  as  a 
yellow oil (0.335 g), which was used without further purification.   H (400 MHz, 
CDCl3) 1.45 (3H, d, J 6.3 Hz, 5-H3), 3.37 (3H, s, OCH2OCH3), 4.09 (2H, d, J 4.9 Hz, 
1-H2), 4.64 (2H, s, OCH2OCH3), 5.52 (1H, quin, J 6.3 Hz, 4-H), 5.76–5.95 (2H, m, 2-H 
and  3-H),  8.30  (1H,  s,  NH).    A  portion  of  this  allylic  trichloroacetimidate 
intermediate  126  (0.142  g,  0.49  mmol)  was  dissolved  in  p-xylene  (10  mL)  and 
potassium carbonate (0.030 g, 0.22 mmol) was added.  The reaction mixture was 
heated to 140 °C and stirred under reflux for 15 h before being allowed to cool to 
room temperature and concentrated in vacuo.  Purification was carried out by silica 
column chromatography, and elution with 1:9 ethyl acetate/petroleum ether gave 
(2S,3E)-1-(methoxymethoxy)-2-(trichloromethylcarbonylamino)pent-3-ene 127 as a 
colourless oil (0.112 g, 66% over 2 steps).  max/cm
-1 (NaCl) 3331 (NH), 2933 (CH), 
1703 (CO), 1517, 1114, 1039, 821; []D
25 -2.0 (c 1.0, CHCl3); H (400 MHz, CDCl3) 
1.74 (3H, d, J 6.5 Hz, 5-H3), 3.38 (3H, s, OCH2OCH3), 3.66–3.76 (2H, m, 1-H2), 4.50–
4.58 (1H, m, 2-H), 4.63–4.69 (2H, m, OCH2OCH3), 5.52 (1H, dd, J 15.4, 6.2 Hz, 3-H), 
5.78 (1H, dqd, J 15.4, 6.5, 1.3 Hz, 4-H); C (100 MHz, CDCl3) 17.9 (CH3), 52.8 (CH), 
55.6 (CH3), 70.0 (CH2), 92.8 (C), 97.0 (CH2), 126.6 (CH), 129.2 (CH), 161.2 (C); m/z  
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(CI) 290.0116 (MH
+. C9H15
35Cl3NO3 requires 290.0118), 260 (100%), 258 (100), 214 
(22), 176 (19), 174 (17), 129 (13), 97 (85), 85 (14). 
 
 
(2S,3E)-1-(Methoxymethoxy)-2-(trichloromethylcarbonylamino)pent-3-ene  (via 
metal-catalysed rearrangement) 
O O
NH
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The  allylic  trichloroacetimidate  starting  material  126  (0.193  g,  0.66  mmol)  was 
dissolved  in  toluene  (10  mL)  and  bis(acetonitrile)palladium(II)  chloride  (0.017  g, 
0.07  mmol)  was  added.    The  reaction  mixture  was  allowed  to  stir  at  room 
temperature for 15 h before being concentrated in vacuo.  Purification was carried 
out by silica column chromatography, and elution with 1:9 ethyl acetate/petroleum 
ether  gave  (2S,3E)-1-(methoxymethoxy)-2-(trichloromethylcarbonylamino)pent-3-
ene 127 as a colourless oil (0.118 g, 51% over 2 steps).  For analytical data, see 
above. 
 
 
(2R)-2-(Trichloromethylcarbonylamino)-3-(methoxymethoxy)propanoic acid 
HO
O
O O
NH
CCl3
O
2
3
128  
(2S,3E)-1-(Methoxymethoxy)-2-(trichloromethylcarbonylamino)pent-3-ene  127 
(0.116 g, 0.40 mmol) was dissolved in acetonitrile (6 mL) and carbon tetrachloride 
(6 mL) and to the stirred solution, sodium periodate (0.350 g, 1.64 mmol, dissolved 
in 9 mL of water) was added, followed by ruthenium(III) chloride hydrate (0.004 g, 
0.02 mmol).  The reaction mixture was stirred at room temperature for 5.5 h, and 
then the organic layers were extracted using dichloromethane (3 × 30 mL).  The 
combined organic phases were dried (MgSO4), filtered, and concentrated in vacuo 
to  give  (2R)-2-(trichloromethylcarbonylamino)-3-(methoxymethoxy)propanoic  acid  
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128  as  a  blue/black  oil  (0.091  g),  which  was  used  without  further  purification.  
H(400 MHz, CDCl3) 3.38 (3H, s, OCH2OCH3), 3.86 (1H, dd, J 10.8, 2.6 Hz, 3-HH), 
4.24 (1H, dd, J 10.8, 2.6 Hz, 3-HH), 4.66 (2H, s, OCH2OCH3), 4.73 (1H, d, J 7.8 Hz, 
2-H), 7.81 (1H, d, J 7.8 Hz, NH). 
 
 
D-Serine hydrochloride
114 
HO OH
O
NH2
2
3
129
·HCl
 
(2R)-2-(Trichloromethylcarbonylamino)-3-(methoxymethoxy)propanoic  acid  128 
(0.086 g) was dissolved in 6 M hydrochloric acid (6 mL) and the reaction mixture 
was heated under reflux for 20 h before being allowed to cool to room temperature.  
The mixture was washed with diethyl ether (2 × 20 mL) and the aqueous phase was 
concentrated in vacuo to give D-serine hydrochloride 129 as a yellow residue (0.035 
g, 100% over 2 steps).  max/cm
-1 (neat) 3129 (NH2/OH), 1613 (CO), 1397, 1215, 1076, 
914, 779; []D
21 -13.4 (c 1.0, 1 M HCl) (lit.
114 []D
23 -14.0 (c 0.74, 1 M HCl)); H (400 
MHz, D2O) 3.83–3.95 (3H, m, 2-H and 3-H2);m/z (CI) 113 (12%), 85 (100), 69 (54). 
 
 
(2S)-2-(tert-Butyldiphenylsilyloxy)-1-iodopropane
115 
I
O
Si
1
2
3
131
 
To a stirred solution of (2S)-2-(tert-butyldiphenylsilyloxy)propan-1-ol 116 (1.00 g, 
3.2 mmol) in toluene (15 mL), triphenylphosphine (0.95 g, 3.6 mmol) was added, 
followed  by  imidazole  (0.49  g,  7.3  mmol)  and  iodine  (0.91  g,  3.6  mmol).    The 
reaction mixture was stirred at room temperature, in the absence of light, for 15 h 
and the solvent was then poured off.  The remaining beige-coloured residue was 
washed with diethyl ether (3 × 20 mL), and the washings were combined with the  
 
131 
reaction solvent and concentrated in vacuo.  Purification was carried out by silica 
column chromatography, and elution with 1:19 ethyl acetate/petroleum ether gave 
(2S)-(tert-butyldiphenylsilyloxy)-1-iodopropane 131 as a colourless oil (1.29 g, 96%).  
max/cm
-1 (NaCl) 3019 (CH), 2932 (CH), 2859 (CH), 1473, 1428, 1112, 1062; []D
25 -
22.5 (c 1.0, CHCl3) (lit.
115 []D
25 -26.7 (c 1.05, CHCl3)); H (400 MHz, CDCl3) 1.08 (9H, 
s, SiC(CH3)3), 1.20 (3H, d, J 6.0 Hz, 3-H2), 3.13 (2H, d, J 4.4 Hz, 1-H2), 3.65–3.73 
(1H, m, 2-H), 7.36–7.47 (6H, m, 6 × ArH), 7.66–7.71 (4H, m, 4 × ArH); C (100 MHz, 
CDCl3) 15.9 (CH2), 19.3 (C), 23.5 (CH3), 26.9 (3 × CH3), 68.2 (CH), 127.6 (2 × CH), 
127.7 (2 × CH), 129.7 (CH), 129.8 (CH), 133.7 (C), 133.9 (C), 135.7 (2 × CH), 135.8 
(2 × CH); m/z (CI) 425.0799 (MH
+. C19H26IOSi requires 425.0798), 384 (100%), 75 (54). 
 
 
3-Phenylpropionyl chloride
116 
Cl
O
2
3
139  
Thionyl chloride (12.2 mL, 167 mmol) was slowly added to hydrocinnamic acid 134 
(5.00 g, 33.3 mmol) with cooling to 0 °C.  The reaction mixture was stirred at 0 °C 
for 0.2 h, and then at room temperature for 4 h before being concentrated in vacuo.  
Residual  thionyl  chloride  was  removed  using  a  toluene  azeotrope,  giving  3-
phenylpropionyl  chloride  139  as  a  yellow  oil  (5.99  g),  which  was  used  without 
further purification.  H (400 MHz, CDCl3) 3.02 (2H, t, J 7.4 Hz, 3-H2), 3.21 (2H, t, J 
7.4 Hz, 2-H2), 7.17–7.34 (5H, m, 5 × ArH). 
 
 
1-Morpholin-4-yl-3-phenylpropan-1-one
117 
N
O
O
2
3
135  
Morpholine  (15.5  mL,  177  mmol)  was  added  slowly  to  a  stirred  solution  of  3-
phenylpropionyl chloride 139 (5.99 g) in dichloromethane at 0 °C, upon which a 
white precipitate formed.  The resulting suspension was heated to 45 °C and stirred  
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under reflux for 18 h.  The mixture was then allowed to cool to room temperature 
and further dichloromethane (50 mL) was added.  The organic phase was washed 
with water (2 × 100 mL) before being dried (MgSO4), filtered, and concentrated in 
vacuo.  Purification was carried out by silica column chromatography and elution 
with  7:3  ethyl  acetate/petroleum  ether  gave  1-morpholin-4-yl-3-phenylpropan-1-
one  135  as  a  colourless  oil  (7.24  g,  99%  over  2  steps).    Rf  (1:1  ethyl 
acetate/petroleum ether) 0.17; H (400 MHz, CDCl3) 2.62 (2H, t, J 7.6 Hz, 3-H2), 
2.98 (2H, t, J 7.6 Hz, 2-H2), 3.36 (2H, t, J 4.4 Hz, CH2), 3.51 (2H, t, J 4.4 Hz, CH2), 
3.60–3.65 (4H, m, 2 x CH2), 7.21–7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 31.5 
(CH2), 34.9 (CH2), 42.0 (CH2), 46.0 (CH2), 66.5 (CH2), 66.9 (CH2), 126.3 (CH), 128.5 
(2 × CH), 128.6 (2 × CH), 141.1 (C), 171.0 (C); m/z (CI) 220.1343 (MH
+. C13H18NO2 
requires 220.1338), 219 (7%), 172 (2), 81 (3). 
 
 
5-Phenylpent-1-en-3-one
118 
O
1
2 4
5
136  
A  stirred  solution  of  1-morpholin-4-yl-3-phenylpropan-1-one  135  (0.550  g,  2.51 
mmol)  in  tetrahydrofuran  (20  mL)  was  cooled  to  0  °C  before  vinylmagnesium 
bromide  solution  (1.0  M  in  tetrahydrofuran,  10.0  mL,  10.0  mmol)  was  added 
dropwise.  The resulting reaction mixture was stirred at 0 °C for 1.75 h before 
being poured into glacial acetic acid (10 mL) and then concentrated in vacuo.  The 
residue was partitioned between dichloromethane (50 mL) and a saturated aqueous 
solution of ammonium chloride (50 mL) and the organic phase was dried (MgSO4), 
filtered and concentrated in vacuo.  Purification was carried out by silica column 
chromatography,  and  elution  with  1:9  ethyl  acetate/petroleum  ether  gave  5-
phenylpent-1-en-3-one  136  as  a  colourless  oil  (0.299  g,  74%).    Rf  (1:4  ethyl 
acetate/petroleum ether) 0.69; H (400 MHz, CDCl3) 2.89–2.98 (4H, m, 4-H2 and 5-
H2), 5.83 (1H, d, J 10.8 Hz, 1-HH), 6.22 (1H, d, J 17.6 Hz, 1-HH), 6.36 (1H, dd, J 
17.6, 10.8 Hz, 2-H), 7.20–7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 29.8 (CH2), 
41.2 (CH2), 126.1 (CH), 128.3 (CH2), 128.4 (2 × CH), 128.5 (2 × CH), 136.5 (CH),  
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141.1 (C), 199.8 (C); m/z (CI) 161.0965 (MH
+. C11H13O requires 161.0966), 160 (5%), 
91 (3). 
 
 
(4E)-1-Phenylnon-4-en-3-one
119 
O
9
8
7
6
5
4 2
1
140  
The reaction was carried out according to general procedure 1 using 5-phenylpent-
1-en-3-one 136 (0.675 g, 4.21 mmol), 1-hexene (1.05 mL, 8.46 mmol) and Grubbs 
2
nd generation catalyst K (0.143 g, 0.17 mmol) in dichloromethane (15 mL).  The 
reaction mixture was stirred under reflux for 20 h.  Purification by silica column 
chromatography,  eluting  with  1:19  ethyl  acetate/petroleum  ether,  gave  (4E)-1-
phenylnon-4-en-3-one  140  as  a  colourless  oil  (0.687  g,  75%).    Rf  (1:4  ethyl 
acetate/petroleum ether) 0.68; max/cm
-1 (NaCl) 2931 (CH), 1711 (CO), 1454, 1180, 
699; H (400 MHz, CDCl3) 0.91 (3H, t, J 7.2 Hz, 1-H3), 1.30–1.49 (4H, m, 2-H2 and 3-
H2), 2.17–2.23 (2H, m, 4-H2), 2.84–2.96 (4H, m, 8-H2 and 9-H2), 6.09 (1H, d, J 15.8, 
6-H), 6.82 (1H, dt, J 15.8, 6.8 Hz, 5-H), 7.17–7.30 (5H, m, 5 × ArH); C (100 MHz, 
CDCl3) 13.9 (CH3), 22.3 (CH2), 30.1 (CH2), 30.2 (CH2), 32.2 (CH2), 41.6 (CH2), 126.1 
(CH), 128.4 (2 × CH), 128.5 (2 × CH), 130.3 (CH), 141.3 (C), 147.9 (CH), 199.7 (C); 
m/z (CI) 217.1596 (MH
+. C15H21O requires 217.1592), 203 (15%), 159 (9), 97 (5), 85 
(32), 69 (29). 
 
 
(4E)-1,7-Diphenylhept-4-en-3-one
120 
O
7 5
4 2
1
6
141  
The reaction was carried out according to general procedure 1 using 5-phenylpent-
1-en-3-one 136 (0.502 g, 3.13 mmol), 4-phenyl-1-butene (0.94 mL, 6.27 mmol) and 
Grubbs 2
nd generation catalyst K (0.106 g, 0.12 mmol) in dichloromethane (15 mL).  
The reaction mixture was stirred under reflux for 18 h before additional Grubbs 2
nd  
 
134 
generation catalyst (0.026 g, 0.03 mmol) was added and the reaction was stirred 
under  reflux  for  a  further  6  h.    Purification  by  silica  column  chromatography, 
eluting with 3:17 diethyl ether/petroleum ether gave (4E)-1,7-diphenylhept-4-en-3-
one 141 as a colourless oil (0.386 g, 47%).  Rf (1:4 ethyl acetate/petroleum ether) 
0.53; H (400 MHz, CDCl3) 2.47–2.53 (2H, m, 2-H2), 2.77 (2H, t, J 7.2 Hz, 1-H2), 2.81–
2.95 (4H, m, 6-H2 and 7-H2), 6.11 (1H, d, J 15.8 Hz, 4-H), 6.84 (1H, dt, J 15.8, 7.2 
Hz, 3-H), 7.14–7.32 (10H, m, 10 × ArH); C (100 MHz, CDCl3) 30.1 (CH2), 34.1 (CH2), 
34.4 (CH2), 41.7 (CH2), 126.1 (CH), 126.2 (CH), 128.3 (2 × CH), 128.4 (2 × CH), 128.5 
(4 × CH), 130.7 (CH), 140.7 (C), 141.2 (C), 146.3 (CH), 199.5 (C); m/z (EI) 264.1516 
(M
+. C19H20O requires 264.1514), 159 (54%), 131 (8), 105 (15), 91 (100), 65 (12), 44 
(49). 
 
 
(4E)-7,7-Dimethyl-1-phenyloct-4-en-3-one 
O
6
5
4 2
1
142
8
 
The reaction was carried out according to general procedure 1 using 5-phenylpent-
1-en-3-one 136 (0.769 g, 4.80 mmol), 4,4-dimethyl-1-pentene (1.40 mL, 9.74 mmol) 
and Grubbs 2
nd generation catalyst (0.163 g, 0.19 mmol) in dichloromethane (20 
mL).  The reaction mixture was stirred under reflux for 24 h and purification by 
silica  column  chromatography,  eluting  with  1:9  ethyl  acetate/petroleum  ether, 
gave (4E)-7,7-dimethyl-1-phenyloct-4-en-3-one 142 as a pale yellow oil (0.646 g, 
58%).    Rf  (1:4  ethyl  acetate/petroleum  ether)  0.65;  max/cm
-1  (NaCl)  2960  (CH), 
1670 (CO), 1474, 1367, 1095, 908, 734; H (400 MHz, CDCl3) 0.92 (9H, s, C(CH3)3), 
2.08 (2H, d, J 8.0 Hz, 3-H2), 2.85–2.96 (4H, m, 7-H2 and 8-H2), 6.08 (1H, d, J 15.6 
Hz, 5-H), 6.84 (1H, dt, J 15.6, 8.0 Hz, 4-H), 7.17–7.31 (5H, m, 5 × ArH); C (100 MHz, 
CDCl3) 29.4 (3 × CH3), 30.2 (CH2), 31.5 (C), 41.7 (CH2), 47.0 (CH2), 126.1 (CH), 128.4 
(2 × CH), 128.5 (2 × CH), 132.3 (CH), 141.3 (C), 145.2 (CH), 199.4 (C); m/z (EI) 
230.1674 (M
+. C16H22O requires 230.1671), 215 (11%), 174 (6), 159 (100), 133 (5), 
105 (18), 91 (46), 84 (42), 57 (56), 47 (6). 
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(4E)-1-Cyano-8-phenyloct-4-en-6-one 
O
CN
1
2
3 5
4
7
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The reaction was set up according to general procedure 1 using 5-phenylpent-1-en-
3-one 136 (0.972 g, 6.07 mmol), 5-hexenenitrile (1.20 mL, 10.6 mmol) and Grubbs 
2
nd generation catalyst K (0.206 g, 0.24 mmol) in dichloromethane (25 mL).  The 
reaction  mixture  was  stirred  under  reflux  for  22  h  before  further  Grubbs  2
nd 
generation  catalyst  K  (0.103  g,  0.12  mmol)  was  added  and  the  reaction  stirred 
under reflux again for 50 h.  Grubbs 2
nd generation catalyst K (0.103 g, 0.12 mmol) 
was then added and the reaction mixture was stirred under reflux for a further 72 h 
before a final addition of Grubbs 2
nd generation catalyst K (0.052 g, 0.06 mmol) and 
stirring under reflux for 24 h.  Purification by silica column chromatography, eluting 
with 1:3 ethyl acetate/petroleum ether gave (4E)-1-cyano-8-phenyloct-4-en-6-one 
143 as a pale brown oil (0.73 g, 53%).  Rf (1:4 ethyl acetate/petroleum ether) 0.15; 
max/cm
-1 (NaCl) 3028 (CH), 2934 (CH), 2246 (CN), 1669 (CO), 1453, 978, 701;  H 
(400 MHz, CDCl3) 1.78–1.87 (2H, m, 1-H2), 2.32–2.42 (4H, m, 2-H2 and 3-H2), 2.84–
2.98 (4H, m, 7-H2 and 8-H2), 6.13 (1H, d, J 15.8 Hz, 5-H), 6.73 (1H, dt, J 15.8, 6.8 
Hz, 4-H), 7.16–7.33 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 16.7 (CH2), 23.8 (CH2), 
30.0 (CH2), 31.0 (CH2), 42.2 (CH2), 119.0 (C), 126.2 (CH), 128.4 (2 × CH), 128.5 (2 × 
CH), 131.6 (CH), 141.1 (C), 143.9 (CH), 199.1 (C); m/z (EI) 227.1308 (M
+. C15H17NO 
requires 227.1310), 159 (20%), 122 (9), 105 (16), 91 (16), 77 (18), 44 (100). 
 
 
(4S)-4-(Methoxymethoxy)-1-pentene 
O O
1
2
3
4
5
145  
A  stirred  solution  of  (4S)-(+)-1-penten-4-ol  144  (0.12  mL,  1.17  mmol)  in 
dichloromethane (10 mL) was cooled to 0 °C before diisopropylethylamine (0.30 mL, 
1.72  mmol)  was  added,  followed  by  bromomethyl  methyl  ether  (0.11  mL,  1.35 
mmol).  The reaction mixture was stirred at 0 °C for 0.5 h and then heated to 45 °C  
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and stirred under reflux for 45 h.  The reaction mixture was then allowed to cool to 
room temperature before further diisopropylethylamine (0.15 mL, 0.86 mmol) and 
bromomethyl  methyl  ether  (0.06  mL,  0.74  mmol)  were  added.    The  reaction 
mixture was again heated to 45 °C and stirred under reflux for 20 h before being 
cooled to room temperature, quenched by the addition of 2 M hydrochloric acid (10 
mL)  and  diluted  with  dichloromethane  (20  mL).    The  organic  phase  was  dried 
(MgSO4), filtered, and concentrated in vacuo to give the desired crude product 145 
as  a  yellow  oil  (0.134  g,  89%  crude  yield),  which  decomposed  upon  attempted 
purification by silica column chromatography.  H (400 MHz, CDCl3) 1.18 (3H, d, J 
6.2  Hz,  5-H3),  2.17–2.26  (1H,  m,  3-HH),  2.29–2.37  (1H,  m,  3-HH),  3.37  (3H,  s, 
OCH2OCH3), 3.76 (1H, sex, J 6.2 Hz, 4-H), 4.64 (1H, d, J 6.8 Hz, OCHHOCH3), 4.69 
(1H, d, J 6.8 Hz, OCHHOCH3), 5.04–5.12 (2H, m, 1-H2), 5.75–5.87 (1H, m, 2-H). 
 
 
(4S)-4-[(tert-butyldimethylsilyl)oxy]-1-pentene
82 
 
 
 
 
A stirred solution of (4S)-(+)-1-penten-4-ol 144 (0.623 g, 7.23 mmol), triethylamine 
(2.00  mL,  14.5  mmol)  and  4-dimethylaminopyridine  (0.088  g,  0.72  mmol)  in 
dichloromethane (30 mL) was cooled to 0 °C before tert-butyldimethylsilyl chloride 
(1.42 g, 9.40 mmol) was added slowly.  The reaction mixture was stirred at 0 °C for 
0.2  h,  and  then  at  room  temperature  for  21  h  before  water  (50  mL)  and 
dichloromethane (20 mL) were added.  The layers were separated, and the organic 
layers  were  further  extracted  using  dichloromethane  (30  mL).    The  combined 
organic  phases  were  then  washed  with  a  saturated  aqueous  solution  of  copper 
sulfate (2 × 40 mL) and then water (40 mL) before being dried (MgSO4), filtered, 
and  concentrated  in  vacuo.    Purification  was  carried  out  by  silica  column 
chromatography, and elution with 1:19 diethyl ether/petroleum ether gave (4S)-4-
[(tert-butyldimethylsilyl)oxy]-1-pentene 146 as a colourless oil (0.754 g, 52%).  Rf 
(1:4 ethyl acetate/petroleum ether) 0.62; max/cm
-1 (NaCl) 2959 (CH), 2092 (CH), 
1643 (C=C), 1472, 1376, 1255, 1093, 1004, 774; []D
24 +18.1 (c 1.0, CHCl3); H (400 
O
Si
1
2
3
4
5
146 
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MHz, CDCl3) 0.05 (6H, s, 2 × SiCH3), 0.89 (9H, s, SiC(CH3)3), 1.13 (3H, d, J 6.0 Hz, 5-
H3), 2.11–2.25 (2H, m, 3-H2), 3.84 (1H, q, J 6.0 Hz, 4-H), 4.99–5.06 (2H, m, 1-H2), 
5.75–5.86 (1H, m, 2-H); C (100 MHz, CDCl3) -5.7 (CH3), -5.6 (CH3), 17.2 (C), 22.4 
(CH3), 24.9 (3 × CH3), 43.3 (CH2), 67.4 (CH), 115.5 (CH2), 134.6 (CH); m/z (CI) 201 
(MH
+, 4%), 193 (9), 167 (8), 151 (7), 113 (29), 95 (22), 69 (100). 
 
 
(4E,7S)-7-[(tert-Butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-one 
O O
Si
8
7
6
5
4 2
1
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The experiment was set up according to general procedure 1 using 5-phenylpent-1-
en-3-one 136 (0.800 g, 5.02 mmol), (4S)-4-[(tert-butyldimethylsilyl)oxy]-1-pentene 
K (1.08 g, 5.39 mmol) and Grubbs 2
nd generation catalyst K (0.170 g, 0.20 mmol) in 
dichloromethane (35 mL).  The reaction mixture was stirred under reflux for 19 h 
before further Grubbs 2
nd generation catalyst K (0.043 g, 0.05 mmol) was added and 
the reaction mixture was stirred under reflux again for 23 h.  Purification by silica 
column chromatography, and elution with 1:19 diethyl ether/petroleum ether gave 
(4E,7S)-7-[(tert-butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-one 147 as a colourless 
oil (1.48 g, 89%).  Rf (1:4 ethyl acetate/petroleum ether) 0.59; max/cm
-1 (NaCl) 
2929 (CH), 1674 (CO), 1632 (C=C), 1454, 1375, 1256, 1128, 1003, 836; []D
22 +14.2 
(c 1.0, CHCl3); H (400 MHz, CDCl3) 0.03 (3H, s, SiCH3), 0.04 (3H, s, SiCH3), 0.87 (9H, 
s, SiC(CH3)3), 1.14 (3H, d, J 6.5 Hz, 1-H3), 2.32 (2H, t, J 6.5 Hz, 3-H2), 2.84–2.96 (4H, 
m, 7-H2 and 8-H2), 3.92 (1H, sex, J 6.5 Hz, 2-H), 6.10 (1H, d, J 16.0 Hz, 5-H), 6.83 
(1H, dt, J 16.0, 6.5 Hz, 4-H), 7.18–7.30 (5H, m, 5 × ArH); C (100 MHz, CDCl3) -4.7 
(CH3), -4.4 (CH3), 18.1 (C), 23.9 (CH3), 25.9 (3 × CH3), 30.1 (CH2), 41.5 (CH2), 42.8 
(CH2), 67.7 (CH), 126.1 (CH), 128.4 (2 × CH), 128.6 (2 × CH), 132.3 (CH), 141.3 (C), 
144.5 (CH), 199.4 (C); m/z (CI) 333.2253 (MH
+. C20H33O2Si requires 333.2250), 275 
(11%), 237 (9), 201 (9), 181 (9), 159 (43), 137 (12), 97 (53), 71 (100). 
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(3R,4E)-1-Phenylnon-4-en-3-ol
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OH
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The  reaction  was  carried  out  according  to  general  procedure  2,  using  (4E)-1-
phenylnon-4-en-3-one  140  (0.300  g,  1.39  mmol),  (S)-(-)-2-methyl-CBS-
oxazaborolidine  solution  (1.0  M  in  toluene,  1.40  mL,  1.40  mmol),  and  borane 
tetrahydrofuran complex solution (1.0 M in tetrahydrofuran, 7.00 mL, 7.00 mmol) in 
tetrahydrofuran (10 mL).  Purification by silica column chromatography, and elution 
with 1:9 ethyl acetate/petroleum ether gave (3R,4E)-1-phenylnon-4-en-3-ol 148 as 
a colourless oil (0.299 g, 99%).  Chiral HPLC (Chiralcel IB column) analysis using 2% 
isopropanol  in  hexane  indicated  84%  ee;  Rf  (1:4  ethyl  acetate/petroleum  ether) 
0.39; []D
22 +17.5 (c 1.0, CHCl3) (lit.
121 []D +6.1 (c 0.952, CHCl3)); H (400 MHz, 
CDCl3) 0.90 (3H, t, J 7.2 Hz, 1-H3), 1.26–1.40 (4H, m, 2-H2 and 3-H2), 1.45 (1H, br s, 
OH), 1.75–1.93 (2H,  m, 8-H2), 1.99–2.07 (2H,  m, 4-H2), 2.62–2.79 (2H,  m, 9-H2), 
4.03–4.12 (1H, m, 7-H), 5.49 (1H, ddt, J 15.2, 6.8, 1.2 Hz, 6-H), 5.66 (1H, dt, J 15.2, 
6.8 Hz, 5-H), 7.16–7.30 (5H, m, 5 × ArH); C (100 MHz,  CDCl3) 14.0 (CH3), 22.2 (CH2), 
31.4 (CH2), 31.8 (CH2), 31.9 (CH2), 38.9 (CH2), 72.5 (CH), 125.8 (CH), 128.4 (3 × CH), 
128.5 (2 × CH), 132.7 (CH), 142.0 (C); m/z (CI) 201.1646 (MH
+. C15H23O-OH requires 
201.1643), 187 (11%), 133 (6), 117 (7), 91 (13), 69 (7). 
 
 
(4E)-1-Phenylnon-4-en-3-ol
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A  stirred  solution  of  (4E)-1-phenylnon-4-en-3-one  140  (0.200  g,  0.93  mmol)  in 
toluene (5 mL) was cooled to 0 °C before diisobutylaluminium hydride solution (1.0 
M in hexanes, 1.40 mL, 1.40 mmol) was added dropwise.  The reaction mixture was 
stirred at 0 °C for 3 h, and then at room temperature for 15 h before being cooled 
again  to  0  °C  and  quenched  by  the  slow  addition  of  methanol  (50  mL).    The 
resulting cloudy suspension was stirred at 0 °C for 1 h, then at room temperature  
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for 0.5 h before being filtered through a pad of Celite
®.  The white gum was washed 
through  with  warm  methanol  (100  mL),  and  the  combined  filtrates  were 
concentrated  in  vacuo.    Purification  was  carried  out  by  silica  column 
chromatography, and elution with 1:9 ethyl acetate/petroleum ether gave (4E)-1-
phenylnon-4-en-3-ol rac-148 as a colourless oil (0.103 g, 51%).  For analytical data, 
see above compound 148. 
 
 
(3R,4E)-1,7-Diphenylhept-4-en-3-ol 
OH
7 5
4
3
2
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The  reaction  was  carried  out  according  to  general  procedure  2  using  (4E)-1,7-
diphenylhept-4-en-3-one  141  (0.190  g,  0.72  mmol),  (S)-(-)-2-methyl-CBS-
oxazaborolidine  solution  (1.0  M  in  toluene,  0.72  mL,  0.72  mmol)  and  borane 
tetrahydrofuran complex solution (1.0 M in tetrahydrofuran, 2.20 mL, 2.20 mmol) in 
tetrahydrofuran (10 mL).  Purification by silica column chromatography and elution 
with  3:7  ethyl  acetate/petroleum  ether  gave  (3R,4E)-1,7-diphenylhept-4-en-3-ol 
149 as a colourless oil (0.133 g, 69%).  Chiral HPLC (Chiralcel IB column) analysis 
using 4% isopropanol in hexane indicated 75% ee; Rf (1:4 ethyl acetate/petroleum 
ether) 0.32; max/cm
-1 (NaCl) 3356 (OH), 2925 (CH), 1602 (C=C), 1454, 970, 698; 
]D
22 +9.2 (c 1.0, CHCl3); H (400 MHz, CDCl3) 1.40 (1H, d, J 3.2 Hz, OH), 1.70–1.90 
(2H, m, 6-H2), 2.37 (2H, dt, J 7.6, 6.8 Hz, 2-H2), 2.57–2.73 (4H, m, 1-H2 and 7-H2), 
4.02–4.10 (1H, m, 5-H), 5.50 (1H, ddt, J 15.6, 7.0, 1.3 Hz, 4-H), 5.69 (1H, dtd, J 
15.6, 6.8, 0.7 Hz, 3-H), 7.15–7.30 (10H, m, 10 × ArH); C (100 MHz, CDCl3) 31.7 
(CH2), 33.9 (CH2), 35.6 (CH2), 38.7 (CH2), 72.3 (CH), 125.8 (CH), 125.9 (CH), 128.3 
(2 × CH), 128.4 (2 × CH), 128.5 (4 × CH), 131.4 (CH), 133.5 (CH), 141.6 (C), 142.0 
(C); m/z (EI) 266.1674 (M
+. C19H22O requires 266.1671), 248 (10%), 161 (21), 144 (28), 
105 (42), 91 (100), 83 (18), 65 (11), 57 (11). 
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(4E)-1,7-Diphenylhept-4-en-3-ol 
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The  reaction  was  carried  out  according  to  general  procedure  3  using  (4E)-1,7-
diphenylhept-4-en-3-one 141 (0.040 g, 0.15 mmol) and diisobutylaluminium hydride 
solution (1.0 M in hexanes, 0.23 mL, 0.23 mmol) in toluene (5 mL).  Purification by 
silica column chromatography, eluting with 3:7 ethyl acetate/petroleum ether gave 
(4E)-1,7-diphenylhept-4-en-3-ol  rac-149  as  a  colourless  oil  (0.024  g,  60%).    For 
analytical data, see above compound 149. 
 
 
(3R,4E)-7,7-Dimethyl-1-phenyloct-4-en-3-ol 
OH
6 4
3
2
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The  reaction  was  carried  out  according  to  general  procedure  2  using  (4E)-7,7-
dimethyl-1-phenyloct-4-en-3-one  142  (0.200  g,  0.87  mmol),  (S)-(-)-2-methyl-CBS-
oxazaborolidine  solution  (1.0  M  in  toluene,  0.90  mL,  0.90  mmol)  and  borane 
tetrahydrofuran complex solution (1.0 M in tetrahydrofuran, 2.60 mL, 2.60 mmol) in 
tetrahydrofuran  (10  mL).    Purification  by  silica  column  chromatography,  eluting 
with 1:9 ethyl acetate/petroleum ether gave (3R,4E)-7,7-dimethyl-1-phenyloct-4-
en-3-ol 150 as a colourless oil (0.156 g, 77%).  Chiral HPLC (Chiralcel IB column) 
analysis  using  3%  isopropanol  in  hexane  indicated  69%  ee;  Rf  (1:4  ethyl 
acetate/petroleum ether) 0.44; max/cm
-1 (NaCl) 3609 (OH), 3019 (CH), 1475, 1216, 
772; []D
22 +8.5 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.89 (9H, s, C(CH3)3), 1.45 (1H, d, 
J 3.6 Hz, OH), 1.76–1.98 (4H, m, 3-H2 and 7-H2), 2.63–2.76 (2H, m, 8-H2), 4.07–4.14 
(1H, m, 6-H), 5.49 (1H, dd, J 15.2, 7.2 Hz, 5-H), 5.69 (1H, dt, J 15.2, 7.6 Hz, 4-H), 
7.16–7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 29.3 (3 × CH3), 30.9 (C), 31.8 (CH2), 
38.9 (CH2), 46.7 (CH2), 72.5 (CH), 125.8 (CH), 128.3 (2 × CH), 128.4 (2 × CH), 129.5 
(CH), 135.1 (CH), 142.0 (C); m/z (EI) 232.1830 (M
+. C16H24O requires 232.1827), 214 
(9%), 161 (26), 143 (24), 127 (46), 91 (100), 83 (51), 57 (98), 44 (15).  
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(4E)-7,7-Dimethyl-1-phenyloct-4-en-3-ol 
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The  reaction  was  carried  out  according  to  general  procedure  3  using  (4E)-7,7-
dimethyl-1-phenyloct-4-en-3-one 142 (0.050 g, 0.22 mmol) and diisobutylaluminium 
hydride  solution  (1.0  M  in  hexanes,  0.40  mL,  0.40  mmol)  in  toluene  (5  mL).  
Purification  by  silica  column  chromatography,  eluting  with  1:9  ethyl 
acetate/petroleum ether gave (4E)-7,7-dimethyl-1-phenyloct-4-en-3-ol rac-150 as a 
colourless oil (0.057 g, 100%).  For analytical data, see above compound 150. 
 
 
(4E,6R)-1-Cyano-8-phenyloct-4-en-6-ol 
OH
CN
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The reaction was carried out according to general procedure 2 using (4E)-1-cyano-8-
phenyloct-4-en-6-one  143  (0.150  g,  0.65  mmol),  (S)-(-)-2-methyl-CBS-
oxazaborolidine  solution  (1.0  M  in  toluene,  0.65  mL,  0.65  mmol)  and  borane 
tetrahydrofuran complex solution (1.0 M in tetrahydrofuran, 1.95 mL, 1.95 mmol) in 
tetrahydrofuran (3 mL).  Purification by silica column chromatography, and elution 
with 3:7 ethyl acetate/petroleum ether gave (4E,6R)-1-cyano-8-phenyloct-4-en-6-ol 
151 as a colourless oil (0.096 g, 63%).  Chiral HPLC (Chiralcel IB column) analysis 
using 6% isopropanol in hexane indicated 87% ee; Rf (1:4 ethyl acetate/petroleum 
ether)  0.09;  max/cm
-1  (NaCl)  3448  (OH),  2932  (CH),  2251  (CN),  1454,  910,  731; 
[]D
23 +3.0 (c 0.5, CHCl3); H (400 MHz, CDCl3) 1.47–1.51 (1H, m, OH), 1.71–1.77 (2H, 
m, 2-H2), 1.78–1.93 (2H, m, 7-H2), 2.19-2.25 (2H, m, 3-H2), 2.35 (2H, t, J 7.2 Hz, 1-
H2), 2.62–2.77 (2H, m, 8-H2), 4.07–4.14 (1H, m, 6-H), 5.59–5.62 (2H, m, 4-H and 5-
H), 7.17–7.32 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 16.5 (CH2), 24.7 (CH2), 31.0 
(CH2), 31.8 (CH2), 38.8 (CH2), 72.1 (CH), 119.6 (C), 125.9 (2 × CH), 128.5 (2 × CH), 
129.0 (2 × CH), 135.1 (CH), 141.8 (C); m/z (CI) 230.1555 (MH
+. C15H20NO requires 
230.1545), 212 (100%), 184 (8), 107 (27), 79 (30).  
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(4E)-1-cyano-8-phenyloct-4-en-6-ol 
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The reaction was carried out according to general procedure 3 using (4E)-1-cyano-8-
phenyloct-4-en-6-one  143 (0.050 g, 0.22  mmol)  and  diisobutylaluminium hydride 
solution (1.0 M in hexanes, 0.33 mL, 0.33 mmol) in toluene (5 mL).  Purification by 
silica column chromatography, eluting with 3:7 ethyl acetate/petroleum ether gave 
(4E)-1-cyano-8-phenyloct-4-en-6-ol rac-151 as a colourless oil (0.027 g, 54%).  For 
analytical data, see above compound 151. 
 
 
(3R,4E,7S)-7-[(tert-Butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-ol 
OH O
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The  reaction  was  carried  out  according  to  general  procedure  2  using  (4E,7S)-7-
[(tert-butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-one  147  (0.500  g,  1.50  mmol), 
(S)-(-)-2-methyl-CBS-oxazaborolidine  solution  (1.0  M  in  toluene,  1.50  mL,  1.50 
mmol),  and  borane  tetrahydrofuran  complex  solution  (1.0  M  in  tetrahydrofuran, 
7.50  mL,  7.50  mmol)  in  tetrahydrofuran  (15  mL).    Purification  by  silica  column 
chromatography,  and  elution  with  3:17  diethyl  ether/petroleum  ether  gave 
(3R,4E,7S)-7-[(tert-butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-ol  152  as  a 
colourless oil (0.439 g, 87%).  Rf (1:4 ethyl acetate/petroleum ether) 0.43; max/cm
-
1 (NaCl) 3395 (OH), 2961 (CH), 1639 (C=C), 1455, 1254, 1084, 835, 774; []D
22 +17.1 
(c 1.0, CHCl3); H (400 MHz, CDCl3) 0.05 (6H, s, 2 × SiCH3), 0.88 (9H, s, SiC(CH3)3), 
1.12 (3H, d, J 6.0 Hz, 1-H3), 1.43 (1H, br s, OH), 1.76–1.93 (2H, m, 7-H2), 2.10–2.25 
(2H, m, 3-H2), 2.63–2.76 (2H, m, 8-H2), 3.83 (1H, sex, J 6.0 Hz, 2-H), 4.05–4.13 (1H, 
m, 6-H), 5.53 (1H, dd, J 15.4, 6.9 Hz, 5-H), 5.67 (1H, dt, J 15.4, 6.9 Hz, 4-H), 7.15–
7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) -4.7 (CH3), -4.5 (CH3), 18.2 (C), 23.5 
(CH3), 25.9 (3 × CH3), 31.8 (CH2), 38.8 (CH2), 42.6 (CH2), 68.5 (CH), 72.5 (CH), 125.8 
(CH),  128.4  (2  ×  CH),  128.5  (2  ×  CH),  129.0  (CH),  135.0  (CH),  142.0  (C);  m/z  
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(FAB/NOBA/NaI) 357.2221 ([MNa]
+. C20H34O2Si requires 357.2226), 333 (21%), 317 (6), 
268 (18), 228 (17), 208 (7), 186 (18), 160 (86), 148 (38), 117 (78), 105 (24), 75 (77). 
 
 
(4E,7S)-7-[(tert-Butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-ol 
OH O
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The  reaction  was  carried  out  according  to  general  procedure  3  using  (4E,7S)-7-
[(tert-butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-one 147 (0.060 g, 0.18 mmol) and 
diisobutylaluminium hydride solution (1.0 M in hexanes, 0.30 mL, 0.30 mmol) in 
toluene  (5  mL).    Purification  by  silica  column  chromatography,  eluting  with  1:9 
ethyl  acetate/petroleum  ether  gave  (4E,7S)-7-[(tert-butyldimethylsilyl)oxy]-1-
phenyloct-4-en-3-ol 217 as a colourless oil (0.032 g, 53%).  For analytical data, see 
above compound 152.   
 
 
(3R)-5-Phenylpent-1-en-3-ol
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The reaction was carried out according to general procedure 2, using 5-phenylpent-
1-en-3-one 136 (0.300 g, 1.87 mmol), (S)-(-)-2-methyl-CBS-oxazaborolidine solution 
(1.0  M  in  toluene,  1.87  mL,  1.87  mmol)  and  borane  tetrahydrofuran  complex 
solution (1.0 M in tetrahydrofuran, 5.62 mL, 5.62 mmol) in tetrahydrofuran (10 mL).  
Purification was carried out by silica column chromatography, and elution with 1:9 
ethyl acetate/petroleum ether gave (3S)-5-phenylpent-1-en-3-ol 153 as a colourless 
oil (0.225 g, 74%).  Chiral HPLC (Chiralcel IB column) analysis using 5% isopropanol 
in hexane indicated 68% ee; Rf (1:4 ethyl acetate/petroleum ether) 0.45; []D
25 +6.7 
(c 1.0, CHCl3), (lit.
123 []D
20 -5.8 (c 1.0, CHCl3)); H (400 MHz, CDCl3) 1.55 (1H, d, J 
3.9 Hz, OH), 1.79–1.93 (2H, m, 5-H2), 2.64–2.80 (2H, m, 4-H2), 4.09–4.17 (1H, m, 3- 
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H), 5.14 (1H, d, J 10.4 Hz, 1-HH), 5.25 (1H, d, J 17.2 Hz, 1-HH), 5.91 (1H, ddd, J 
17.2, 10.4, 6.2 Hz, 2-H), 7.16–7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 31.6 (CH2), 
38.5 (CH2), 72.5 (CH), 115.0 (CH2), 125.8 (CH), 128.4 (2 × CH), 128.5 (2 × CH), 141.0 
(CH), 141.8 (C); m/z (EI) 162.1041 (M
+. C11H14O requires 162.1045), 144 (43%), 129 
(76), 105 (91), 91 (100), 5 (66), 51 (24), 44 (12). 
 
 
5-Phenylpent-1-en-3-ol
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The reaction was carried out according to general procedure 3, using 5-phenylpent-
1-en-3-one 136 (0.200 g, 1.25 mmol) and diisobutylaluminium hydride solution (1.0 
M in hexanes, 1.90 mL, 1.90 mmol) in toluene (5 mL).  Purification by silica column 
chromatography,  eluting  with  1:4  ethyl  acetate/petroleum  ether  gave  5-
phenylpent-1-en-3-ol rac-153 as a colourless oil (0.085 g, 42%).  For analytical data, 
see above compound 153. 
 
 
(3E,5S)-1-Phenyl-5-(trichloromethylcarbonylamino)non-3-ene 
O
CCl3
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The trichloroacetimidate formation reaction was carried out according to general 
procedure 4, using (3R,4E)-1-phenylnon-4-en-3-ol 148 (0.253 g, 1.16 mmol), 1,8-
diazabicyclo[5.4.0]undec-7-ene  (0.087  mL,  0.58  mmol),  and  trichloroacetonitrile 
(0.175  mL,  1.74  mmol)  in  dichloromethane  (10  mL)  to  give  the  desired  allylic 
trichloroacetimidate intermediate 154 (0.484 g).  H (400 MHz, CDCl3) 0.88 (3H, t, J 
7.0 Hz, 1-H3), 1.26–1.46 (4H, m, 2-H2 and 3-H2), 1.93–2.18 (4H, m, 4-H2 and 8-H2), 
2.65–2.81 (2H, m, 9-H2), 5.36 (1H, q, J 6.8 Hz, 7-H), 5.49 (1H, dd, J 15.4, 6.8 Hz, 6-
H), 5.81 (1H, dt, J 15.4, 6.7 Hz, 5-H), 7.16–7.31 (5H, m, 5 × ArH), 8.27 (1H, s, NH).   
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This  intermediate  was  then  subjected  to  an  Overman  rearrangement  reaction, 
carried out according to general procedure 5 using potassium carbonate (0.060 g, 
0.43  mmol)  in  p-xylene  (20  mL).    Purification  by  silica  column  chromatography, 
eluting  with  1:19  diethyl  ether/petroleum  ether,  gave  (3E,5S)-1-phenyl-5-
(trichloromethylcarbonylamino)non-3-ene 155 as a colourless oil (0.283 g, 67% over 
2 steps).  Rf (1:4 ethyl acetate/petroleum ether) 0.61; max/cm
-1 (NaCl) 3423 (NH), 
2933 (CH), 1712 (CO), 1509, 908, 741; []D
17 +16.0 (c 0.3, CHCl3); H (400 MHz, 
CDCl3) 0.89 (3H, t, J 7.0 Hz, 1-H3), 1.21–1.36 (4H, m, 2-H2 and 3-H2), 1.54–1.59 (2H, 
m, 4-H2), 2.37 (2H, q, J 7.4 Hz, 8-H2), 2.70 (2H, t, J 7.4 Hz, 9-H2), 4.29-4.36 (1H, m, 
5-H), 5.35 (1H, dd, J 15.6, 6.4 Hz, 6-H), 5.69 (1H, dt, J 15.6, 7.4 Hz, 7-H), 6.43 (1H, 
br d, J 7.6 Hz, NH), 7.13–7.30 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 13.9 (CH3), 22.4 
(CH2), 27.7 (CH2), 34.0 (CH2), 34.5 (CH2), 35.4 (CH2), 53.2 (CH), 92.9 (C), 125.9 (CH), 
128.3 (2 × CH), 128.5 (2 ×CH), 129.2 (CH), 132.2 (CH), 141.4 (C), 160.9 (C); m/z (CI) 
362.0842 (MH
+. C17H23
35Cl3NO requires 362.0845), 329 (46%), 293 (80), 259 (35), 233 
(76), 219 (100), 201 (36), 145 (51), 101 (25), 81 (48), 71 (46). 
 
 
(3S,4E)-1,7-Diphenyl-3-(trichloromethylcarbonylamino)hept-4-ene 
O
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The trichloroacetimidate formation reaction was carried out according to general 
procedure  4  using  (3R,4E)-1,7-diphenylhept-4-en-3-ol  149  (0.098  g,  0.37  mmol), 
1,8-diazabicyclo[5.4.0]undec-7-ene (0.03 mL, 0.18 mmol) and trichloroacetonitrile 
(0.06  mL,  0.55  mmol)  in  dichloromethane  (5  mL)  to  give  the  desired  allylic 
trichloroacetimidate intermediate (0.163 g).  H (400 MHz, CDCl3) 1.90–2.00 (1H, m, 
6-HH), 2.04–2.15 (1H, m, 6-HH), 2.38 (2H, q, J 6.8 Hz, 2-H2), 2.60–2.76 (4H, m, 1-H2 
and 7-H2), 5.34 (1H, q, J 6.6 Hz, 5-H), 5.50 (1H, ddt, J 15.4, 6.6, 1.3 Hz, 4-H), 5.84 
(1H, dt, J 15.4, 6.8 Hz, 3-H), 7.13–7.21 (5H, m, 5 × ArH), 7.23–7.31 (5H, m, 5 × ArH), 
8.26 (1H, s, NH).  This was then subjected to an Overman rearrangement reaction, 
carried out according to general procedure 5 using  potassium carbonate (0.015 g,  
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0.11 mmol) in p-xylene (5 mL).  Purification by silica column chromatography and 
elution  with  1:9  ethyl  acetate/petroleum  ether  gave  (3S,4E)-1,7-diphenyl-3-
(trichloromethylcarbonylamino)hept-4-ene  156  as  a  colourless  oil  (0.111  g,  73% 
over 2 steps).  Rf (1:4 ethyl acetate/petroleum ether) 0.53; max/cm
-1 (NaCl) 3422 
(NH), 3019 (CH), 1713 (CO), 1509, 1216, 756; []D
21 -12.7 (c 1.0, CHCl3); H (400 
MHz, CDCl3) 1.84–1.98 (2H, m, 2-H2), 2.39–2.47 (2H, m, 6-H2), 2.61 (2H, t, J 7.6 Hz, 
1-H2), 2.70 (2H, t, J 7.6 Hz, 7-H2), 4.33–4.41 (1H, m, 3-H), 5.39 (1H, dd, J 15.6, 6.4 
Hz, 4-H), 5.71 (1H, dt, J 15.6, 6.4 Hz, 5-H), 6.48 (1H, d, J 8.0 Hz, NH), 7.12–7.31 
(10H, m, 10 × ArH); C (100 MHz, CDCl3) 29.7 (CH2), 32.0 (CH2), 35.5 (CH2), 36.4 
(CH2), 53.1 (CH), 92.9 (C), 126.1 (CH), 126.3 (CH), 128.5 (4 × CH), 128.6 (2 × CH), 
128.7 (2 × CH), 128.8 (CH), 132.8 (CH), 141.0 (C), 141.4 (C), 161.1 (C); m/z (CI) 
410.0847 (MH
+. C21H23
35Cl3NO requires 410.0845), 376 (18%), 343 (12), 307 (8), 249 
(11), 216 (5), 167 (7), 136 (12), 85 (66), 73 (100). 
 
 
(3E,5S)-7,7-Dimethyl-5-(trichloromethylcarbonylamino)-1-phenyloct-3-ene 
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The acetimidate formation reaction was carried out according to general procedure 
4 using (3R,4E)-7,7-dimethyl-1-phenyloct-4-en-3-ol 150 (0.123 g, 0.53 mmol), 1,8-
diazabicyclo[5.4.0]undec-7-ene  (0.04  mL,  0.27  mmol)  and  trichloroacetonitrile 
(0.08  mL,  0.79  mmol)  in  dichloromethane  (5  mL)  to  give  the  desired  allylic 
trichloroacetimidate (0.284 g).  H (400 MHz, CDCl3) 0.87 (9H, s, C(CH3)3), 1.93 (2H, 
d, J 7.6 Hz, 3-H2), 1.95–2.05 (1H, m, 7-HH), 2.09–2.20 (1H, m, 7-HH), 2.66–2.83 (2H, 
m, 8-H2), 5.36 (1H, dt, J 6.8, 6.2 Hz, 6-H), 5.48 (1H, dd, J 15.3, 6.8 Hz, 5-H), 5.86 
(1H, dt, J 15.3, 7.6 Hz, 4-H), 7.16–7.31 (5H, m, 5 × ArH), 8.28 (1H, s, NH).  This was 
then subjected to an Overman rearrangement reaction, carried out according to 
general procedure 5 using potassium carbonate (0.018 g, 0.13 mmol) in p-xylene (6 
mL).    Purification  by  silica  column  chromatography,  eluting  with  1:19  ethyl 
acetate/petroleum  ether  gave  (3E,5S)-7,7-dimethyl-5-
(trichloromethylcarbonylamino)-1-phenyloct-3-ene  157  as  a  white  solid  (0.206  g,  
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100%  over 2 steps).  Mp 66–69  °C; Rf (1:4 ethyl  acetate/petroleum  ether) 0.59; 
max/cm
-1 (NaCl) 3338 (NH), 2955 (CH), 1689 (CO), 1518, 1245, 822; []D
22 -24.2 (c 
1.0, CHCl3); H (400 MHz, CDCl3) 0.95 (9H, s, C(CH3)3), 1.44 (1H, dd, J 14.4, 8.0 Hz, 
3-HH), 1.53 (1H, dd, J 14.4, 4.8 Hz, 3-HH), 2.35 (2H, dt, J 7.2, 7.0 Hz, 7-H2), 2.68 
(2H, t, J 7.2, 8-H2), 4.40–4.49 (1H, m, 4-H), 5.36 (1H, ddt, J 15.4, 6.8, 1.2 Hz, 5-H), 
5.68 (1H, dtd, J 15.4, 7.0, 1.2 Hz, 6-H), 6.41 (1H, d, J 8.0 Hz, NH), 7.14–7.29 (5H, 
m, 5 × ArH); C (100 MHz, CDCl3) 29.9 (3 × CH3), 30.5 (C), 34.0 (CH2), 35.4 (CH2), 
48.9 (CH2), 50.8 (CH), 92.9 (C), 125.9 (CH), 128.3 (2 × CH), 128.5 (2 × CH), 130.8 
(CH),  131.0  (CH),  141.5  (C),  160.2  (C);  m/z  (CI)  376.1005  (MH
+.  C18H25
35Cl3NO 
requires 376.1002), 342 (49%), 306 (100), 272 (43), 270 (15), 215 (10), 168 (36), 154 
(6), 107 (57), 71 (49). 
 
 
(4S,5E)-1-Cyano-4-(trichloromethylcarbonylamino)-8-phenyloct-5-ene 
 
O
CN
CCl3
NH
1
2
3
4
5
6 8
7
158  
The  trichloroacetimidate  formation  reaction  was  set  up  according  to  general 
procedure 4 using (4E,6R)-1-cyano-8-phenyloct-4-en-6-ol 151 (0.182 g, 0.79 mmol), 
1,8-diazabicyclo[5.4.0]undec-7-ene (0.060 mL, 0.40 mmol) and trichloroacetonitrile 
(0.120 mL, 1.20 mmol) in dichloromethane (6 mL).  After stirring for 18 h, further 
1,8-diazabicyclo[5.4.0]undec-7-ene (0.030 mL, 0.20 mmol) and trichloroacetonitrile 
(0.060 mL, 0.60 mmol) were added and the reaction mixture was stirred again at 
room  temperature  for  6  h  to  give  the  desired  allylic  trichloroacetimidate 
intermediate (0.318 g).  H (400 MHz, CDCl3) 1.71–1.79 (2H, m, 2-H2), 1.94–2.04 (1H, 
m, 7-HH), 2.09–2.19 (1H, m, 7-HH), 2.23 (2H, q, J 6.9 Hz, 3-H2), 2.32 (2H, t, J 7.2 
Hz, 1-H2), 2.66–2.83 (2H, m, 8-H2), 5.31–5.38 (1H, m, 6-H), 5.59 (1H, dd, J 15.4, 6.5 
Hz, 5-H), 5.74 (1H, dtd, J 15.4, 6.9, 0.9 Hz, 4-H), 7.16–7.32 (5H, m, 5 × ArH), 8.29 
(1H,  s,  NH).    This  was  then  subjected  to  an  Overman  rearrangement  reaction, 
carried out according to general procedure 5 using potassium carbonate (0.020 g,  
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0.14 mmol) in p-xylene (7 mL).  Purification by silica column chromatography, and 
elution  with  1:4  ethyl  acetate/petroleum  ether  gave  (4S,5E)-1-cyano-4-
(trichloromethylcarbonylamino)-8-phenyloct-5-ene 158 as a pale yellow oil (0.241 g, 
81% over 2 steps).  Rf (1:4 ethyl acetate/petroleum ether) 0.24; max/cm
-1 (NaCl) 
3330 (NH), 2928 (CH), 2250 (CN), 1702 (CO), 1517, 822, 734; []D
23 -13.6 (c 1.0, 
CHCl3); H (400 MHz, CDCl3) 1.55–1.65 (2H, m, 2-H2), 1.68–1.77 (2H, m, 3-H2), 2.35–
2.43 (4H, m, 1-H2 and 7-H2), 2.71 (2H, t, J 7.4 Hz, 8-H2), 4.30–4.38 (1H, m, 4-H), 
5.33 (1H, ddt, J 15.4, 6.8, 1.3 Hz, 5-H), 5.73 (1H, dtd, J 15.4, 6.8, 1.0 Hz, 6-H), 
6.46 (1H, d, J 8.1 Hz, NH), 7.13–7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 16.9 
(CH2), 21.7 (CH2), 33.7 (CH2), 33.9 (CH2), 35.2 (CH2), 52.5 (CH), 92.8 (C), 119.2 (C), 
126.1 (CH), 128.2 (CH), 128.4 (2 × CH), 128.5 (2 × CH), 133.7 (CH), 141.1 (C), 161.3 
(C); m/z (CI) 373.0640 (MH
+. C17H20
35Cl3N2O requires 373.0641), 339 (30%), 305 (13), 
288 (12), 269 (8), 212 (11), 186 (17), 162 (23), 132 (13), 128 (8), 107 (37), 85 (23), 
79 (100), 69 (28). 
 
 
(2S,4S,5E)-2-[(tert-Butyldimethylsilyl)oxy]-4-(trichloromethylcarbonylamino)-8-
phenyloct-5-ene 
O O
Si
CCl3
NH
1
2
3
4
5
6
7
8
159  
The trichloroacetimidate formation reaction was carried out according to general 
procedure 4, using (3R,4E,7S)-7-[(tert-butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-ol 
152  (0.100  g,  0.30  mmol),  1,8-diazabicyclo[5.4.0]undec-7-ene  (0.022  mL,  0.15 
mmol) and trichloroacetonitrile (0.045 mL, 0.45 mmol) in dichloromethane (5 mL) 
to  give  the  desired  allylic  trichloroacetimidate  intermediate  as  a  colourless  oil 
(0.130 g).  H (400 MHz, CDCl3) 0.03 (6H, s, 2 × SiCH3), 0.87 (9H, s, SiC(CH3)3), 1.11 
(3H, d, J 6.1 Hz, 1-H3), 1.92–2.04 (1H, m, 3-HH), 2.07–2.28 (3H, m, 3-HH and 7-H2), 
2.64–2.82 (2H, m, 8-H2), 3.78–3.89 (1H, m, 2-H), 5.33–5.42 (1H, m, 6-H), 5.54 (1H, 
dd, J 15.3, 7.0 Hz, 5-H), 5.82 (1H, dt, J 15.3, 7.2 Hz, 4-H), 7.15–7.32 (5H, m, 5 × 
ArH), 8.27 (1H, s, NH).  This was then subjected to an Overman rearrangement 
reaction, carried out according to general procedure 5, using potassium carbonate  
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(0.015  g,  0.11  mmol)  in  p-xylene  (5  mL).    Purification  by  silica  column 
chromatography, eluting with 1:19 ethyl acetate/petroleum ether gave (2S,4S,5E)-
2-[(tert-butyldimethylsilyl)oxy]-4-(trichloromethylcarbonylamino)-8-phenyloct-5-
ene  159  as  a  colourless  oil  (0.124  g,  87%  over  2  steps).    Rf  (1:4  ethyl 
acetate/petroleum ether) 0.57; max/cm
-1 (NaCl) 3373 (NH), 2928 (CH), 1702 (CO), 
1514, 1254, 1079, 835; []D
19 -12.0 (c 0.3, CHCl3); H (400 MHz, CDCl3) 0.04 (3H, s, 
SiCH3), 0.05 (3H, s, SiCH3), 0.89 (9H, s, SiC(CH3)3), 1.18 (3H, d, J 6.0 Hz, 1-H3), 
1.60–1.68 (1H, m, 3-HH), 1.71–1.79 (1H, m, 3-HH), 2.37 (2H, q, J 7.0 Hz, 7-H2), 2.70 
(2H, t, J 7.0 Hz, 8-H2), 3.82 (1H, q, J 6.0 Hz, 2-H), 4.46 (1H, quin, J 6.8 Hz, 4-H), 
5.40 (1H, dd, J 15.4, 6.8 Hz, 5-H), 5.72 (1H, dt, J 15.4, 7.0 Hz, 6-H), 6.52 (1H, d, J 
8.0 Hz, NH), 7.14–7.30 (5H, m, 5 × ArH); C (100 MHz, CDCl3) -4.6 (CH3), -4.1 (CH3), 
18.1 (C), 24.0 (CH3), 25.9 (3 × CH3), 34.0 (CH2), 35.4 (CH2), 44.8 (CH2), 50.7 (CH), 
65.8 (CH), 92.9 (C), 126.0 (CH), 128.4 (2 × CH), 128.5 (2 × CH), 129.1 (CH), 132.4 
(CH),  141.4  (C),  160.7  (C);  m/z  (CI)  480.1490  (MH
+.  C22H35
35Cl2
37ClNO2Si  requires 
480.1477), 478 (97%), 444 (75), 410 (19), 408 (15), 352 (14), 346 (8), 318 (5), 159 
(11), 133 (8), 81 (4). 
 
 
(2S)-2-(Trichloromethylcarbonylamino)hexanoic acid
47 
HO
O
CCl3
NH
O
2
3
4
5
6
160  
(5S,6E)-9-Phenyl-5-(trichloromethylcarbonylamino)non-6-ene  155  (0.240  g,  0.66 
mmol) was dissolved in acetonitrile (9 mL) and carbon tetrachloride (9 mL) and to 
the stirred solution, sodium periodate (0.580 g, 2.71 mmol, dissolved in 12 mL of 
water) was added.  Ruthenium(III) chloride hydrate (0.007 g, 0.03 mmol) was then 
added, and the resulting reaction mixture was stirred at room temperature for 26 h 
before further sodium periodate (0.283 g, 1.32 mmol) and ruthenium(III) chloride 
hydrate (0.004 g, 0.02 mmol) were added.  The  reaction mixture was stirred at 
room temperature for a further 22 h and the organic layers were extracted from 
the mixture using dichloromethane (100 mL), combined and then concentrated in  
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vacuo.  The residue was dissolved in ethyl acetate (100 mL) and washed with a 
saturated  aqueous  solution  of  sodium  hydrogen  carbonate  (100  mL)  and  then  a 
saturated aqueous solution of ammonium chloride (100 mL).  The aqueous phases, 
found to contain the desired product, were then combined and acidified using 2 M 
hydrochloric acid before being extracted using ethyl acetate (2 × 125 mL).  The 
organic phases were then combined, dried (MgSO4), filtered and concentrated in 
vacuo.    Purification  was  carried  out  using  silica  column  chromatography,  and 
elution  with  1:1  ethyl  acetate/petroleum  ether  gave  (2S)-2-
(trichloromethylcarbonylamino)hexanoic acid 160 as a colourless oil (0.053 g, 29%).  
Rf  (1:4  ethyl  acetate/petroleum  ether)  0.23;  []D
22  +15.9  (c  0.85,  CHCl3)  (lit.
46 
[]D
29 +35.2) (c 0.27, CHCl3)); H (400 MHz, CDCl3) 0.92 (3H, t, J 7.0 Hz, 6-H3), 1.32–
1.42 (4H, m, 4-H2 and 5-H2), 1.79–1.91 (1H, m, 3-HH), 1.99–2.10 (1H, m, 3-HH), 4.63 
(1H, dt, J 7.3, 5.5 Hz, 2-H), 7.16 (1H, d, J 7.3 Hz, NH); C (100 MHz, CDCl3) 13.8 
(CH3), 22.2 (CH2), 27.0 (CH2), 31.5 (CH2), 53.8 (CH), 92.1 (C), 161.6 (C), 176.1 (C); 
m/z (CI) 275.9953 (MH
+. C8H13
35Cl3NO3 requires 275.9961), 242 (71%), 230 (5), 208 
(13), 196 (9), 162 (24), 158 (11), 113 (11), 81 (23), 69 (24). 
 
 
Methyl (2S)-2-(trichloromethylcarbonylamino)hexanoate 
MeO
O
CCl3
NH
O
2
3
4
5
6
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The reaction  was carried out according to general procedure 6,  using (5S,6E)-9-
phenyl-5-(trichloromethylcarbonylamino)non-6-ene  155  (0.142  g,  0.39  mmol), 
sodium  periodate  (0.343  g,  1.61  mmol,  dissolved  in  9  mL  of  water),  and 
ruthenium(III)  chloride  hydrate  (0.010  g,  0.05  mmol)  in  acetonitrile  (6  mL)  and 
carbon tetrachloride (6 mL) to give a green/blue oil (0.122 g), which was reacted 
with thionyl chloride (0.20 mL, 2.74 mmol) in methanol (5 mL).  Purification by 
silica column chromatography, eluting with 1:9 diethyl ether/petroleum ether gave 
methyl  (2S)-2-(trichloromethylcarbonylamino)hexanoate  161  as  a  colourless  oil 
(0.039 g, 34% over 2 steps).  Rf (1:4 ethyl acetate/petroleum ether) 0.58; []D
25  
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+19.0 (c 0.2, CHCl3); H (400 MHz, CDCl3) 0.87–0.93 (3H, m, 6-H3), 1.30–1.40 (4H, m, 
4-H2  and  5-H2),  1.72–1.83  (1H,  m,  3-HH),  1.92–2.04  (1H,  m,  3-HH),  3.81  (3H,  s, 
OCH3), 4.58 (1H, q, J 6.2 Hz, 2-H), 7.14 (1H, d, J 6.2 Hz, NH); C (100 MHz, CDCl3) 
13.9 (CH3), 22.2 (CH2), 27.0 (CH2), 31.7 (CH2), 52.9 (CH3), 54.0 (CH), 92.2 (C), 161.4 
(C), 171.9 (C); m/z (CI) 290.0130 (MH
+. C9H15
35Cl3NO3 requires 290.0118), 256 (100%), 
222 (20), 179 (10), 127 (5), 85 (40), 69 (55). 
 
 
Methyl (2S)-4-phenyl-2-(trichloromethylcarbonylamino)butanoate 
MeO
O
CCl3
NH
O
4
3
2
162  
The reaction was carried out according to general procedure 6 using (3S,4E)-1,7-
diphenyl-3-(trichloromethylcarbonylamino)hept-4-ene  156  (0.100  g,  0.24  mmol), 
sodium  periodate  (0.213  g,  1.00  mmol,  dissolved  in  9  mL  of  water)  and 
ruthenium(III)  chloride  hydrate  (0.003  g,  0.01  mmol)  in  acetonitrile  (6  mL)  and 
carbon tetrachloride (6 mL) to give a blue/black oil (0.094 g), which was reacted 
with thionyl chloride (0.12 mL, 1.65 mmol) in methanol (5 mL).  Purification by 
silica column chromatography, eluting with 1:9 ethyl acetate/petroleum ether gave 
methyl  (2S)-4-phenyl-2-(trichloromethylcarbonylamino)butanoate  162  as  a 
colourless oil (0.035 g, 42%).  Rf (1:4 ethyl acetate/petroleum ether) 0.39; max/cm
-
1 (NaCl) 3344 (NH), 2925 (CH), 1742 (CO), 1713 (CO), 1513, 1455, 1215, 821; []D
21 
+29.9 (c 0.3, CHCl3); H (400 MHz, CDCl3) 2.05–2.14 (1H, m, 3-HH), 2.22–2.32 (1H, m, 
3-HH), 2.55–2.69 (2H, m, 4-H2), 3.71 (3H, s, OCH3), 4.56 (1H, q, J 5.2 Hz, 2-H), 
7.08–7.33 (6H, m, 5 × ArH and NH); C (100 MHz, CDCl3) 31.3 (CH2), 33.3 (CH2), 52.9 
(CH3), 53.7 (CH), 93.6 (C), 126.5 (CH), 128.4 (2 × CH), 128.7 (2 × CH), 140.0 (C), 
161.5 (C), 171.5 (C); m/z (CI) 338.0117 (MH
+.C13H15
35Cl3NO3 requires 338.0118), 304 
(45%), 69 (12). 
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Methyl (2S)-4,4-dimethyl-2-(trichloromethylcarbonylamino)pentanoate 
MeO
O
CCl3
NH
O
2
3
163  
The reaction was carried out according to general procedure 6 using (4S,5E)-2,2-
dimethyl-4-(trichloromethylcarbonylamino)-8-phenyloct-5-ene  157  (0.150  g,  0.40 
mmol), sodium periodate (0.349 g, 1.63  mmol,  dissolved in 9 mL of  water) and 
ruthenium(III)  chloride  (0.008  g,  0.04  mmol)  in  acetonitrile  (6  mL)  and  carbon 
tetrachloride (6 mL) to give a blue/black oil (0.160 g), which was then reacted with 
thionyl  chloride (0.2 mL, 2.74 mmol) in methanol (5 mL).  Purification by silica 
column  chromatography,  eluting  with  3:17  diethyl  ether/petroleum  ether  gave 
methyl  (2S)-4,4-dimethyl-2-(trichloromethylcarbonylamino)pentanoate  163  as  a 
pale yellow solid (0.075 g, 62%).  Mp 76-79 °C; Rf (1:4 ethyl acetate/petroleum 
ether) 0.41; max/cm
-1 (NaCl) 3422 (NH), 2960 (CH), 1743 (CO), 1716 (CO), 1516, 
1371, 1215, 908; []D
22 -3.3 (c 1.0, CHCl3); H (400 MHz, CDCl3) 1.00 (9H, s, C(CH3)3), 
1.58–1.70 (1H, m, 3-HH), 1.88 (1H, dd, J 14.6, 3.1 Hz, 3-HH), 3.78 (3H, s, OCH3), 
4.62 (1H, td, J 8.6, 3.1 Hz, 2-H), 6.94 (1H, br m, NH); C (100 MHz, CDCl3) 29.5 (3 × 
CH3), 30.7 (C), 45.8 (CH2), 51.8 (CH3), 52.8 (CH), 106.9 (C), 161.4 (C), 172.3 (C); 
m/z (CI) 304.0264 (MH
+. C10H17
35Cl3NO3 requires 304.0274), 270 (86%), 254 (10), 236 
(19), 113 (9), 81 (32), 69 (29). 
 
 
Methyl (2S)-5-cyano-2-(trichloromethylcarbonylamino)pentanoate 
MeO
O
CN
CCl3
NH
O
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The reaction was carried out according to general procedure 6, using  (4S,5E)-1-
cyano-4-(trichloromethylcarbonylamino)-8-phenyloct-5-ene  158  (0.120  g,  0.32 
mmol), sodium periodate (0.282 g,  1.37  mmol,  dissolved in 6 mL of  water) and 
ruthenium(III)  chloride  hydrate  (0.007  g,  0.03  mmol)  in  acetonitrile  (4  mL)  and  
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carbon tetrachloride (4 mL), stirring for 18 h to give a black oil (0.099 g), which was 
reacted  with  thionyl  chloride  (0.240  mL,  3.29  mmol)  in  methanol  (7  mL).  
Purification  by  silica  column  chromatography,  eluting  with  3:7  ethyl 
acetate/petroleum  ether  gave  methyl  (2S)-5-cyano-2-
(trichloromethylcarbonylamino)pentanoate 164 as a colourless oil (0.056g, 58%).  Rf 
(1:4 ethyl acetate/petroleum ether) 0.09; max/cm
-1 (NaCl) 3339 (NH), 2918 (CH), 
2253 (CN), 1744 (CO), 1712 (CO), 1521, 1439, 1217, 912, 735; []D
21 +8.1 (c 0.5, 
CHCl3); H (400 MHz, CDCl3) 1.65–1.85 (2H, m, 4-H2), 1.88–1.98 (1H, m, 3-HH), 2.13–
2.23 (1H, m, 3-HH), 2.44 (2H, t, J 7.0 Hz, 5-H2), 3.85 (3H, s, OCH3), 4.61 (1H, td, J 
7.5, 6.0 Hz, 2-H), 7.33 (1H, d, J 6.0 Hz, NH); C (100 MHz, CDCl3) 16.8 (CH2), 21.4 
(CH2), 31.3 (CH2), 53.1 (CH3), 53.3 (CH), 92.0 (C), 118.8 (C), 161.9 (C), 171.1 (C); 
m/z (CI) 300.9900 (MH
+. C9H12
35Cl3N2O3 requires 300.9914), 267 (76%), 251 (10), 233 
(48), 199 (9), 183 (9), 155 (12), 142 (8), 113 (25), 107 (85), 71 (100). 
 
 
(2S)-Dimethyl-2-(trichloromethylcarbonylamino)-hexadioate  
MeO
O
O
OMe
NH
CCl3
O
2
3
4
5
165  
The reaction  was carried out according to general procedure 6,  using (4S,5E)-1-
cyano-4-(trichloromethylcarbonylamino)-8-phenyloct-5-ene  158  (0.109  g,  0.29 
mmol), sodium periodate (0.256 g, 1.20  mmol,  dissolved in 6 mL of  water) and 
ruthenium(III)  chloride  hydrate  (0.006  g,  0.03  mmol)  in  acetonitrile  (4  mL)  and 
carbon  tetrachloride  (4  mL).    After  stirring  for  18  h,  further  sodium  periodate 
(0.064 g, 0.30 mmol) and ruthenium(III) chloride hydrate (0.002 g, 0.01 mmol) were 
added, and the reaction was stirred for a futher 6 h to give a blue/black oil (0.102 
g), which was reacted with thionyl chloride (0.30 mL, 4.11 mmol) in methanol (7 
mL).    Purification  by  silica  column  chromatography,  and  elution  with  1:4  ethyl 
acetate/petroleum  ether  gave  (2S)-dimethyl-2-(trichloromethylcarbonylamino)-
hexadioate 165 as a colourless oil (0.034 g, 35%).  max/cm
-1 (neat) 3300 (NH), 2955 
(CH), 1738 (CO), 1719 (CO), 1703 (CO), 1520, 1439, 1360, 1263, 1209, 1163, 1121,  
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821; []D
23 +19.5 (c 0.2, CHCl3); H (400 MHz, CDCl3) 1.59–1.78 (2H, m, 4-H2), 1.79–
1.90 (1H, m, 3-HH), 1.96–2.08 (1H, m, 3-HH), 2.37 (2H, t, J 7.2 Hz, 5-H2), 3.68 (3H, 
s, OCH3), 3.82 (3H, s, OCH3), 4.58 (1H, td, J 7.0, 5.2 Hz, 2-H), 7.34 (1H, d, J 7.0 Hz, 
NH); C (100 MHz, CDCl3) 20.3 (CH2), 31.2 (CH2), 33.1 (CH2), 51.7 (CH3), 53.0 (CH3), 
53.7  (CH),  92.1  (C),  161.6  (C),  171.4  (C),  173.3  (C);  m/z  (CI)  334.0002  (MH
+. 
C10H15
35Cl3NO5 requires 334.0016), 300 (24%), 266 (10), 167 (8), 137 (21), 107 (51), 
73 (100).  Further elution with 1:3 ethyl acetate/petroleum ether also gave methyl 
(2S)-5-nitrile-2-(trichloromethylcarbonylamino)pentanoate  141  as  a  colourless  oil 
(0.015 g, 17%).  (For full analytical data, see above compound 141). 
 
 
Methyl  (2S,4S)-4-[(tert-butyldimethylsilyl)oxy]-2-(trichloromethylcarbonyl-
amino)pentanoate 
MeO
O O
Si
CCl3
NH
O
2
3
4
5
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(2S,4S,5E)-2-[(tert-butyldimethylsilyl)oxy]-4-(trichloromethylcarbonylamino)-8-
phenyloct-5-ene 159 (0.107 g, 0.22 mmol) was dissolved in tert-butanol (2 mL) and 
to the stirred solution, potassium carbonate (0.093 g, 0.67 mmol, dissolved in 4 mL 
of  water)  was  added,  followed  by  sodium  periodate  (0.143  g,  0.67  mmol)  and 
potassium permanganate (0.032 g, 0.20 mmol).  The reaction mixture was stirred at 
room  temperature  for  48  h  before  further  potassium  carbonate  (0.047  g,  0.34 
mmol), sodium periodate (0.072 g, 0.34 mmol) and potassium permanganate (0.016 
g, 0.10 mmol) were added.  The reaction mixture was stirred at room temperature 
for  a  further  40  h  before  potassium  carbonate  (0.031  g,  0.22  mmol),  sodium 
periodate (0.048 g, 0.22 mmol) and potassium permanganate (0.011 g, 0.07 mmol) 
were added.  The reaction was stirred again at room temperature for 18 h and then 
filtered through a pad of Celite
® and washed with ethyl acetate (50 mL).  Water (50 
mL) was added to the filtrate, and the layers were separated.  The organic layers 
were further extracted using ethyl acetate (3 × 50 mL) and the combined organic 
phases were dried (MgSO4), filtered, and concentrated in vacuo to give a yellow oil 
(0.094 g).  This residue was then dissolved in toluene (5 mL) and methanol (5 mL),  
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and (trimethylsilyl)diazomethane solution (2.0 M in  diethyl  ether, 2.20 mL,  4.40 
mmol) was added dropwise.  The reaction mixture was stirred at room temperature 
for 1.75  h before being concentrated  in vacuo.   Purification was carried  out by 
silica column chromatography, and elution with 1:9 diethyl ether/petroleum ether 
gave  methyl  (2S,4S)-4-[(tert-butyldimethylsilyl)oxy]-2-
(trichloromethylcarbonylamino)pentanoate  166  as  a  colourless  oil  (0.027  g,  30% 
over 2 steps).  Rf (1:4 ethyl acetate/petroleum ether) 0.46; max/cm
-1 (NaCl) 3420 
(NH), 2858 (CH), 1638 (CO), 1254, 1142, 822; []D
20 +25.6 (c 0.75, CHCl3); H (400 
MHz, CDCl3) 0.06 (3H, s, SiCH3), 0.07 (3H, s, SiCH3), 0.88 (9H, s, SiC(CH3)3), 1.20 (3H, 
d, J 6.0 Hz, 5-H3), 1.98–2.08 (1H, m, 3-HH), 2.09–2.18 (1H, m, 3-HH), 3.79 (3H, s, 
OCH3), 3.95–4.04 (1H, m, 4-H), 4.57 (1H, q, J 5.9 Hz, 2-H), 7.51 (1H, d, J 5.9 Hz, 
NH); C (100 MHz, CDCl3) -4.5 (CH3), -4.3 (CH3), 18.2 (C), 23.6 (CH3), 26.0 (3 × CH3), 
40.4 (CH2), 51.8 (CH3), 52.8 (CH), 65.7 (CH), 92.2 (C), 161.5 (C), 171.7 (C); m/z (CI) 
408.0746 (MH
+. C14H27
35Cl2
37ClNO4Si requires 408.0748), 372 (39%), 338 (13), 314 (5), 
271 (9), 240 (11), 207 (6), 173 (9), 133 (7), 113 (40), 69 (100). 
 
 
(2S)-2-Aminohexanoic acid hydrochloride
125 
HO
NH2
O
2
3
4
5
6
167
·HCl
 
The reaction was carried out according to general procedure 7, using methyl (2S)-2-
(trichloromethylcarbonylamino)hexanoate  161  (0.027  g,  0.09  mmol)  in  6  M 
hydrochloric acid (5 mL), stirring under reflux for 18 h to give (2S)-2-aminohexanoic 
acid hydrochloride 167 as a pale yellow solid (0.012 g, 77%).  Mp 184–190 °C; []D
24 
+26.7 (c 1.0, 6 M HCl) (lit.
125 []D
20 +10.3 (c 1.05, H2O); H (400 MHz, D2O) 0.87 (3H, 
t, J 6.7 Hz, 6-H3), 1.30–1.42 (4H, m, 4-H2 and 5-H2), 1.80–2.00 (2H, m, 3-H2), 4.00 
(1H, t, J 6.1 Hz, 2-H); C (100 MHz, D2O) 12.9 (CH3), 21.5 (CH2), 26.2 (CH2), 29.4 
(CH2), 53.2 (CH), 172.7 (C); m/z (CI) 132.1023 (MH
+. C6H14NO2 requires 132.1025), 
113 (13%), 97 (13), 81 (23), 71 (22). 
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(2S)-2-Amino-4-phenylbutanoic acid hydrochloride
126 
·HCl
HO
NH2
O
2
3
4
168  
The reaction was carried out according to general procedure 7 using methyl (2S)-4-
phenyl-2-(trichloromethylcarbonylamino)butanoate 162 (0.018 g, 0.05 mmol) in 6 M 
hydrochloric  acid,  stirring  under  reflux  for  20  h  to  give  (2S)-2-amino-4-
phenylbutanoic acid hydrochloride 168 as a yellow solid (0.024 g, 100%).  Mp 244–
247 °C (lit.
126 Mp 250–260 °C); []D
23 +4.7 (c 1.0, 1 M HCl) (lit.
126 []D
20 +40.0 (c 0.6, 
3 M HCl); H (400 MHz, D2O) 2.15–2.36 (2H, m, 3-H2), 2.70–2.88 (2H, m, 4-H2), 4.07 
(1H, t, J 5.8 Hz, 2-H), 7.27–7.43 (5H, m, 5 × ArH); C (100 MHz, D2O) 30.5 (CH2), 
31.9 (CH2), 57.4 (CH), 126.6 (CH), 128.5 (2 × CH), 128.9 (2 × CH), 140.3 (C), 173.3 
(C); m/z (CI) 180 (MH
+, 4%), 161 (22), 137 (56), 113 (31), 97 (33), 81 (73), 69 (100). 
 
 
(2S)-2-Amino-4,4-dimethylpentanoic acid hydrochloride
127 
HO
NH2
O
2
3
169
·HCl
 
The reaction was carried out according to general procedure 7 using methyl (2S)-
4,4-dimethyl-2-(trichloromethylcarbonylamino)pentanoate  163  (0.047  g,  0.15 
mmol) in 6 M hydrochloric acid (5 mL), stirring under reflux for 24 h to give (2S)-2-
amino-4,4-dimethylpentanoic acid hydrochloride 169 as a pale yellow solid (0.040 g, 
100%).  Mp 198–202 °C; max/cm
-1 (neat) 3395 (NH), 2955 (CH), 1744 (CO), 1636, 
1404, 1211, 1072, 1026; []D
21 -50.0 (c 0.1, AcOH); H (400 MHz, D2O) 1.00 (9H, s, 
C(CH3)3), 1.70 (1H, dd, J 15.0, 5.6 Hz, 3-HH), 2.04 (1H, dd, J 15.0, 5.6 Hz, 3-HH), 
4.07 (1H, t, J 5.6 Hz, 2-H); C (100 MHz, D2O) 28.3 (3 × CH3), 29.6 (C), 43.8 (CH2), 
50.5 (CH), 173.2 (C); m/z (CI) 146.1188 (MH
+. C7H16NO2 requires 146.1181), 135 (6%), 
113 (10), 97 (13), 81 (26), 69 (32). 
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(2S,4S)-4-Hydroxy-2-aminopentanoic acid
128 
OH NH2
O
HO
2
3
4
5
170  
 
The  reaction  was  carried  out  according  to  general  procedure  7,  using  methyl 
(2S,4S)-4-[(tert-butyldimethylsilyl)oxy]-2-(trichloromethylcarbonylamino) 
pentanoate 166 (0.026 g, 0.06 mmol) in 6.0 M hydrochloric acid (4 mL), stirring 
under reflux for 16 h.  Purification was carried out using a DOWEX ion exchange 
column  and  elution  with  0.5  M  ammonium  hydroxide  solution  gave  (2S,4S)-4-
hydroxy-2-aminopentanoic acid 170 as a yellow solid (0.006 g, 71%).  Mp >250 °C 
(decomposition) (lit.
128 Mp 228–230 °C); max/cm
-1 3350 (NH2, OH), 1601 (CO), 1406, 
1117, 1022, 721; []D
20 +18.6 (c 0.2, H2O) (lit.
128 []D
20 +21.0 (c 1.3, H2O)); H (400 
MHz, D2O) 1.27 (3H, d, J 6.6 Hz, 5-H3), 1.76–1.84 (1H, m, 3-HH), 2.09–2.15 (1H, m, 
3-HH), 3.82 (1H, dd, J 9.4, 4.4 Hz, 2-H), 4.08–4.12 (1H, m, 4-H); C (100 MHz, D2O) 
22.7 (CH3), 38.6 (CH2), 54.2 (CH), 66.7 (CH), 174.7 (C); m/z (CI) 134 (MH
+, 5%), 116 
(100), 97 (13), 71 (23). 
 
 
L-2-aminoadipic acid-6-amide hydrochloride 
HO
NH2
O
O
NH2
2
3
4
5
172
·HCl
 
A  stirred  solution  of  methyl  (2S)-5-cyano-2-
(trichloromethylcarbonylamino)pentanoate  164  (0.025  g,  0.08  mmol)  in  tert-
butanol (0.6 mL) and water (0.3 mL) was cooled to 0 °C before lithium hydroxide 
hydrate (0.008 g, 0.18 mmol) was added.  The reaction mixture was stirred at 0 °C 
for 0.25 h, and then at room temperature for 3 h before being concentrated  in 
vacuo  to  give a  pale yellow residue (0.033 g), which was then dissolved in 6 M 
hydrochloric acid (5 mL).  The reaction mixture was allowed to stir under reflux for 
24 h before being allowed to cool to room temperature and concentrated in vacuo.  
The residue was partitioned between water (20 mL) and diethyl ether (20 mL), and  
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the aqueous phase was concentrated in vacuo to give L-2-aminoadipic acid-6-amide 
hydrochloride  172  as  a  white  solid  (0.023  g,  100%).    Mp  168–172  °C;  max/cm
-1 
(NaCl) 3329 (NH2), 2949 (CH), 1697 (CO), 1526, 1437, 1342, 1209, 1026, 821, 779; 
[]D
23 +10.0 (c 2.0, 1 M HCl); H (400 MHz, D2O) 1.59–1.80 (2H, m, 4-H2), 1.84–2.02 
(2H, m, 3-H2), 2.46 (2H, t, J 7.2 Hz, 5-H2), 3.88 (1H, t, J 6.0 Hz, 2-H); C (100 MHz, 
D2O) 22.7 (CH2), 32.1 (CH2), 35.9 (CH2), 56.1 (CH), 175.5 (C), 180.7 (C); m/z (CI) 
151 (8%), 135 (23), 113 (62), 85 (72), 71 (90). 
 
 
L-2-aminoadipic acid hydrochloride
129 
HO
O
OH
O NH2
2
3
4
5
173
·HCl
 
The reaction was carried out according to general procedure 7, using (2S)-dimethyl 
-2-(trichloromethylcarbonylamino)hexadioate  165  (0.027  g,  0.08  mmol)  in  6  M 
hydrochloric acid (5 mL), stirring under reflux for 19 h to give L-2-aminoadipic acid 
hydrochloride 173 as a pale yellow solid (0.018 g, 100%).  Mp 173–175 °C (lit.
129 Mp 
170–172 °C); max/cm
-1 3366 (NH2), 2936 (CH), 1670 (CO), 1643 (CO), 1587, 1497, 
1292, 1217, 1132, 1030, 764; []D
25 +27.8 (c 0.3, 6 M HCl) (lit.
129 []D
25 +23.5 (c 1.0, 
5 M HCl)); H (400 MHz, D2O) 1.63–1.84 (2H, m, 4-H2), 1.89–2.09 (2H, m, 3-H2), 2.47 
(2H, t, J 7.2 Hz, 5-H2), 4.07 (1H, t, J 6.2 Hz, 2-H); C (100 MHz, D2O) 23.0 (CH2), 
32.4 (CH2), 36.2 (CH2), 56.1 (CH), 175.5 (C), 181.0 (C); m/z (CI) 144 (100%), 107 
(19), 85 (34), 69 (50). 
 
 
5-Methyl-1-phenyloct-4-en-3-one 
O
8
7
6 4 2
1
174  
To a stirred solution of 5-phenylpent-1-en-3-one 136 (0.10 g, 0.6 mmol) in toluene 
(5  mL),  2-methyl-1-pentene  (0.230  mL,  1.86  mmol)  was  added,  followed  by  
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Hoveyda-Grubbs  2
nd  generation  catalyst  L  (0.078  g,  0.12  mmol).    The  reaction 
mixture was heated to 80 °C and stirred for 24 h before being allowed to cool to 
room temperature and concentrated in vacuo.  Purification was carried out by silica 
column chromatography, and elution with 1:39 diethyl ether/petroleum ether gave 
(4Z)-5-methyl-1-phenyloct-4-en-3-one Z-174 as a colourless oil (0.026 g, 19%), and 
(4E)-5-methyl-1-phenyloct-4-en-3-one E-174 as a colourless oil (0.030 g, 22%).  (NB: 
1H NMR spectroscopic analysis of the crude reaction product prior to purification 
indicated a 1:2 Z:E-product ratio). 
Z-isomer: 
Rf (1:4 ethyl acetate/petroleum ether) 0.64; max/cm
-1 (neat) 2960 (CH), 1686 (CO), 
1614 (C=C), 1454, 1363, 1115, 1031, 748; H (400 MHz, CDCl3) 0.88 (3H, t, J 7.4 Hz, 
1-H3), 1.35–1.45 (2H, m, 2-H2), 1.79 (3H, d, J 1.4 Hz, 4-CH3), 2.48–2.53 (2H, m, 3-
H2), 2.64–2.69 (2H, m, 7-H2), 2.82–2.87 (2H, m, 8-H2), 5.96–5.98 (1H, m, 5-H), 7.09–
7.23 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 14.2 (CH3), 21.5 (CH2), 25.5 (CH3), 30.1 
(CH2), 35.7 (CH2), 45.8 (CH2), 123.7 (CH), 125.9 (CH), 128.3 (2 × CH), 128.4 (2 × CH), 
141.5 (C), 159.7 (C), 199.5 (C); m/z (EI) 216.1518 (M
+. C15H20O requires 216.1514), 
183 (17%), 173 (100), 145 (5), 133 (16), 111 (94), 91 (73), 84 (72), 49 (55), 47 (10). 
E-isomer: 
Rf (1:4 ethyl acetate/petroleum ether) 0.57; max/cm
-1 (neat) 3003 (CH), 1710 (CO), 
1420, 1358, 1219, 1092, 903, 785; H (400 MHz, CDCl3) 0.83 (3H, t, J 7.3 Hz, 1-H3), 
1.37–1.48 (2H, m, 2-H2), 2.02 (2H, td, J 7.6, 1.2 Hz, 3-H2), 2.06 (3H, d, J 1.2 Hz, 4-
CH3), 2.63–2.71 (2H, m, 7-H2), 2.81–2.88 (2H, m, 8-H2), 5.97 (1H, sex, J 1.2 Hz, 5-H), 
7.07–7.24 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 14.2 (CH3), 21.5 (CH2), 25.5 (CH3), 
30.1 (CH2), 35.7 (CH2), 45.9 (CH2), 123.7 (CH), 125.9 (CH), 128.3 (2 × CH), 128.4 (2 
× CH), 141.5 (C), 159.7 (C), 199.5 (C); m/z (CI) 217.1588 (MH
+. C15H21O requires 
217.1592), 215 (13%), 191 (13), 151 (49), 149 (16), 133 (15), 85 (22), 69 (26). 
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(3R,4E)-5-methyl-1-phenyloct-4-en-3-ol 
OH
8
7
6 4
3
2
1
175  
A  stirred  solution  of  (4E)-5-methyl-1-phenyloct-4-en-3-one  E-174  (0.281  g,  1.30 
mmol) and (S)-(-)-2-methyl-CBS-oxazaborolidine solution (1.0 M in toluene, 1.30 mL, 
1.30  mmol)  in  tetrahydrofuran  (8  mL)  was  cooled  to  -20  °C  before  borane 
dimethylsulfide complex solution (2.0 M in toluene, 0.98 mL, 1.96 mmol) was slowly 
added.  The reaction mixture was stirred at -20 °C for 7 h before being quenched 
by the addition of methanol (6 mL) and concentrated in vacuo.  Purification was 
carried  out  by  silica  column  chromatography,  and  elution  with  3:37  diethyl 
ether/petroleum  ether  gave  (3R,4E)-5-methyl-1-phenyl-4-en-3-ol  175  as  a 
colourless oil (0.289 g, 100%).  Chiral HPLC (Chiralcel IB column) analysis using 4% 
isopropanol  in  hexane  indicated  46%  ee;  Rf  (1:4  ethyl  acetate/petroleum  ether) 
0.54; max/cm
-1 (neat) 2959 (OH), 2924, 2295 (CH) 1460, 1379, 725; []D
21 +22.0 (c 
1.0, CHCl3); H (400 MHz, CDCl3) 0.89 (3H, t, J 7.3 Hz, 1-H3), 1.38 (1H, br s, OH), 
1.39–1.51 (2H, m, 2-H2), 1.63 (3H, d, J 1.2 Hz, 4-CH3), 1.70–1.81 (1H, m, 7-HH), 
1.87–1.96 (1H, m, 7-HH), 1.98 (2H, t, J 7.4 Hz, 3-H2), 2.59–2.74 (2H, m, 8-H2), 4.38 
(1H, dt, J 8.6, 6.6 Hz, 6-H), 5.21 (1H, dq, J 8.6, 1.2 Hz, 5-H), 7.14–7.31 (5H, m, 5 × 
ArH); C (100 MHz, CDCl3) 13.7 (CH3), 16.5 (CH3), 20.8 (CH2), 31.9 (CH2), 39.3 (CH2), 
41.7 (CH2), 68.1 (CH), 125.8 (CH), 127.7 (CH), 128.3 (2 × CH), 128.4 (2 × CH), 139.2 
(C), 142.1 (C); m/z (CI) 201.1642 (MH
+. C15H23O-H2O requires 201.1643), 175 (6%), 
167 (10), 85 (31), 69 (22). 
 
 
(4E)-5-methyl-1-phenyloct-4-en-3-ol 
OH
8
7
6 4
3
2
1
rac-175  
The reaction was carried out according to general procedure 3, using (4E)-5-methyl-
1-phenyloct-4-en-3-one  E-174  (0.050  g,  0.23  mmol)  and  diisobutylaluminium 
hydride  solution  (1.0  M  in  hexanes,  0.35  mL,  0.35  mmol)  in  toluene  (4  mL).   
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Purification  by  silica  column  chromatography,  eluting  with  1:19  ethyl 
acetate/petroleum  ether  gave  (4E)-5-methyl-1-phenyloct-4-en-3-ol  rac-175  as  a 
colourless oil (0.027 g, 54%).  For analytical data, see above compound 175. 
 
 
(3E,5S)-5-methyl-1-phenyl-5-(trichloromethylcarbonylamino)oct-3-ene 
NH
CCl3
O
177 8
6
4
3
2
1
7

A stirred solution of (3R,4E)-5-methyl-1-phenyl-4-en-3-ol 175 (0.040 g, 0.18mmol) 
in dichloromethane (4 mL) was cooled to 0 °C before 1,8-diazabicyclo[5.4.0]undec-
7-ene (0.014 mL, 0.09 mmol) was added, followed by trichloroacetonitrile (0.028 
mL, 0.28 mmol).  The reaction mixture was heated to 45 °C and allowed to stir 
under reflux for 72 h before being cooled to room temperature and filtered through 
a plug of silica, which was washed through with diethyl ether (200 mL).  The filtrate 
was  then  concentrated  in  vacuo  to  give  the  allylic  trichloroacetimidate 
intermediate  176  (0.066  g),  which  was  dissolved  in  toluene  (5  mL).    Potassium 
carbonate (0.015 g) was added, and the reaction mixture was degassed with argon 
for 5 min before being heated to 130 °C in a sealed Shlenck tube for 72 h.  The 
mixture  was  then  cooled  to  room  temperature  and  concentrated  in  vacuo.  
Purification  by  silica  column  chromatography  gave  (3E,5S)-5-methyl-1-phenyl-5-
(trichloromethylcarbonylamino)oct-3-ene 177 as a colourless oil (0.007 g, 11% over 
2 steps).  H (400 MHz, CDCl3)  0.92 (3H, t, J 7.5 Hz, 1-H3), 1.49 (2H, q, J 7.5 Hz, 2-
H2), 1.57 (3H, s, 4-CH3), 2.12–2.19 (2H, m, 3-H2), 2.37–2.48 (2H, m, 7-H2), 2.68–2.76 
(2H, m, 8-H2), 5.74 (1H, dt, J 15.8, 6.9 Hz, 6-H), 6.09 (1H, d, J 15.8 Hz, 5-H), 7.16–
7.32 (5H, m, 5 × ArH). 
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(2S)-2-(Benzyloxycarbonylamino)-6-hydroxyhexanoic acid
93 
HO
OH
O
NH
O
O
2
3
4
5
6
181  
A  stirred  suspension  of  N
2-(carbobenxyloxy)-L-lysine  180  (5.00  g,  17.8  mmol)  in 
water (35 mL) was heated to 60 °C and 4 M sodium hydroxide solution was added to 
adjust the solution to pH 10 before sodium nitroferricyanide(III) dihydrate (6.64 g, 
22.3 mmol) was added slowly.  The resulting dark brown solution was stirred at 
60  °C  for  7  h,  while  maintaining  the  reaction  mixture  between  pH  8–10  using 
regular additions of 4 M sodium hydroxide solution.  The mixture was then allowed 
to cool to room temperature and filtered through a pad of Celite
® and the filtrate 
was  acidified  to  pH  1  using  2  M  hydrochloric  acid.    The  organic  layers  were 
extracted  using  ethyl  acetate  (3  ×  150  mL),  which  were  then  combined,  dried 
(MgSO4),  filtered,  and  concentrated  in  vacuo  to  give  (2S)-2-
(benzyloxycarbonylamino)-6-hydroxyhexanoic  acid  181  as  a  green  oil  (5.29  g), 
which was used without further purification.  H (400 MHz, CDCl3) 1.40–1.90 (6H, m, 
3-H2, 4-H2 and 5-H2), 3.65 (2H, t, J 5.6 Hz, 6-H2), 4.38–4.44 (1H, m, 2-H), 5.11 (2H, 
s, OCH2C6H5), 5.44 (1H, d, J 8.0 Hz, NH), 7.30–7.37 (5H, m, 5 × ArH). 
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Methyl (2S)-2-(benzyloxycarbonylamino)-6-hydroxyhexanoate
130 
HO
OMe
O
NH
O
O
2
3
4
5
6
182  
Concentrated hydrochloric acid (3.8 mL) was added slowly to a stirred solution of 
(2S)-2-(benzyloxycarbonylamino)-6-hydroxyhexanoic acid 181 (5.29 g, 18.8 mmol) 
in toluene (130 mL) and methanol (95 mL).  The reaction mixture was heated to 
90 °C and stirred for 18 h before being allowed to cool to room temperature.  The 
mixture was then neutralised by the addition of a saturated aqueous solution of 
sodium hydrogen carbonate and the organic solvent was removed in vacuo.  The 
organic  layers  were  then  extracted  using  ethyl  acetate  (3  ×  150  mL)  and  the 
combined organic phases were dried (MgSO4), filtered, and concentrated in vacuo.  
Purification  was  carried  out  by  silica  column  chromatography,  and  elution  with 
ethyl  acetate  gave  methyl  (2S)-2-(benzyloxycarbonylamino)-6-hydroxyhexanoate 
182 as a yellow oil (2.80 g, 53% over 2 steps).  max/cm
-1 (NaCl) 3433 (NH/OH), 3019 
(CH), 2953 (CH), 1718 (CO), 1510, 1216, 1058, 755; []D
25 +12.5 (c 1.0, CHCl3); H 
(400 MHz, CDCl3) 1.38–1.88 (6H, m, 3-H2, 4-H2 and 5-H2), 3.63 (2H, t, J 6.4 Hz, 6-H2), 
3.74 (3H, s, OCH3), 4.36–4.42 (1H, m, 2-H), 5.11 (2H, s, OCH2C6H5), 5.33 (1H, d, J 
8.0 Hz, NH), 7.29–7.36 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 21.5 (CH2), 32.0 (CH2), 
32.5 (CH2), 52.4 (CH3), 53.7 (CH), 62.4 (CH2), 67.0 (CH2), 128.1 (CH), 128.2 (2 × CH), 
128.6 (2 × CH), 136.2 (C), 156.0 (C), 173.0 (C); m/z (EI) 295.1420 (M
+. C15H21NO5 
requires 295.1417), 263 (6%), 236 (66), 192 (89), 143 (19), 91 (100), 85 (32), 65 (17). 
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Methyl (2S)-2-(benzyloxycarbonylamino)-6-oxohexanoate 
O
H
O
O
NH
O
O
2
3
4
5
187  
 
A stirred solution of oxalyl chloride (0.055 mL, 0.65 mmol) in dichloromethane (2 
mL) was cooled to -78 °C, and dimethylsulfoxide (0.090 mL, 1.27 mmol) was added 
dropwise.  The mixture was stirred at -78 °C for 0.25 h and then a solution of (2S)-
2-(benzyloxycarbonylamino)-6-hydroxyhexanoate  182  (0.150  g,  0.51  mmol)  in 
dichloromethane (3 mL) was added.  The mixture was stirred at -78 °C for a further 
0.25  h  before  triethylamine  (0.355  mL,  2.55  mmol)  was  added.    The  reaction 
mixture was stirred at -78 °C for 1 h, and then at room temperature for 4 h before 
being concentrated in vacuo.  The residue was then dissolved in dichloromethane 
(50 mL) and washed with 1 M hydrochloric acid (50 mL) and water (50 mL).  The 
organic layer was then dried (MgSO4), filtered, and concentrated in vacuo to give 
methyl (2S)-2-(benzyloxycarbonylamino)-6-oxohexanoate 187 as a yellow oil (0.129 
g), which was used immediately without further purification.  H (400 MHz, CDCl3) 
1.64–1.73 (3H, m, 3-HH and 4-H2), 1.79–1.92 (1H, m, 3-HH), 2.42–2.53 (2H, m, 5-H2), 
3.75 (3H, s, OCH3), 4.35–4.43 (1H, m, 2-H), 5.11 (2H, s, CH2C6H5), 5.33 (1H, d, J 8.5 
Hz, NH), 7.30–7.38 (5H, m, 5 × ArH), 9.75 (1H, s, CHO). 
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1-Methyl 8-ethyl (2S)-2-(benzyloxycarbonylamino)oct-6-enedioate 
OMe
O
NH
O
O
EtO
O
2
3
4
5
6
7
188  
A suspension of oven-dried lithium chloride (0.054 g, 1.27 mmol) in acetonitrile (5 
mL) was stirred for 0.2 h before triethyl phosphonoacetate (0.255 mL, 1.29 mmol) 
was added, followed by 1,8-diazabicyclo[5.4.0]undec-7-ene (0.190 mL, 1.27 mmol).   
The mixture  was stirred  at room  temperature for 0.75  h before being  added to 
methyl  (2S)-2-(benzyloxycarbonylamino)-6-oxohexanoate  187  (0.129  g).    The 
reaction  mixture  was  then  stirred  at  room  temperature  for  20  h  before  being 
quenched by the addition of a saturated aqueous solution of ammonium chloride 
(20 mL).  The organic solvent was removed in vacuo and then water (50 mL) and 
ethyl acetate (100 mL) were added to the flask.  The layers were separated and the 
organic  layers  were  further  extracted  with  ethyl  acetate  (2  ×  50  mL).    The 
combined organic phases were then dried (MgSO4), filtered, and concentrated in 
vacuo.  Purification was carried out by silica column chromatography, and elution 
with  1:4  ethyl  acetate/petroleum  ether  gave  1-methyl  8-ethyl  (2S)-2-
(benzyloxycarbonylamino)oct-6-ene-dioate  188  as  a  colourless  oil  (0.086  g,  47% 
over 2 steps).  max/cm
-1 (neat) 3329 (NH), 2953 (CH), 1713 (CO), 1524, 1456, 1206, 
1043, 739; []D
25 +14.5 (c 1.0, CHCl3); H (400 MHz, CDCl3) 1.22 (3H, t, J 7.1 Hz, 
OCH2CH3), 1.36–1.52 (2H, m, 4-H2), 1.54–1.66 (1H, m, 3-HH), 1.73–1.87 (1H, m, 3-
HH), 2.07–2.23 (2H, m, 5-H2), 3.68 (3H, s, OCH3), 4.12 (2H, q, J 7.1 Hz, OCH2CH3), 
4.27–4.37 (1H, m, 2-H), 5.04 (2H, s, CH2C6H5), 5.22 (1H, d, J 7.8 Hz, NH), 5.74 (1H, 
d, J 15.6 Hz, 7-H), 6.83 (1H, dt, J 15.6, 7.0 Hz, 6-H), 7.22–7.33 (5H, m, 5 × ArH); C 
(100 MHz, CDCl3) 14.3 (CH3), 23.7 (CH2), 31.5 (CH2), 32.3 (CH2), 52.5 (CH3), 53.6 
(CH), 60.3 (CH2), 67.1 (CH2), 122.0 (CH), 128.2 (CH), 128.3 (2 × CH), 128.6 (2 × CH), 
136.2  (C),  147.9  (CH),  155.9  (C),  166.6  (C),  172.8  (C);  m/z  (CI)  364.1758  (MH
+. 
C19H26NO6 requires 364.1760), 363 (5%), 320 (16), 276 (5), 256 (12), 207 (56), 206 
(27), 191 (12), 151 (15), 83 (14).  
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Dimethyl (2S)-N-(tert-butoxycarbonyl)-2-aminobutane-1,4-dioate
101 
OMe
O
MeO
O HN
O
O
192  
A stirred suspension of L-aspartic acid 191 (3.00 g, 22.5 mmol) in methanol (60 mL) 
was cooled to 0 °C before chlorotrimethylsilane (12.6 mL, 99.2 mmol) was added 
dropwise.  The reaction mixture was stirred at 0 °C for 0.1 h and then at room 
temperature for 24 h before being cooled again to 0 °C.  Triethylamine (20.0 mL, 
143 mmol) was added slowly, followed by di-tert-butyl dicarbonate (5.40 g, 24.8 
mmol).  The reaction mixture was stirred at room temperature for a further 2 h 
before being concentrated in vacuo.  The residue was suspended in diethyl ether 
(100 mL) and filtered, and the filtrate was concentrated in vacuo.  Purification was 
carried  out  by  silica  column  chromatography,  and  elution  with  1:3  ethyl 
acetate/petroleum  ether  gave  dimethyl  (2S)-N-(tert-butoxycarbonyl)-2-
aminobutane-1,4-dioate 192 as a white solid (4.85 g, 82%).  Mp 62–65 °C; max/cm
-1 
(neat) 2980 (CH), 1738 (CO), 1701 (CO), 1501, 1346, 1215, 1157, 1032, 997, 783; 
[]D
25 +39.5 (c 1.0, CHCl3) (lit.
101 []D
25 +35.8 (c 1.0, CHCl3)); H (400 MHz, CDCl3) 
1.45 (9H, s, C(CH3)3), 2.83 (1H, dd, J 16.9, 4.5 Hz, 3-HH), 3.01 (1H, dd, J 16.9, 4.1 
Hz, 3-HH), 3.70 (3H, s, OCH3), 3.76 (3H, s, OCH3), 4.53–4.64 (1H, m, 2-H), 5.49 (1H, 
br d, J 7.3 Hz, NH); C (100 MHz, CDCl3) 28.3 (3 × CH3), 36.7 (CH2), 49.9 (CH), 52.1 
(CH3), 52.8 (CH3), 80.2 (C), 155.4 (C), 171.5 (C), 171.6 (C); m/z (CI) 262.1293 (MH
+. 
C11H20NO6 requires 262.1291), 206 (100%), 162 (29), 113 (7), 97 (6), 85 (14), 69 (16). 
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N-Benzylidenebenzenesulfonamide
131 
N
S
O O
202  
Benzenesulfonamide  201  (15.0  g,  95.4  mmol)  was  added  to  a  flask  containing 
Amberlyst 15 ion-exchange resin (0.190 g), 5 Å molecular sieves, and toluene (75 
mL).  Benzaldehyde (9.90 mL, 97.5 mmol) was added, and the reaction mixture was 
stirred under Dean-Stark condensation conditions for 27 h.  The mixture was then 
allowed to cool to room temperature without stirring, and filtered.  The filtrate 
was concentrated in vacuo, and pentane (80 mL) was added to the orange residue.  
The flask was cooled in the refrigerator overnight, upon which a precipitate formed, 
which was then separated by filtration and washed with pentane (2 × 20 mL).  The 
solid was then dissolved in ethyl acetate (10 mL) with heating and then pentane (30 
mL) was added slowly, upon which the solid product began to precipitate.  The 
suspension was allowed to stand for 2 h before being filtered, and the solid was 
washed  with  pentane  (30  mL)  and  air-dried  to  give  N-
benzylidenebenzenesulfonamide 202 as a pale brown solid (12.1 g, 52%).  Mp 70–
73 °C (lit.
131 Mp 76–80 °C); max/cm
-1 (neat) 3059 (CH), 1697, 1597, 1570, 1447, 
1312, 1155, 1088, 1001, 866, 748; H (400 MHz, CDCl3) 7.45–7.68 (6H, m, 6 × ArH), 
7.94  (2H,  d,  J  7.8  Hz,  2  ×  ArH),  8.02  (2H,  d,  J  7.3  Hz,  2  ×  ArH),  9.07  (1H,  s, 
CHC6H5); C (100 MHz, CDCl3) 128.0 (2 × CH), 129.1 (2 × CH), 129.2 (2 × CH), 131.4 
(2  ×  CH),  132.3  (C),  133.6  (CH),  135.1  (CH),  138.2  (C),  170.6  (CH);  m/z  (EI) 
245.0510 (M
+. C13H12NO2S requires 245.0511), 214 (8%), 181 (14), 141 (89), 104 (52), 
77 (100), 51 (32), 49 (26). 
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(±)-trans-2-(Phenylsulfonyl)-3-phenyloxaziridine
131 
N
O
S
O O
H
193  
N-Benzylidenebenzenesulfonamide  202  (9.84  g,  40.1  mmol)  was  dissolved  in 
chloroform  (30  mL),  and  a  saturated  aqueous  solution  of  sodium  hydrogen 
carbonate (40 mL) was added, followed by benzyl triethylammonium chloride (1.01 
g,  4.41  mmol).    The  mixture  was  cooled  to  0  °C,  then  a  solution  of  m-
chloroperoxybenzoic  acid  (7.61  g,  44.1  mmol)  in  chloroform  (80  mL)  was  added 
dropwise over 0.3 h and the reaction mixture was stirred at 0 °C for 1.5 h.  The 
mixture was allowed to warm to room temperature and then washed with water (70 
mL),  10%  aqueous  sodium  sulfite  solution  (100  mL),  water  (2  ×  70  mL)  and  a 
saturated  aqueous  solution  of  sodium  chloride  (30  mL)  before  being  dried  over 
anhydrous  potassium  carbonate  for  1.5  h,  filtered,  and  concentrated  in  vacuo 
(rotary evaporator water bath temperature maintained below 40 °C).  The white 
solid residue was then dissolved in minimal ethyl acetate (~80 mL), and the solution 
was  filtered  through  fluted  filter  paper.    Pentane  (40  mL)  was  added,  and  the 
solution was cooled in the refrigerator overnight, upon which a white precipitate 
formed.  The precipitate was collected by filtration, washed with pentane (20 mL) 
and air-dried for 1 h to give (±)-trans-2-(phenylsulfonyl)-3-phenyloxaziridine 193 as 
a white solid (4.15 g).  The filtrate was then partially concentrated in vacuo and 
cooled  in  the  refrigerator,  upon  which  a  yellow  precipitate  formed  which  was 
collected by filtration.  Diethyl ether (6 mL) was added to this solid, followed by 
pentane (8 mL), and the precipitate formed was collected by filtration and air-
dried to give a second batch of (±)-trans-2-(phenylsulfonyl)-3-phenyloxaziridine 193 
as  a  white  solid  (3.48  g,  73%  total  yield).    Mp  91–93  °C  (lit.
131  Mp  92–94  °C); 
max/cm
-1 (neat) 3354, 2513 (CH), 1906, 1447, 1348, 1233, 1167, 1086, 829, 760; H 
(400 MHz, CDCl3) 5.50 (1H, s, CHC6H5), 7.37–7.51 (5H, m, 5 × ArH), 7.64 (2H, t, J 7.9 
Hz, 2 × ArH), 7.76 (1H, t, J 7.2 Hz, ArH), 8.06 (2H, d, J 7.9 Hz, 2 × ArH); C (100 
MHz, CDCl3) 76.3 (CH), 128.3 (2 × CH), 128.8 (CH), 129.1 (CH), 129.4 (2 × CH), 129.5 
(CH), 129.8 (CH), 130.5 (C), 131.5 (CH), 134.7 (C), 135.1 (CH); m/z (CI) 262.0534  
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(MH
+. C13H12NO3S requires 262.0538), 246 (100%), 183 (5), 158 (39), 143 (21), 106 
(66), 85 (12), 71 (15). 
 
 
Dimethyl (2S,3R)-N-(tert-butoxycarbonyl)-2-amino-3-hydroxybutane-1,4-
dioate
132 
OMe
O
MeO
O HN
OH
O
O
2
3
anti-194  
A  stirred  solution  of  dimethyl  (2 S)-N-(tert-butoxycarbonyl)-2-aminobutane-1,4-
dioate  192  (0.460  g,  1.75  mmol)  and  (±)-trans-2-(phenylsulfonyl)-3-
phenyloxaziridine 193 (0.690 g, 2.64 mmol) in tetrahydrofuran (7 mL) was cooled to 
-78 °C before sodium bis(trimethylsilyl)amide solution (1.0 M in tetrahydrofuran, 
5.30 mL, 5.30 mmol) was added dropwise.  The reaction mixture was stirred at -
78  °C  for  24  h  before  being  quenched  by  the  addition  of  a  saturated  aqueous 
solution of ammonium chloride (20 mL).  The organic layers were extracted using 
diethyl ether (2 × 50 mL) and then dried (MgSO4), filtered, and concentrated in 
vacuo.  Purification was carried out by silica column chromatography, and elution 
with  7:13  ethyl  acetate/petroleum  ether  gave  dimethyl  (2S,3R)-N-(tert-
butoxycarbonyl)-2-amino-3-hydroxybutane-1,4-dioate  anti-194  as  a  colourless  oil 
(0.098 g, 20%).  max/cm
-1 (neat) 3370 (OH), 2957 (CH), 1708 (CO), 1508, 1364, 1221, 
1163, 1059, 1017, 723; []D
25 -33.9; H (400 MHz, CDCl3) 1.25 (1H, br s, OH), 1.43 
(9H, s, OC(CH3)3), 3.82 (3H, s, OCH3), 3.83 (3H, s, OCH3), 4.70 (1H, d, J 4.5 Hz, 3-H), 
4.79 (1H, d, J 8.8 Hz, 2-H), 5.28 (1H, br d, NH); C (100 MHz, CDCl3) 28.2 (3 × CH3), 
53.0 (CH3), 53.3 (CH3), 56.1 (CH), 71.0 (CH), 80.4 (C), 155.3 (C), 169.9 (C), 172.5 
(C); m/z (CI) 278 (MH
+, 8%), 246 (6), 222 (100), 220 (8), 178 (34), 158 (21), 123 (6), 
106 (7), 85 (11), 71 (12). 
Also  isolated  from  the  column  was  dimethyl  (2S,3S)-N-(tert-butoxycarbonyl)-2-
amino-3-hydroxybutane-1,4-dioate  syn-194  as  a  colourless  oil  (0.094  g,  19%).  
max/cm
-1 (neat) 2957 (CH), 1748 (CO), 1420, 1360, 1221, 1165, 1092, 1019, 723;  
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[]D
25 +3.7 (c 0.9, CHCl3); H (400 MHz, CDCl3) 1.25 (1H, br s, OH), 1.46 (9H, s, 
OC(CH3)3), 3.75 (3H, s, OCH3), 3.84 (3H, s, OCH3), 4.54 (1H, br s, 3-H), 4.86 (1H, d, 
J 7.7 Hz, 2-H), 5.52 (1H, br d, NH); C (100 MHz, CDCl3) 28.3 (3 × CH3), 52.8 (CH3), 
53.0 (CH3), 57.1 (CH), 72.2 (CH), 80.7 (C), 155.6 (C), 169.1 (C), 172.0 (C); m/z (CI) 
278 (MH
+, 4%), 262 (15), 222 (100), 204 (10), 178 (65), 158 (46), 122 (30), 71 (29). 
  
 
(R)-N-(tert-Butoxycarbonyl)-D-serine
133 
HO OH
O
NH
O
O
2
3
211  
A stirred solution of D-serine 129 (4.77 g, 45.4 mmol) in 1,4-dioxane (40 mL) and 
1.0 M aqueous sodium hydroxide solution (90 mL, 90.0 mmol) was cooled to 0 °C 
before  di-tert-butyl  dicarbonate  (11.9  g,  54.5  mmol)  was  added  slowly.    The 
reaction mixture was stirred at 0 °C for 0.25 h and then at room temperature for 6 
h  before  the  organic  solvent  was  removed  in  vacuo  (maintaining  water  bath 
temperature at 35 °C).  The remaining aqueous phase was acidified to pH 2 using 
2.5 M sulfuric acid, and the organic layers were extracted using ethyl acetate (3 × 
100  mL).    The  combined  organic  phases  were  then  dried  (MgSO4),  filtered,  and 
concentrated  in  vacuo  to  give  (R)-N-(tert-butoxycarbonyl)-D-serine  211  as  a 
colourless  oil  (11.28  g),  which  was  used  without  further  purification.    max/cm
-1 
(neat) 3021 (NH), 1707 (CO), 1506, 1420, 1215, 1167, 742; []D
23 -0.6 (c 1.0, CHCl3); 
H (400 MHz, CDCl3) 1.46 (9H, s, C(CH3)3), 3.86 (1H, d, J 11.1 Hz, 3-HH), 3.96–4.14 
(1H, m, 3-HH), 4.29–4.44 (1H, m, 2-H), 5.71 (1H, d, J 6.6 Hz, NH); C (100 MHz, 
CDCl3) 28.3 (3 × CH3), 55.4 (CH), 63.0 (CH2), 80.9 (C), 156.4 (C), 173.8 (C); m/z (CI) 
206.1029 (MH
+. C8H16NO5 requires 206.1028), 188 (9%), 150 (100), 132 (6), 106 (20), 
104 (6), 71 (8). 
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Methyl (2R)-2-tert-butoxycarbonylamino-3-hydroxypropionate
134 
O OH
O
NH
O
O
2
3
203  
A  stirred  solution  of  crude  (R)-N-(tert-butoxycarbonyl)-D-serine  211  (11.28  g)  in 
N,N-dimethylformamide (70 mL) was cooled to 0 °C before potassium carbonate 
(6.91 g, 50.0 mmol) was added, followed by methyl iodide (5.70 mL, 91.6 mmol).  
The reaction mixture was stirred at 0 °C for 0.2 h, and then at room temperature 
for 20 h before being concentrated in vacuo.  The residue was partitioned between 
water (100 mL) and ethyl acetate (100 mL) and the layers were separated.  The 
organic  layers  were  extracted  further  with  ethyl  acetate  (2  ×  100  mL)  and  the 
combined organic phases were dried (MgSO4), filtered, and concentrated in vacuo 
to  give  methyl  (2R)-2-tert-butoxycarbonylamino-3-hydroxypropionate  203  as  a 
yellow oil (10.73 g), which was used without further purification.   H (400 MHz, 
CDCl3) 1.46 (9H, s, C(CH3)3), 3.79 (3H, s, OCH3), 3.86–4.03 (2H, m, 3-H2), 4.34–4.44 
(1H, m, 2-H), 5.40–5.58 (1H, m, NH); C (100 MHz, CDCl3) 28.3 (3 × CH3), 52.7 (CH3), 
55.7  (CH),  63.7  (CH2),  80.4  (C),  155.8  (C),  171.2  (C);  m/z  (CI)  220.1187  (MH
+. 
C9H18NO5 requires 220.1185), 164 (100%), 146 (18), 120 (28), 107 (27), 85 (12), 73 
(18). 
 
 
Methyl  (2R)-2-tert-butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy] 
propionate
135 
O
O O
Si
NH
O
O
2
3
212  
To  a  stirred  solution  of  crude  methyl  (2R)-2-tert-butoxycarbonylamino-3-
hydroxypropionate  203  (10.73  g)  in  N,N-dimethylformamide  (70  mL),  imidazole  
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(4.33 g, 63.6 mmol) was added, followed by tert-butyldimethylsilyl chloride (8.30 g, 
55.1 mmol).  The reaction mixture was stirred at room temperature for 20 h before 
being concentrated in vacuo.  The residue was partitioned between water (100 mL) 
and ethyl acetate (150 mL), the layers were separated and the organic layers were 
further extracted with ethyl acetate (2 × 150 mL).  The combined organic phasess 
were  then  dried (MgSO4), filtered,  and  concentrated  in  vacuo.    Purification  was 
carried  out  by  silica  column  chromatography,  and  elution  with  1:19  ethyl 
acetate/petroleum  ether  gave  methyl  (2R)-2-tert-butoxycarbonylamino-3-[(tert-
butyldimethylsilyl)oxy]  propionate  212  as  a  colourless  oil  (11.29  g,  75%  over  3 
steps).   []D
23 -16.1 (c 1.0, CHCl3) (lit.
135 []D
23 -19.2 (c 1.34, CHCl3)); H (400 MHz, 
CDCl3) 0.02 (3H, s, SiCH3), 0.04 (3H, s, SiCH3), 0.86 (9H, s, SiC(CH3)3), 1.46 (9H, s, 
OC(CH3)3), 3.74 (3H, s, OCH3), 3.82 (1H, dd, J 10.0, 2.8 Hz, 3-HH), 4.05 (1H, dd, J 
10.0, 2.8 Hz, 3-HH), 4.36 (1H, dt, J 8.8 Hz, 2.8 Hz, 2-H), 5.35 (1H, d, J 8.8 Hz, NH); 
C (100 MHz, CDCl3) -5.6 (CH3), -5.5 (CH3), 18.2 (C), 25.7 (3 × CH3), 28.4 (3 × CH3), 
52.3 (CH3), 55.6 (CH), 63.8 (CH2), 79.9 (C), 155.5 (C), 171.3 (C); m/z (CI) 334.2051 
(MH
+. C15H32NO5Si requires 334.2050), 278 (100%), 220 (17), 85 (6), 69 (7). 
 
 
(2S)-2-tert-Butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy] propan-1-ol 
HO O
Si
NH
O
O
1
2
3
204  
A  stirred  solution  of  methyl  (2R)-2-tert-butoxycarbonylamino-3-[(tert-
butyldimethylsilyl)oxy] propionate 212 (1.45 g, 4.35 mmol) in diethyl ether (30 mL) 
was cooled to -78 °C before diisobutylaluminium hydride solution (1.0 M in hexanes, 
9.50 mL, 9.50 mmol) was added dropwise.  The reaction mixture was stirred at -
78 °C for 1 h and then at room temperature for 18 h before being quenched by the 
addition of a saturated aqueous solution of ammonium chloride (5 mL) at 0 °C.  The 
mixture was stirred at 0 °C for 0.5 h and then at room temperature for 0.5 h before 
being filtered through a pad of Celite
® and washed with diethyl ether (200 mL).  
The filtrate was washed with water (3 × 50 mL) and then dried (MgSO4), filtered,  
 
173 
and  concentrated  in  vacuo.    Purification  was  carried  out  by  silica  column 
chromatography, and elution with 3:17 ethyl acetate/petroleum ether gave (2S)-2-
tert-butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy]-propan-1-ol  204  as  a 
colourless oil (0.615 g, 46%).  max/cm
-1 (neat) 3449 (OH), 2930 (CH), 1692 (CO), 
1501, 1366, 1252, 1169, 1051, 833, 775; []D
23 -9.8 (c 1.0, CHCl3); H (400 MHz, 
CDCl3) 0.08 (6H, s, 2 × SiCH3), 0.90 (9H, s, SiC(CH3)3), 1.45 (9H, s, OC(CH3)3), 2.58–
2.80 (1H, br s, OH), 3.62–3.72 (2H, m, 2-H and 3-HH), 3.77–3.90 (3H, m, 3-HH and 
1-H2); C (100 MHz, CDCl3) -5.6 (2 × CH3), 18.2 (C), 25.8 (3 × CH3), 28.4 (3 × CH3), 
52.5 (CH), 64.2 (2 × CH2), 79.6 (C), 156.0 (C); m/z (CI) 306.2097 (MH
+. C14H32NO4Si 
requires 306.2101), 301 (11%), 250 (26), 232 (16), 196 (8), 195 (5), 169 (5), 155 (6), 
127 (8), 113 (31), 85 (63), 73 (100). 
 
 
(2S)-2-tert-Butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy] propan-1-al 
O
H
O
Si
NH
O
O
2
3
213  
A stirred solution of oxalyl chloride (0.69 mL, 8.18 mmol) in dichloromethane (50 
mL) was cooled to -78 °C before dimethylsulfoxide (1.16 mL, 16.4 mmol) was added 
dropwise.  The reaction mixture was stirred at -78 °C for 0.25 h and then a solution 
of (2S)-2-tert-butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy] propan-1-ol 204 
(2.08 g, 6.82 mmol) in dichloromethane (20 mL) was slowly added.  The reaction 
was stirred at -78 °C for 0.5 h and then triethylamine (4.75 mL, 34.1 mmol) was 
added.  The reaction mixture was stirred again at -78 °C for 0.5 h and then at room 
temperature for 6 h before being concentrated in vacuo to give crude (2S)-2-tert-
butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy]  propan-1-al  213  as  a  yellow 
residue, which was used without further purification. 
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Ethyl (2E,4S)-4-tert-butoxycarbonylamino-5-[(tert-butyldimethylsilyl)oxy] pent-
2-enoate
136 
EtO O
Si
NH
O
O
O
2
3
4
5
205  
To  a  stirred  suspension  of  oven-dried  lithium  chloride  (0.723  g,  17.0  mmol)  in 
acetonitrile (70 mL), 1,8-diazabicyclo[5.4.0]undec-7-ene (2.55 mL, 17.0 mmol) was 
added, followed by triethyl phosphonoacetate (3.40 mL, 17.0 mmol).  The mixture 
was stirred at room temperature for 1 h before being added to the crude aldehyde, 
(2S)-2-tert-butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy]  propan-1-al  213.  
The reaction mixture was then stirred at room temperature for 24 h before being 
quenched by the addition of a saturated aqueous solution of ammonium chloride 
(30 mL).  The organic solvent was removed in vacuo, and the organic layers were 
extracted using ethyl acetate (3 × 150 mL).  The combined organic phases were 
then dried (MgSO4), filtered, and concentrated in vacuo.  Purification was carried 
out  by  silica  column  chromatography,  and  elution  with  1:19  ethyl 
acetate/petroleum  ether  gave  ethyl  (2E,4S)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy] pent-2-enoate 205 as a colourless oil (1.94 g, 76%).  []D
23 
+3.0 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.04 (3H, s, SiCH3), 0.05 (3H, s, SiCH3), 0.88 
(9H, s, SiC(CH3)3), 1.28 (3H, t, J 7.1 Hz, OCH2CH3), 1.45 (9H, s, OC(CH3)3), 3.66–3.76 
(2H, m, 5-H2), 4.19 (2H, q, J 7.1 Hz, OCH2CH3), 4.31–4.42 (1H, m, 4-H), 4.92 (1H, d, 
J 6.8 Hz, NH), 5.96 (1H, dd, J 15.7, 1.8 Hz, 2-H), 6.91 (1H, dd, J 15.7, 5.2 Hz, 3-H); 
C (100 MHz, CDCl3) -5.4 (2 × CH3), 14.2 (CH3), 18.3 (C), 25.8 (3 × CH3), 28.2 (C), 
28.4 (3 × CH3), 60.4 (CH2), 64.7 (CH2), 77.2 (CH), 122.0 (CH), 146.4 (CH), 155.2 (C), 
166.2 (C); m/z (CI) 374.2367 (MH
+. C18H36NO5Si requires 374.2363), 319 (100%), 257 
(12), 118 (7), 85 (8), 69 (10). 
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(2E,4S)-4-tert-Butoxycarbonylamino-5-[(tert-butyldimethylsilyl)oxy]  pent-2-en-
1-ol 
HO O
Si
NH
O
O
1
2
3
4
5
206  
 
A  stirred  solution  of  ethyl  (2E,4S)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy] pent-2-enoate 205 (3.19 g, 8.54 mmol) in dichloromethane 
(100 mL) was cooled to -78 °C before boron trifluoride diethyl etherate (2.00 mL, 
11.6 mmol) was added dropwise.  The mixture was stirred at -78 °C for 0.5 h before 
diisobutylaluminium hydride solution (1.0 M in hexanes, 25.5 mL, 25.5 mmol) was 
added dropwise.  The reaction mixture was then stirred at -78 °C for 3 h before 
being quenched by the addition of 5.0 M acetic acid solution in dichloromethane (30 
mL).  The mixture was poured into 10% aqueous tartaric acid solution (100 mL), and 
the  organic  layers  were  extracted  using  dichloromethane  (2  ×  200  mL).    The 
combined organic phases were washed with a saturated aqueous solution of sodium 
hydrogen  carbonate  (150  mL)  before  being  dried  (MgSO4),  filtered,  and 
concentrated  in  vacuo.    Purification  was  carried  out  by  silica  column 
chromatography, and elution with 1:3 ethyl acetate/petroleum ether gave (2E,4S)-
4-tert-butoxycarbonylamino-5-[(tert-butyldimethylsilyl)oxy] pent-2-en-1-ol 206 as a 
colourless oil (2.20 g, 78%).  max/cm
-1 (neat) 3451 (OH), 2930 (CH), 1701 (CO), 1499, 
1368,  1254,  1171,  1111,  909,  837,  733; []D
21 +2.8 (c 1.0,  CHCl3); H (400 MHz, 
CDCl3) 0.04 (3H, s, SiCH3), 0.05 (3H, s, SiCH3), 0.89 (9H, s, SiC(CH3)3), 1.45 (9H, s, 
OC(CH3)3), 3.61 (1H, dd, J 10.0, 4.2 Hz, 5-HH), 3.69 (1H, dd, J 10.0, 4.4 Hz, 5-HH), 
4.16 (2H, dt, J 5.3, 1.3 Hz, 1-H2), 4.17–4.24 (1H, m, 4-H), 4.76–4.93 (1H, br, NH), 
5.71 (1H, ddt, J 15.6, 5.7, 1.3 Hz, 3-H), 5.84 (1H, dtd, J 15.6, 5.3, 1.3 Hz, 2-H); C 
(100 MHz, CDCl3) -5.4 (CH3), -5.4 (CH3), 18.3 (C), 25.9 (3 × CH3), 28.4 (3 × CH3), 
63.1 (CH2), 65.4 (CH2), 77.2 (CH), 79.4 (C), 130.0 (CH), 130.5 (CH), 155.4 (C); m/z 
(CI) 332.2253 (MH
+. C16H34NO4Si requires 332.2257), 314 (6%), 277 (100), 259 (23), 
225 (16), 213 (24), 159 (7), 133 (10), 113 (21), 81 (52), 69 (77).  
 
176 
(3R,4S)-3-(trichloromethylcarbonylamino)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy]  pent-1-ene  and  (3S,4S)-3-
(trichloromethylcarbonylamino)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy] pent-1-ene
41 
O
NH
Si
O
O
NH
CCl3
O
1
2
3
4
5
O
NH
Si
O
O
NH
CCl3
O
1
2
3
4
5
+
syn-207 anti-207  
The  trichloroacetimidate  formation  reaction  was  set  up  according  to  general 
procedure  4,  using  (2E,4S)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy]-pent-2-en-1-ol  206  (0.100  g,  0.30  mmol),  1,8-
diazabicyclo[5.4.0]undec-7-ene  (0.023  mL,  0.15  mmol)  and  trichloroacetonitrile 
(0.045 mL, 0.45 mmol) in dichloromethane (4 mL), stirring at room temperature for 
5 h to give the desired allylic trichloroacetimidate intermediate 214 (0.138 g).  H 
(400 MHz, CDCl3) 0.04 (3H, s, SiCH3), 0.05 (3H, s, SiCH3), 0.88 (9H, s, SiC(CH3)3), 
1.45 (9H, s, OC(CH3)3), 3.61–3.73 (2H, m, 5-H2), 4.12–4.32 (1H, m, 4-H), 4.75–4.93 
(3H, m, 1-H2 and NH), 5.82–5.90 (2H, m, 2-H and 3-H), 8.30 (1H, s, NH).  This was 
then dissolved in dichloromethane (5 mL), and (S)-(+)-COP-Cl (0.013 g, 0.01 mmol) 
was added.  The reaction mixture was heated to 38 °C and stirred under reflux for 
46 h before further (S)-(+)-COP-Cl (0.013 g, 0.01 mmol) was added.  The reaction 
was stirred at 38 °C for 44 h before a final addition of (S)-(+)-COP-Cl (0.009 g, 0.006 
mmol) was added.  The reaction was stirred at 38 °C for a further 71 h before being 
filtered through a pad of Celite
®, which was washed through with diethyl ether (50 
mL).  The filtrate was concentrated in vacuo, and purification was carried out by 
silica  column  chromatography.    Elution  with  3:37  diethyl  ether/petroleum  ether 
gave  (3R,4S)-3-(trichloromethylcarbonylamino)-4-tert-butoxycarbonylamino-5-
[(tert-butyldimethylsilyl)oxy]-pent-1-ene  and  (3S,4S)-3-
(trichloromethylcarbonylamino)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy]-pent-1-ene 207 (0.109 g, 76% total yield over 2 steps).  
1H  
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NMR  spectroscopic  analysis  prior  to  purification  indicated  approximately  4.7:1 
(3S,4S):(3R,4S) ratio of product diastereoisomers. 
(3S,4S)-diastereoisomer (anti-207):
41 
Mp 83–87 °C; max/cm
-1 (neat) 3347 (NH), 2930 (CH), 1697 (CO), 1684 (CO), 1514, 
1252, 1169, 1096, 1055, 833; []D
21 +4.0 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.11 (6H, 
s, 2 × SiCH3), 0.91 (9H, s, SiC(CH3)3), 1.45 (9H, s, OC(CH3)3), 3.74 (1H, dd, J 10.1, 
3.8 Hz, 5-HH), 3.82–3.94 (2H, m, 4-H and 5-HH), 4.65–4.74 (1H, m, 3-H), 4.95 (1H, 
br d, J 7.4 Hz, NH), 5.26–5.35 (2H, m, 1-H2), 5.81 (1H, ddd, J 17.2, 10.5, 5.2 Hz, 2-
H), 8.24 (1H, br d, J 7.2 Hz, NH); C (100 MHz, CDCl3) -5.4 (CH3), -5.3 (CH3), 18.5 
(C), 26.0 (3 × CH3), 28.3 (3 × CH3), 53.0 (CH), 56.6 (CH), 63.4 (CH2), 80.4 (C), 92.9 
(C),  117.3  (CH2),  133.1  (CH),  156.0  (C),  161.8  (C);  m/z  (CI)  475.1346  (MH
+. 
C19H34
35Cl3N2O4Si requires 475.1353) 421 (100%), 419 (96), 385 (37), 375 (30), 341 
(15), 274 (13), 218 (32), 174 (12), 133 (8), 85 (15). 
(3R,4S)-diastereoisomer (syn-207): 
Mp 97–102 °C; max/cm
-1 (neat) 3325 (NH), 2930 (CH), 1688 (CO), 1530, 1366, 1250, 
1165, 1115, 1055, 831, 775; []D
25 +2.3 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.07 (3H, 
s, SiCH3), 0.08 (3H, s, SiCH3), 0.92 (9H, s, SiC(CH3)3), 1.44 (9H, s, OC(CH3)3), 3.66–
3.75 (2H, m, 4-H and 5-HH), 3.80 (1H, dd, J 9.9, 2.5 Hz, 5-HH), 4.45 (1H, dt, J 9.1, 
7.6 Hz, 3-H), 5.11 (1H, br d, J 7.6 Hz, NH), 5.32 (1H, d, J 10.2 Hz, 1-HH), 5.41 (1H, 
d, J 17.1 Hz, 1-HH), 5.69 (1H, ddd, J 17.1, 10.2, 7.5 Hz, 2-H), 7.95 (1H, br d, J 6.2 
Hz, NH); C (100 MHz, CDCl3) -5.3 (2 × CH3), 18.4 (C), 26.0 (3 × CH3), 28.6 (3 × CH3), 
54.2 (CH), 57.1 (CH), 62.2 (CH2), 80.7 (C), 92.7 (C), 119.8 (CH2), 133.5 (CH), 157.2 
(C), 162.0 (C); m/z (CI) 475.1370 (MH
+. C18H34
35Cl3N2O4Si requires 475.1353), 419 
(100%), 421 (97), 377 (69), 375 (67), 341 (18), 274 (21), 218 (59), 174 (44), 133 (50), 
69 (23). 
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